id	sid	tid	token	lemma	pos
iajs-2137	1	1	83	83	NUM
iajs-2137	1	2	ibn	ibn	PROPN
iajs-2137	1	3	al	al	PROPN
iajs-2137	1	4	-	-	PUNCT
iajs-2137	1	5	haitham	haitham	PROPN
iajs-2137	1	6	jour	jour	X
iajs-2137	1	7	.	.	PROPN
iajs-2137	1	8	for	for	ADP
iajs-2137	1	9	pure	pure	ADJ
iajs-2137	1	10	&	&	CCONJ
iajs-2137	1	11	appl	appl	PROPN
iajs-2137	1	12	.	.	PUNCT
iajs-2137	2	1	sci	sci	PROPN
iajs-2137	2	2	.	.	PROPN
iajs-2137	2	3	32	32	NUM
iajs-2137	2	4	(	(	PUNCT
iajs-2137	2	5	2	2	NUM
iajs-2137	2	6	)	)	PUNCT
iajs-2137	2	7	2019	2019	NUM
iajs-2137	2	8	abstract	abstract	NOUN
iajs-2137	2	9	the	the	DET
iajs-2137	2	10	present	present	ADJ
iajs-2137	2	11	study	study	NOUN
iajs-2137	2	12	was	be	AUX
iajs-2137	2	13	included	include	VERB
iajs-2137	2	14	a	a	DET
iajs-2137	2	15	measurements	measurement	NOUN
iajs-2137	2	16	of	of	ADP
iajs-2137	2	17	fasting	fast	VERB
iajs-2137	2	18	serum	serum	NOUN
iajs-2137	2	19	glucose	glucose	NOUN
iajs-2137	2	20	,	,	PUNCT
iajs-2137	2	21	total	total	ADJ
iajs-2137	2	22	protein	protein	NOUN
iajs-2137	2	23	,	,	PUNCT
iajs-2137	2	24	potassium	potassium	NOUN
iajs-2137	2	25	,	,	PUNCT
iajs-2137	2	26	and	and	CCONJ
iajs-2137	2	27	calcium	calcium	NOUN
iajs-2137	2	28	levels	level	NOUN
iajs-2137	2	29	in	in	ADP
iajs-2137	2	30	the	the	DET
iajs-2137	2	31	sera	sera	NOUN
iajs-2137	2	32	of	of	ADP
iajs-2137	2	33	25	25	NUM
iajs-2137	2	34	diabetic	diabetic	ADJ
iajs-2137	2	35	male	male	ADJ
iajs-2137	2	36	patients	patient	NOUN
iajs-2137	2	37	suffer	suffer	VERB
iajs-2137	2	38	from	from	ADP
iajs-2137	2	39	chronic	chronic	ADJ
iajs-2137	2	40	renal	renal	ADJ
iajs-2137	2	41	failure	failure	NOUN
iajs-2137	2	42	;	;	PUNCT
iajs-2137	2	43	their	their	PRON
iajs-2137	2	44	ages	age	NOUN
iajs-2137	2	45	range	range	VERB
iajs-2137	2	46	were	be	AUX
iajs-2137	2	47	(	(	PUNCT
iajs-2137	2	48	32	32	NUM
iajs-2137	2	49	-	-	SYM
iajs-2137	2	50	75	75	NUM
iajs-2137	2	51	)	)	PUNCT
iajs-2137	2	52	and	and	CCONJ
iajs-2137	2	53	compared	compare	VERB
iajs-2137	2	54	them	they	PRON
iajs-2137	2	55	with	with	ADP
iajs-2137	2	56	25	25	NUM
iajs-2137	2	57	healthy	healthy	ADJ
iajs-2137	2	58	males	male	NOUN
iajs-2137	2	59	as	as	ADP
iajs-2137	2	60	control	control	NOUN
iajs-2137	2	61	group	group	NOUN
iajs-2137	2	62	.	.	PUNCT
iajs-2137	3	1	the	the	DET
iajs-2137	3	2	aim	aim	NOUN
iajs-2137	3	3	of	of	ADP
iajs-2137	3	4	this	this	DET
iajs-2137	3	5	study	study	NOUN
iajs-2137	3	6	was	be	AUX
iajs-2137	3	7	to	to	PART
iajs-2137	3	8	study	study	VERB
iajs-2137	3	9	the	the	DET
iajs-2137	3	10	effects	effect	NOUN
iajs-2137	3	11	of	of	ADP
iajs-2137	3	12	antidiabetic	antidiabetic	ADJ
iajs-2137	3	13	drugs	drug	NOUN
iajs-2137	3	14	on	on	ADP
iajs-2137	3	15	some	some	DET
iajs-2137	3	16	biochemical	biochemical	ADJ
iajs-2137	3	17	parameters	parameter	NOUN
iajs-2137	3	18	such	such	ADJ
iajs-2137	3	19	as	as	ADP
iajs-2137	3	20	fasting	fast	VERB
iajs-2137	3	21	serum	serum	NOUN
iajs-2137	3	22	glucose	glucose	NOUN
iajs-2137	3	23	,	,	PUNCT
iajs-2137	3	24	serum	serum	NOUN
iajs-2137	3	25	total	total	ADJ
iajs-2137	3	26	protein	protein	NOUN
iajs-2137	3	27	,	,	PUNCT
iajs-2137	3	28	serum	serum	NOUN
iajs-2137	3	29	potassium	potassium	NOUN
iajs-2137	3	30	and	and	CCONJ
iajs-2137	3	31	calcium	calcium	NOUN
iajs-2137	3	32	.	.	PUNCT
iajs-2137	4	1	the	the	DET
iajs-2137	4	2	current	current	ADJ
iajs-2137	4	3	results	result	NOUN
iajs-2137	4	4	demonstrated	demonstrate	VERB
iajs-2137	4	5	a	a	DET
iajs-2137	4	6	hyperkalemia	hyperkalemia	NOUN
iajs-2137	4	7	in	in	ADP
iajs-2137	4	8	patients	patient	NOUN
iajs-2137	4	9	and	and	CCONJ
iajs-2137	4	10	this	this	DET
iajs-2137	4	11	increasing	increase	VERB
iajs-2137	4	12	of	of	ADP
iajs-2137	4	13	potassium	potassium	NOUN
iajs-2137	4	14	is	be	AUX
iajs-2137	4	15	significantly	significantly	ADV
iajs-2137	4	16	(	(	PUNCT
iajs-2137	4	17	p	p	X
iajs-2137	4	18	=	=	NOUN
iajs-2137	4	19	0.03	0.03	NUM
iajs-2137	4	20	)	)	PUNCT
iajs-2137	4	21	,	,	PUNCT
iajs-2137	4	22	but	but	CCONJ
iajs-2137	4	23	calcium	calcium	NOUN
iajs-2137	4	24	level	level	NOUN
iajs-2137	4	25	showed	show	VERB
iajs-2137	4	26	no	no	DET
iajs-2137	4	27	significant	significant	ADJ
iajs-2137	4	28	variations	variation	NOUN
iajs-2137	4	29	(	(	PUNCT
iajs-2137	4	30	p>0.05	p>0.05	NOUN
iajs-2137	4	31	)	)	PUNCT
iajs-2137	4	32	,	,	PUNCT
iajs-2137	4	33	and	and	CCONJ
iajs-2137	4	34	serum	serum	NOUN
iajs-2137	4	35	total	total	ADJ
iajs-2137	4	36	protein	protein	NOUN
iajs-2137	4	37	was	be	AUX
iajs-2137	4	38	significantly	significantly	ADV
iajs-2137	4	39	decreased	decrease	VERB
iajs-2137	4	40	in	in	ADP
iajs-2137	4	41	patients	patient	NOUN
iajs-2137	4	42	as	as	SCONJ
iajs-2137	4	43	compared	compare	VERB
iajs-2137	4	44	to	to	ADP
iajs-2137	4	45	the	the	DET
iajs-2137	4	46	controls	control	NOUN
iajs-2137	4	47	(	(	PUNCT
iajs-2137	4	48	p	p	X
iajs-2137	4	49	=	=	NOUN
iajs-2137	4	50	0.0002	0.0002	NUM
iajs-2137	4	51	)	)	PUNCT
iajs-2137	4	52	.	.	PUNCT
iajs-2137	5	1	keywords	keyword	NOUN
iajs-2137	5	2	:	:	PUNCT
iajs-2137	5	3	metformin	metformin	NOUN
iajs-2137	5	4	,	,	PUNCT
iajs-2137	5	5	glimeperide	glimeperide	NOUN
iajs-2137	5	6	,	,	PUNCT
iajs-2137	5	7	chronic	chronic	ADJ
iajs-2137	5	8	renal	renal	ADJ
iajs-2137	5	9	failure	failure	NOUN
iajs-2137	5	10	,	,	PUNCT
iajs-2137	5	11	diabetes	diabetes	NOUN
iajs-2137	5	12	mellitus	mellitus	NOUN
iajs-2137	5	13	.	.	PUNCT
iajs-2137	6	1	1	1	X
iajs-2137	6	2	.	.	X
iajs-2137	6	3	introduction	introduction	NOUN
iajs-2137	6	4	diabetes	diabetes	NOUN
iajs-2137	6	5	mellitus	mellitus	NOUN
iajs-2137	6	6	was	be	AUX
iajs-2137	6	7	considered	consider	VERB
iajs-2137	6	8	a	a	DET
iajs-2137	6	9	disease	disease	NOUN
iajs-2137	6	10	which	which	PRON
iajs-2137	6	11	is	be	AUX
iajs-2137	6	12	chronic	chronic	ADJ
iajs-2137	6	13	progressive	progressive	ADJ
iajs-2137	6	14	,	,	PUNCT
iajs-2137	6	15	could	could	AUX
iajs-2137	6	16	be	be	AUX
iajs-2137	6	17	diagnostics	diagnostic	NOUN
iajs-2137	6	18	by	by	ADP
iajs-2137	6	19	control	control	NOUN
iajs-2137	6	20	losing	losing	NOUN
iajs-2137	6	21	of	of	ADP
iajs-2137	6	22	glycaemic	glycaemic	NOUN
iajs-2137	6	23	over	over	ADP
iajs-2137	6	24	time	time	NOUN
iajs-2137	6	25	as	as	ADP
iajs-2137	6	26	the	the	DET
iajs-2137	6	27	lose	lose	ADJ
iajs-2137	6	28	capacity	capacity	NOUN
iajs-2137	6	29	of	of	ADP
iajs-2137	6	30	insulin	insulin	NOUN
iajs-2137	6	31	-	-	PUNCT
iajs-2137	6	32	secreting	secrete	VERB
iajs-2137	6	33	pancreatic	pancreatic	ADJ
iajs-2137	6	34	β	β	NOUN
iajs-2137	6	35	-	-	NOUN
iajs-2137	6	36	cells	cell	NOUN
iajs-2137	6	37	to	to	PART
iajs-2137	6	38	amende	amende	VERB
iajs-2137	6	39	for	for	ADP
iajs-2137	6	40	the	the	DET
iajs-2137	6	41	predominant	predominant	ADJ
iajs-2137	6	42	levels	level	NOUN
iajs-2137	6	43	of	of	ADP
iajs-2137	6	44	insulin	insulin	NOUN
iajs-2137	6	45	sensitivity	sensitivity	NOUN
iajs-2137	6	46	[	[	X
iajs-2137	6	47	1	1	NUM
iajs-2137	6	48	]	]	PUNCT
iajs-2137	6	49	.	.	PUNCT
iajs-2137	7	1	there	there	PRON
iajs-2137	7	2	are	be	VERB
iajs-2137	7	3	numbers	number	NOUN
iajs-2137	7	4	of	of	ADP
iajs-2137	7	5	disorders	disorder	NOUN
iajs-2137	7	6	or	or	CCONJ
iajs-2137	7	7	diseases	disease	NOUN
iajs-2137	7	8	could	could	AUX
iajs-2137	7	9	cause	cause	VERB
iajs-2137	7	10	chronic	chronic	ADJ
iajs-2137	7	11	kidney	kidney	NOUN
iajs-2137	7	12	diseases	disease	NOUN
iajs-2137	7	13	,	,	PUNCT
iajs-2137	7	14	that	that	DET
iajs-2137	7	15	effect	effect	NOUN
iajs-2137	7	16	on	on	ADP
iajs-2137	7	17	blood	blood	NOUN
iajs-2137	7	18	delivery	delivery	NOUN
iajs-2137	7	19	to	to	ADP
iajs-2137	7	20	the	the	DET
iajs-2137	7	21	kidneys	kidney	NOUN
iajs-2137	7	22	via	via	ADP
iajs-2137	7	23	renal	renal	ADJ
iajs-2137	7	24	arteries	artery	NOUN
iajs-2137	7	25	.	.	PUNCT
iajs-2137	8	1	one	one	NUM
iajs-2137	8	2	of	of	ADP
iajs-2137	8	3	these	these	DET
iajs-2137	8	4	diseases	disease	NOUN
iajs-2137	8	5	that	that	SCONJ
iajs-2137	8	6	causing	cause	VERB
iajs-2137	8	7	kidney	kidney	NOUN
iajs-2137	8	8	disease	disease	NOUN
iajs-2137	8	9	and	and	CCONJ
iajs-2137	8	10	risk	risk	NOUN
iajs-2137	8	11	on	on	ADP
iajs-2137	8	12	microvascular	microvascular	NOUN
iajs-2137	8	13	is	be	AUX
iajs-2137	8	14	diabetes	diabetes	NOUN
iajs-2137	8	15	mellitus	mellitus	NOUN
iajs-2137	8	16	[	[	X
iajs-2137	8	17	2	2	NUM
iajs-2137	8	18	]	]	PUNCT
iajs-2137	8	19	.	.	PUNCT
iajs-2137	9	1	and	and	CCONJ
iajs-2137	9	2	this	this	DET
iajs-2137	9	3	risk	risk	NOUN
iajs-2137	9	4	increased	increase	VERB
iajs-2137	9	5	with	with	ADP
iajs-2137	9	6	glucose	glucose	NOUN
iajs-2137	9	7	abnormalities	abnormality	NOUN
iajs-2137	9	8	[	[	X
iajs-2137	9	9	3	3	NUM
iajs-2137	9	10	]	]	PUNCT
iajs-2137	9	11	.	.	PUNCT
iajs-2137	10	1	the	the	DET
iajs-2137	10	2	volume	volume	NOUN
iajs-2137	10	3	and	and	CCONJ
iajs-2137	10	4	composition	composition	NOUN
iajs-2137	10	5	of	of	ADP
iajs-2137	10	6	body	body	NOUN
iajs-2137	10	7	fluids	fluid	NOUN
iajs-2137	10	8	are	be	AUX
iajs-2137	10	9	tightly	tightly	ADV
iajs-2137	10	10	regulated	regulate	VERB
iajs-2137	10	11	by	by	ADP
iajs-2137	10	12	kidney	kidney	NOUN
iajs-2137	10	13	,	,	PUNCT
iajs-2137	10	14	and	and	CCONJ
iajs-2137	10	15	the	the	DET
iajs-2137	10	16	kidneys	kidney	NOUN
iajs-2137	10	17	are	be	AUX
iajs-2137	10	18	largely	largely	ADV
iajs-2137	10	19	responsible	responsible	ADJ
iajs-2137	10	20	for	for	ADP
iajs-2137	10	21	maintaining	maintain	VERB
iajs-2137	10	22	regulatory	regulatory	ADJ
iajs-2137	10	23	or	or	CCONJ
iajs-2137	10	24	homeostasis	homeostasis	NOUN
iajs-2137	10	25	of	of	ADP
iajs-2137	10	26	electrolytes	electrolyte	NOUN
iajs-2137	10	27	and	and	CCONJ
iajs-2137	10	28	fluids	fluid	NOUN
iajs-2137	10	29	in	in	ADP
iajs-2137	10	30	the	the	DET
iajs-2137	10	31	body	body	NOUN
iajs-2137	11	1	[	[	X
iajs-2137	11	2	4	4	NUM
iajs-2137	11	3	]	]	PUNCT
iajs-2137	11	4	.	.	PUNCT
iajs-2137	12	1	renal	renal	ADJ
iajs-2137	12	2	failure	failure	NOUN
iajs-2137	12	3	is	be	AUX
iajs-2137	12	4	described	describe	VERB
iajs-2137	12	5	a	a	DET
iajs-2137	12	6	reduction	reduction	NOUN
iajs-2137	12	7	of	of	ADP
iajs-2137	12	8	glomerular	glomerular	ADJ
iajs-2137	12	9	filtration	filtration	NOUN
iajs-2137	12	10	rate	rate	NOUN
iajs-2137	12	11	,	,	PUNCT
iajs-2137	12	12	it	it	PRON
iajs-2137	12	13	can	can	AUX
iajs-2137	12	14	occur	occur	VERB
iajs-2137	12	15	abruptly	abruptly	ADV
iajs-2137	12	16	as	as	ADP
iajs-2137	12	17	an	an	DET
iajs-2137	12	18	acute	acute	ADJ
iajs-2137	12	19	renal	renal	ADJ
iajs-2137	12	20	failure	failure	NOUN
iajs-2137	12	21	or	or	CCONJ
iajs-2137	12	22	it	it	PRON
iajs-2137	12	23	occurs	occur	VERB
iajs-2137	12	24	unexpected	unexpected	ADJ
iajs-2137	12	25	rate	rate	NOUN
iajs-2137	12	26	and	and	CCONJ
iajs-2137	12	27	a	a	DET
iajs-2137	12	28	variable	variable	NOUN
iajs-2137	12	29	[	[	X
iajs-2137	12	30	5	5	NUM
iajs-2137	12	31	,	,	PUNCT
iajs-2137	12	32	6	6	NUM
iajs-2137	12	33	]	]	PUNCT
iajs-2137	12	34	.	.	PUNCT
iajs-2137	13	1	ca	can	AUX
iajs-2137	13	2	+2	+2	PROPN
iajs-2137	13	3	is	be	AUX
iajs-2137	13	4	formalizes	formalize	VERB
iajs-2137	13	5	the	the	DET
iajs-2137	13	6	most	most	ADV
iajs-2137	13	7	abundant	abundant	ADJ
iajs-2137	13	8	mineral	mineral	NOUN
iajs-2137	13	9	in	in	ADP
iajs-2137	13	10	human	human	ADJ
iajs-2137	13	11	body	body	NOUN
iajs-2137	13	12	,	,	PUNCT
iajs-2137	13	13	which	which	PRON
iajs-2137	13	14	has	have	VERB
iajs-2137	13	15	a	a	DET
iajs-2137	13	16	several	several	ADJ
iajs-2137	13	17	important	important	ADJ
iajs-2137	13	18	functions	function	NOUN
iajs-2137	13	19	[	[	X
iajs-2137	13	20	7	7	NUM
iajs-2137	13	21	]	]	PUNCT
iajs-2137	13	22	.	.	PUNCT
iajs-2137	14	1	more	more	ADJ
iajs-2137	14	2	than	than	ADP
iajs-2137	14	3	99	99	NUM
iajs-2137	14	4	%	%	NOUN
iajs-2137	14	5	of	of	ADP
iajs-2137	14	6	ca	ca	NOUN
iajs-2137	14	7	+	+	PROPN
iajs-2137	14	8	+	+	NUM
iajs-2137	14	9	of	of	ADP
iajs-2137	14	10	total	total	ADJ
iajs-2137	14	11	body	body	NOUN
iajs-2137	14	12	is	be	AUX
iajs-2137	14	13	stored	store	VERB
iajs-2137	14	14	in	in	ADP
iajs-2137	14	15	the	the	DET
iajs-2137	14	16	bones	bone	NOUN
iajs-2137	14	17	and	and	CCONJ
iajs-2137	14	18	teeth	tooth	NOUN
iajs-2137	14	19	to	to	ADP
iajs-2137	14	20	an	an	DET
iajs-2137	14	21	assistant	assistant	NOUN
iajs-2137	14	22	and	and	CCONJ
iajs-2137	14	23	supporting	supporting	NOUN
iajs-2137	14	24	of	of	ADP
iajs-2137	14	25	their	their	PRON
iajs-2137	14	26	composition	composition	NOUN
iajs-2137	14	27	[	[	X
iajs-2137	14	28	8	8	NUM
iajs-2137	14	29	]	]	PUNCT
iajs-2137	14	30	.	.	PUNCT
iajs-2137	15	1	the	the	DET
iajs-2137	15	2	remaining	remain	VERB
iajs-2137	15	3	percentage	percentage	NOUN
iajs-2137	15	4	1	1	NUM
iajs-2137	15	5	%	%	NOUN
iajs-2137	15	6	is	be	AUX
iajs-2137	15	7	founded	found	VERB
iajs-2137	15	8	in	in	ADP
iajs-2137	15	9	the	the	DET
iajs-2137	15	10	muscle	muscle	NOUN
iajs-2137	15	11	and	and	CCONJ
iajs-2137	15	12	blood	blood	NOUN
iajs-2137	15	13	.	.	PUNCT
iajs-2137	16	1	and	and	CCONJ
iajs-2137	16	2	the	the	DET
iajs-2137	16	3	fluid	fluid	NOUN
iajs-2137	16	4	between	between	ADP
iajs-2137	16	5	cells	cell	NOUN
iajs-2137	16	6	,	,	PUNCT
iajs-2137	16	7	which	which	PRON
iajs-2137	16	8	was	be	AUX
iajs-2137	16	9	needed	need	VERB
iajs-2137	16	10	for	for	ADP
iajs-2137	16	11	muscle	muscle	NOUN
iajs-2137	16	12	contraction	contraction	NOUN
iajs-2137	16	13	,	,	PUNCT
iajs-2137	16	14	also	also	ADV
iajs-2137	16	15	blood	blood	NOUN
iajs-2137	16	16	vessel	vessel	NOUN
iajs-2137	16	17	expansion	expansion	NOUN
iajs-2137	16	18	and	and	CCONJ
iajs-2137	16	19	a	a	DET
iajs-2137	16	20	contraction	contraction	NOUN
iajs-2137	16	21	,	,	PUNCT
iajs-2137	16	22	secretion	secretion	NOUN
iajs-2137	16	23	of	of	ADP
iajs-2137	16	24	hormone	hormone	NOUN
iajs-2137	16	25	and	and	CCONJ
iajs-2137	16	26	enzymes	enzyme	NOUN
iajs-2137	16	27	,	,	PUNCT
iajs-2137	16	28	and	and	CCONJ
iajs-2137	16	29	sending	send	VERB
iajs-2137	16	30	messages	message	NOUN
iajs-2137	16	31	throughout	throughout	ADP
iajs-2137	16	32	the	the	DET
iajs-2137	16	33	nervous	nervous	ADJ
iajs-2137	16	34	system	system	NOUN
iajs-2137	16	35	so	so	SCONJ
iajs-2137	16	36	that	that	SCONJ
iajs-2137	16	37	these	these	DET
iajs-2137	16	38	biological	biological	ADJ
iajs-2137	16	39	alimaa1978@gmail.com	alimaa1978@gmail.com	PUNCT
iajs-2137	17	1	10.30526/32.2.2137	10.30526/32.2.2137	PROPN
iajs-2137	17	2	doi	doi	NOUN
iajs-2137	17	3	:	:	PUNCT
iajs-2137	17	4	effect	effect	NOUN
iajs-2137	17	5	of	of	ADP
iajs-2137	17	6	metformin	metformin	NOUN
iajs-2137	17	7	and	and	CCONJ
iajs-2137	17	8	glimepiride	glimepiride	NOUN
iajs-2137	17	9	treatment	treatment	NOUN
iajs-2137	17	10	on	on	ADP
iajs-2137	17	11	some	some	DET
iajs-2137	17	12	biochemical	biochemical	ADJ
iajs-2137	17	13	parameters	parameter	NOUN
iajs-2137	17	14	in	in	ADP
iajs-2137	17	15	diabetic	diabetic	ADJ
iajs-2137	17	16	male	male	ADJ
iajs-2137	17	17	patients	patient	NOUN
iajs-2137	17	18	with	with	ADP
iajs-2137	17	19	chronic	chronic	ADJ
iajs-2137	17	20	renal	renal	ADJ
iajs-2137	17	21	failure	failure	NOUN
iajs-2137	17	22	ibn	ibn	PROPN
iajs-2137	17	23	al	al	PROPN
iajs-2137	17	24	haitham	haitham	PROPN
iajs-2137	17	25	journal	journal	PROPN
iajs-2137	17	26	for	for	ADP
iajs-2137	17	27	pure	pure	ADJ
iajs-2137	17	28	and	and	CCONJ
iajs-2137	17	29	applied	apply	VERB
iajs-2137	17	30	science	science	NOUN
iajs-2137	17	31	journal	journal	PROPN
iajs-2137	17	32	homepage	homepage	NOUN
iajs-2137	17	33	:	:	PUNCT
iajs-2137	17	34	http://jih.uobaghdad.edu.iq/index.php/j/index	http://jih.uobaghdad.edu.iq/index.php/j/index	PROPN
iajs-2137	17	35	ali	ali	PROPN
iajs-2137	17	36	mohammed	mohammed	PROPN
iajs-2137	17	37	abbed	abbed	PROPN
iajs-2137	17	38	department	department	PROPN
iajs-2137	17	39	of	of	ADP
iajs-2137	17	40	chemistry	chemistry	NOUN
iajs-2137	17	41	,	,	PUNCT
iajs-2137	17	42	college	college	NOUN
iajs-2137	17	43	of	of	ADP
iajs-2137	17	44	science	science	NOUN
iajs-2137	17	45	,	,	PUNCT
iajs-2137	17	46	mustansiriyah	mustansiriyah	NOUN
iajs-2137	17	47	university	university	NOUN
iajs-2137	17	48	,	,	PUNCT
iajs-2137	17	49	baghdad	baghdad	PROPN
iajs-2137	17	50	,	,	PUNCT
iajs-2137	17	51	iraq	iraq	PROPN
iajs-2137	17	52	.	.	PUNCT
iajs-2137	18	1	article	article	NOUN
iajs-2137	18	2	history	history	NOUN
iajs-2137	18	3	:	:	PUNCT
iajs-2137	18	4	received	receive	VERB
iajs-2137	18	5	15	15	NUM
iajs-2137	18	6	november	november	PROPN
iajs-2137	18	7	2018	2018	NUM
iajs-2137	18	8	,	,	PUNCT
iajs-2137	18	9	accepted	accept	VERB
iajs-2137	18	10	20	20	NUM
iajs-2137	18	11	january	january	PROPN
iajs-2137	18	12	2019	2019	NUM
iajs-2137	18	13	,	,	PUNCT
iajs-2137	18	14	publish	publish	VERB
iajs-2137	18	15	may	may	AUX
iajs-2137	18	16	2019	2019	NUM
iajs-2137	18	17	mailto:alimaa1978@gmail.com	mailto:alimaa1978@gmail.com	NOUN
iajs-2137	18	18	mailto:alimaa1978@gmail.com	mailto:alimaa1978@gmail.com	PROPN
iajs-2137	18	19	83	83	NUM
iajs-2137	18	20	ibn	ibn	PROPN
iajs-2137	18	21	al	al	PROPN
iajs-2137	18	22	-	-	PUNCT
iajs-2137	18	23	haitham	haitham	PROPN
iajs-2137	18	24	jour	jour	X
iajs-2137	18	25	.	.	PROPN
iajs-2137	18	26	for	for	ADP
iajs-2137	18	27	pure	pure	ADJ
iajs-2137	18	28	&	&	CCONJ
iajs-2137	18	29	appl	appl	PROPN
iajs-2137	18	30	.	.	PUNCT
iajs-2137	19	1	sci	sci	PROPN
iajs-2137	19	2	.	.	PROPN
iajs-2137	19	3	32	32	NUM
iajs-2137	19	4	(	(	PUNCT
iajs-2137	19	5	2	2	NUM
iajs-2137	19	6	)	)	PUNCT
iajs-2137	19	7	2019	2019	NUM
iajs-2137	19	8	processes	process	NOUN
iajs-2137	19	9	of	of	ADP
iajs-2137	19	10	body	body	NOUN
iajs-2137	19	11	function	function	VERB
iajs-2137	19	12	efficiently	efficiently	ADV
iajs-2137	19	13	[	[	X
iajs-2137	19	14	9	9	NUM
iajs-2137	19	15	]	]	PUNCT
iajs-2137	19	16	.	.	PUNCT
iajs-2137	20	1	ca	can	AUX
iajs-2137	20	2	+2	+2	PROPN
iajs-2137	20	3	have	have	AUX
iajs-2137	20	4	been	be	AUX
iajs-2137	20	5	regulated	regulate	VERB
iajs-2137	20	6	by	by	ADP
iajs-2137	20	7	calcitonine	calcitonine	ADJ
iajs-2137	20	8	and	and	CCONJ
iajs-2137	20	9	parathyroid	parathyroid	ADJ
iajs-2137	20	10	hormones	hormone	NOUN
iajs-2137	20	11	(	(	PUNCT
iajs-2137	20	12	pth	pth	NOUN
iajs-2137	20	13	)	)	PUNCT
iajs-2137	21	1	[	[	X
iajs-2137	21	2	10	10	NUM
iajs-2137	21	3	]	]	PUNCT
iajs-2137	21	4	.	.	PUNCT
iajs-2137	22	1	extracellular	extracellular	ADJ
iajs-2137	22	2	ca	can	AUX
iajs-2137	22	3	+2	+2	PROPN
iajs-2137	22	4	decreases	decrease	VERB
iajs-2137	22	5	it	it	PRON
iajs-2137	22	6	stimulates	stimulate	VERB
iajs-2137	22	7	the	the	DET
iajs-2137	22	8	secretion	secretion	NOUN
iajs-2137	22	9	of	of	ADP
iajs-2137	22	10	(	(	PUNCT
iajs-2137	22	11	pth	pth	NOUN
iajs-2137	22	12	)	)	PUNCT
iajs-2137	22	13	that	that	PRON
iajs-2137	22	14	stimulates	stimulate	VERB
iajs-2137	22	15	the	the	DET
iajs-2137	22	16	reconversion	reconversion	NOUN
iajs-2137	22	17	of	of	ADP
iajs-2137	22	18	vitamin	vitamin	NOUN
iajs-2137	22	19	d	d	NOUN
iajs-2137	22	20	to	to	ADP
iajs-2137	22	21	its	its	PRON
iajs-2137	22	22	active	active	ADJ
iajs-2137	22	23	form	form	NOUN
iajs-2137	22	24	(	(	PUNCT
iajs-2137	22	25	calcitriol	calcitriol	NOUN
iajs-2137	22	26	)	)	PUNCT
iajs-2137	22	27	in	in	ADP
iajs-2137	22	28	the	the	DET
iajs-2137	22	29	kidneys	kidney	NOUN
iajs-2137	23	1	[	[	X
iajs-2137	23	2	11	11	NUM
iajs-2137	23	3	]	]	PUNCT
iajs-2137	23	4	.	.	PUNCT
iajs-2137	24	1	calcitriol	calcitriol	NOUN
iajs-2137	24	2	increases	increase	VERB
iajs-2137	24	3	intestinal	intestinal	ADJ
iajs-2137	24	4	ca	ca	NOUN
iajs-2137	24	5	+2	+2	PROPN
iajs-2137	24	6	absorption	absorption	NOUN
iajs-2137	24	7	.	.	PUNCT
iajs-2137	25	1	when	when	SCONJ
iajs-2137	25	2	blood	blood	NOUN
iajs-2137	25	3	ca	can	AUX
iajs-2137	25	4	+2	+2	PROPN
iajs-2137	25	5	returns	return	VERB
iajs-2137	25	6	to	to	ADP
iajs-2137	25	7	normal	normal	ADJ
iajs-2137	25	8	concentration	concentration	NOUN
iajs-2137	25	9	,	,	PUNCT
iajs-2137	25	10	the	the	DET
iajs-2137	25	11	parathyroid	parathyroid	NOUN
iajs-2137	25	12	glands	gland	NOUN
iajs-2137	25	13	stop	stop	VERB
iajs-2137	25	14	secreting	secrete	VERB
iajs-2137	25	15	pth	pth	NOUN
iajs-2137	25	16	and	and	CCONJ
iajs-2137	25	17	the	the	DET
iajs-2137	25	18	kidneys	kidney	NOUN
iajs-2137	25	19	start	start	VERB
iajs-2137	25	20	to	to	ADP
iajs-2137	25	21	excrete	excrete	NOUN
iajs-2137	25	22	may	may	AUX
iajs-2137	25	23	any	any	DET
iajs-2137	25	24	ca	ca	NOUN
iajs-2137	25	25	+2	+2	PROPN
iajs-2137	25	26	excess	excess	VERB
iajs-2137	25	27	in	in	ADP
iajs-2137	25	28	to	to	ADP
iajs-2137	25	29	the	the	DET
iajs-2137	25	30	urine	urine	NOUN
iajs-2137	25	31	[	[	X
iajs-2137	25	32	7,12	7,12	NUM
iajs-2137	25	33	]	]	PUNCT
iajs-2137	25	34	.	.	PUNCT
iajs-2137	26	1	potassium	potassium	NOUN
iajs-2137	26	2	(	(	PUNCT
iajs-2137	26	3	k	k	NOUN
iajs-2137	26	4	+	+	CCONJ
iajs-2137	26	5	)	)	PUNCT
iajs-2137	26	6	is	be	AUX
iajs-2137	26	7	the	the	DET
iajs-2137	26	8	major	major	ADJ
iajs-2137	26	9	mono	mono	NOUN
iajs-2137	26	10	charged	charge	VERB
iajs-2137	26	11	cation	cation	NOUN
iajs-2137	26	12	found	find	VERB
iajs-2137	26	13	in	in	ADP
iajs-2137	26	14	the	the	DET
iajs-2137	26	15	cells	cell	NOUN
iajs-2137	26	16	or	or	CCONJ
iajs-2137	26	17	intracellular	intracellular	NOUN
iajs-2137	26	18	.	.	PUNCT
iajs-2137	27	1	where	where	SCONJ
iajs-2137	27	2	is	be	AUX
iajs-2137	27	3	97	97	NUM
iajs-2137	27	4	%	%	NOUN
iajs-2137	27	5	founded	found	VERB
iajs-2137	27	6	in	in	ADP
iajs-2137	27	7	the	the	DET
iajs-2137	27	8	intracellulare	intracellulare	NOUN
iajs-2137	27	9	fluid	fluid	NOUN
iajs-2137	27	10	and	and	CCONJ
iajs-2137	27	11	(	(	PUNCT
iajs-2137	27	12	2	2	NUM
iajs-2137	27	13	-	-	SYM
iajs-2137	27	14	3)%	3)%	NUM
iajs-2137	27	15	is	be	AUX
iajs-2137	27	16	found	find	VERB
iajs-2137	27	17	in	in	ADP
iajs-2137	27	18	the	the	DET
iajs-2137	27	19	extracellulare	extracellulare	NOUN
iajs-2137	27	20	fluid	fluid	NOUN
iajs-2137	27	21	for	for	ADP
iajs-2137	27	22	example	example	NOUN
iajs-2137	27	23	intravasculare	intravasculare	NOUN
iajs-2137	27	24	and	and	CCONJ
iajs-2137	27	25	fluids	fluid	NOUN
iajs-2137	27	26	of	of	ADP
iajs-2137	27	27	intestinal	intestinal	ADJ
iajs-2137	27	28	alsosmall	alsosmall	NOUN
iajs-2137	27	29	amount	amount	NOUN
iajs-2137	27	30	in	in	ADP
iajs-2137	27	31	the	the	DET
iajs-2137	27	32	bone	bone	NOUN
iajs-2137	27	33	and	and	CCONJ
iajs-2137	27	34	blood.which	blood.which	PROPN
iajs-2137	27	35	is	be	AUX
iajs-2137	27	36	damaged	damage	VERB
iajs-2137	27	37	cells	cell	NOUN
iajs-2137	27	38	lead	lead	VERB
iajs-2137	27	39	to	to	ADP
iajs-2137	27	40	releasing	releasing	NOUN
iajs-2137	27	41	of	of	ADP
iajs-2137	27	42	k	k	PROPN
iajs-2137	28	1	+	+	CCONJ
iajs-2137	28	2	into	into	ADP
iajs-2137	28	3	the	the	DET
iajs-2137	28	4	blood	blood	NOUN
iajs-2137	28	5	[	[	X
iajs-2137	29	1	13	13	NUM
iajs-2137	29	2	]	]	PUNCT
iajs-2137	29	3	.	.	PUNCT
iajs-2137	30	1	the	the	DET
iajs-2137	30	2	normal	normal	ADJ
iajs-2137	30	3	of	of	ADP
iajs-2137	30	4	k	k	PROPN
iajs-2137	30	5	+	+	CCONJ
iajs-2137	30	6	concentration	concentration	NOUN
iajs-2137	30	7	in	in	ADP
iajs-2137	30	8	the	the	DET
iajs-2137	30	9	cell	cell	NOUN
iajs-2137	30	10	water	water	NOUN
iajs-2137	30	11	is	be	AUX
iajs-2137	30	12	145.0	145.0	NUM
iajs-2137	30	13	meq	meq	NUM
iajs-2137	30	14	/	/	SYM
iajs-2137	30	15	l	l	NOUN
iajs-2137	30	16	,	,	PUNCT
iajs-2137	30	17	that	that	SCONJ
iajs-2137	30	18	(	(	PUNCT
iajs-2137	30	19	1.0	1.0	NUM
iajs-2137	30	20	meq	meq	NOUN
iajs-2137	30	21	of	of	ADP
iajs-2137	30	22	k	k	PROPN
iajs-2137	30	23	+	+	X
iajs-2137	30	24	is	be	AUX
iajs-2137	30	25	equal	equal	ADJ
iajs-2137	30	26	to	to	ADP
iajs-2137	30	27	39	39	NUM
iajs-2137	30	28	mg	mg	NOUN
iajs-2137	30	29	)	)	PUNCT
iajs-2137	30	30	.	.	PUNCT
iajs-2137	31	1	while	while	SCONJ
iajs-2137	31	2	the	the	DET
iajs-2137	31	3	normal	normal	ADJ
iajs-2137	31	4	serum	serum	NOUN
iajs-2137	31	5	k	k	PROPN
iajs-2137	32	1	+	+	CCONJ
iajs-2137	32	2	range	range	NOUN
iajs-2137	32	3	is	be	AUX
iajs-2137	32	4	(	(	PUNCT
iajs-2137	32	5	3.5	3.5	NUM
iajs-2137	32	6	-	-	SYM
iajs-2137	32	7	5.5	5.5	NUM
iajs-2137	32	8	meq	meq	NUM
iajs-2137	32	9	)	)	PUNCT
iajs-2137	32	10	.these	.these	PRON
iajs-2137	32	11	ranges	range	NOUN
iajs-2137	32	12	is	be	AUX
iajs-2137	32	13	regulated	regulate	VERB
iajs-2137	32	14	by	by	ADP
iajs-2137	32	15	kidneys	kidney	NOUN
iajs-2137	32	16	.	.	PUNCT
iajs-2137	33	1	recently	recently	ADV
iajs-2137	33	2	researches	research	VERB
iajs-2137	33	3	in	in	ADP
iajs-2137	33	4	the	the	DET
iajs-2137	33	5	united	united	PROPN
iajs-2137	33	6	states	states	PROPN
iajs-2137	33	7	of	of	ADP
iajs-2137	33	8	america	america	PROPN
iajs-2137	33	9	have	have	AUX
iajs-2137	33	10	been	be	AUX
iajs-2137	33	11	demonstrated	demonstrate	VERB
iajs-2137	33	12	that	that	SCONJ
iajs-2137	33	13	a	a	DET
iajs-2137	33	14	low	low	ADJ
iajs-2137	33	15	k	k	NOUN
iajs-2137	33	16	+	+	X
iajs-2137	33	17	intake	intake	NOUN
iajs-2137	33	18	,	,	PUNCT
iajs-2137	33	19	which	which	PRON
iajs-2137	33	20	is	be	AUX
iajs-2137	33	21	thoroughly	thoroughly	ADV
iajs-2137	33	22	common	common	ADJ
iajs-2137	33	23	and	and	CCONJ
iajs-2137	33	24	tends	tend	VERB
iajs-2137	33	25	to	to	PART
iajs-2137	33	26	hypertension	hypertension	NOUN
iajs-2137	33	27	[	[	X
iajs-2137	33	28	14	14	NUM
iajs-2137	33	29	,	,	PUNCT
iajs-2137	33	30	13	13	NUM
iajs-2137	33	31	]	]	PUNCT
iajs-2137	33	32	.	.	PUNCT
iajs-2137	34	1	the	the	DET
iajs-2137	34	2	total	total	ADJ
iajs-2137	34	3	serum	serum	NOUN
iajs-2137	34	4	protein	protein	NOUN
iajs-2137	34	5	consists	consist	VERB
iajs-2137	34	6	of	of	ADP
iajs-2137	34	7	both	both	DET
iajs-2137	34	8	globulins	globulin	NOUN
iajs-2137	34	9	40	40	NUM
iajs-2137	34	10	%	%	NOUN
iajs-2137	34	11	and	and	CCONJ
iajs-2137	34	12	albumin	albumin	NOUN
iajs-2137	34	13	(	(	PUNCT
iajs-2137	34	14	60	60	NUM
iajs-2137	34	15	%	%	NOUN
iajs-2137	34	16	)	)	PUNCT
iajs-2137	34	17	.	.	PUNCT
iajs-2137	35	1	all	all	PRON
iajs-2137	35	2	they	they	PRON
iajs-2137	35	3	are	be	AUX
iajs-2137	35	4	share	share	VERB
iajs-2137	35	5	some	some	DET
iajs-2137	35	6	parts	part	NOUN
iajs-2137	35	7	to	to	ADP
iajs-2137	35	8	the	the	DET
iajs-2137	35	9	coiled	coil	VERB
iajs-2137	35	10	oncotic	oncotic	ADJ
iajs-2137	35	11	pressure	pressure	NOUN
iajs-2137	35	12	(	(	PUNCT
iajs-2137	35	13	cop	cop	NOUN
iajs-2137	35	14	)	)	PUNCT
iajs-2137	35	15	of	of	ADP
iajs-2137	35	16	the	the	DET
iajs-2137	35	17	plasma	plasma	NOUN
iajs-2137	35	18	,	,	PUNCT
iajs-2137	35	19	which	which	PRON
iajs-2137	35	20	is	be	AUX
iajs-2137	35	21	essential	essential	ADJ
iajs-2137	35	22	for	for	ADP
iajs-2137	35	23	normal	normal	ADJ
iajs-2137	35	24	hemodynamics	hemodynamic	NOUN
iajs-2137	35	25	.	.	PUNCT
iajs-2137	36	1	unlike	unlike	ADP
iajs-2137	36	2	that	that	DET
iajs-2137	36	3	salts	salt	NOUN
iajs-2137	36	4	of	of	ADP
iajs-2137	36	5	sodium	sodium	NOUN
iajs-2137	36	6	and	and	CCONJ
iajs-2137	36	7	glucose	glucose	NOUN
iajs-2137	36	8	,	,	PUNCT
iajs-2137	36	9	the	the	DET
iajs-2137	36	10	movement	movement	NOUN
iajs-2137	36	11	of	of	ADP
iajs-2137	36	12	protein	protein	NOUN
iajs-2137	36	13	from	from	ADP
iajs-2137	36	14	plasma	plasma	NOUN
iajs-2137	36	15	into	into	ADP
iajs-2137	36	16	the	the	DET
iajs-2137	36	17	interstitial	interstitial	ADJ
iajs-2137	36	18	fluid	fluid	NOUN
iajs-2137	36	19	is	be	AUX
iajs-2137	36	20	limited	limited	ADJ
iajs-2137	36	21	.	.	PUNCT
iajs-2137	37	1	a	a	DET
iajs-2137	37	2	total	total	ADJ
iajs-2137	37	3	protein	protein	NOUN
iajs-2137	37	4	is	be	AUX
iajs-2137	37	5	attended	attend	VERB
iajs-2137	37	6	by	by	ADP
iajs-2137	37	7	changing	change	VERB
iajs-2137	37	8	of	of	ADP
iajs-2137	37	9	fluid	fluid	ADJ
iajs-2137	37	10	balance	balance	NOUN
iajs-2137	37	11	.	.	PUNCT
iajs-2137	38	1	thereby	thereby	ADV
iajs-2137	38	2	dehydration	dehydration	NOUN
iajs-2137	38	3	causes	cause	VERB
iajs-2137	38	4	a	a	DET
iajs-2137	38	5	proportional	proportional	ADJ
iajs-2137	38	6	increasing	increasing	NOUN
iajs-2137	38	7	in	in	ADP
iajs-2137	38	8	all	all	PRON
iajs-2137	38	9	of	of	ADP
iajs-2137	38	10	the	the	DET
iajs-2137	38	11	serum	serum	NOUN
iajs-2137	38	12	protein	protein	NOUN
iajs-2137	38	13	[	[	X
iajs-2137	38	14	15	15	NUM
iajs-2137	38	15	]	]	PUNCT
iajs-2137	38	16	.	.	PUNCT
iajs-2137	39	1	glimepiride	glimepiride	PROPN
iajs-2137	39	2	is	be	AUX
iajs-2137	39	3	a	a	DET
iajs-2137	39	4	sulfonylurea	sulfonylurea	NOUN
iajs-2137	39	5	and	and	CCONJ
iajs-2137	39	6	one	one	NUM
iajs-2137	39	7	of	of	ADP
iajs-2137	39	8	the	the	DET
iajs-2137	39	9	drugs	drug	NOUN
iajs-2137	39	10	was	be	AUX
iajs-2137	39	11	used	use	VERB
iajs-2137	39	12	by	by	ADP
iajs-2137	39	13	patient	patient	NOUN
iajs-2137	39	14	with	with	ADP
iajs-2137	39	15	diabetes	diabetes	NOUN
iajs-2137	39	16	mellitus	mellitus	NOUN
iajs-2137	39	17	,	,	PUNCT
iajs-2137	39	18	which	which	PRON
iajs-2137	39	19	is	be	AUX
iajs-2137	39	20	classified	classify	VERB
iajs-2137	39	21	either	either	CCONJ
iajs-2137	39	22	second	second	ADJ
iajs-2137	39	23	generation	generation	NOUN
iajs-2137	39	24	or	or	CCONJ
iajs-2137	39	25	first	first	ADJ
iajs-2137	39	26	third	third	ADJ
iajs-2137	39	27	generation	generation	NOUN
iajs-2137	39	28	as	as	ADP
iajs-2137	39	29	sulfonylureas	sulfonylureas	ADJ
iajs-2137	39	30	[	[	PUNCT
iajs-2137	39	31	16	16	NUM
iajs-2137	39	32	-	-	SYM
iajs-2137	39	33	18	18	NUM
iajs-2137	39	34	]	]	PUNCT
iajs-2137	39	35	.	.	PUNCT
iajs-2137	40	1	where	where	SCONJ
iajs-2137	40	2	the	the	DET
iajs-2137	40	3	mechanism	mechanism	NOUN
iajs-2137	40	4	of	of	ADP
iajs-2137	40	5	action	action	NOUN
iajs-2137	40	6	in	in	ADP
iajs-2137	40	7	a	a	DET
iajs-2137	40	8	first	first	ADJ
iajs-2137	40	9	stimulation	stimulation	NOUN
iajs-2137	40	10	and	and	CCONJ
iajs-2137	40	11	secretatory	secretatory	NOUN
iajs-2137	40	12	of	of	ADP
iajs-2137	40	13	insulin	insulin	NOUN
iajs-2137	40	14	releasing	release	VERB
iajs-2137	40	15	from	from	ADP
iajs-2137	40	16	the	the	DET
iajs-2137	40	17	ß	ß	NOUN
iajs-2137	40	18	-	-	NOUN
iajs-2137	40	19	cell	cell	NOUN
iajs-2137	40	20	of	of	ADP
iajs-2137	40	21	pancreas	pancrea	NOUN
iajs-2137	40	22	and	and	CCONJ
iajs-2137	40	23	increased	increase	VERB
iajs-2137	40	24	of	of	ADP
iajs-2137	40	25	intracellular	intracellular	ADJ
iajs-2137	40	26	insulin	insulin	NOUN
iajs-2137	40	27	receptors	receptor	NOUN
iajs-2137	40	28	,	,	PUNCT
iajs-2137	40	29	in	in	ADP
iajs-2137	40	30	the	the	DET
iajs-2137	40	31	second	second	ADJ
iajs-2137	40	32	way	way	NOUN
iajs-2137	40	33	reduction	reduction	NOUN
iajs-2137	40	34	of	of	ADP
iajs-2137	40	35	serum	serum	NOUN
iajs-2137	40	36	glucagon	glucagon	NOUN
iajs-2137	40	37	level	level	NOUN
iajs-2137	40	38	,	,	PUNCT
iajs-2137	40	39	and	and	CCONJ
iajs-2137	40	40	the	the	DET
iajs-2137	40	41	third	third	ADJ
iajs-2137	40	42	pathway	pathway	NOUN
iajs-2137	40	43	increasing	increase	VERB
iajs-2137	40	44	binding	bind	VERB
iajs-2137	40	45	of	of	ADP
iajs-2137	40	46	insulin	insulin	NOUN
iajs-2137	40	47	to	to	ADP
iajs-2137	40	48	receptor	receptor	NOUN
iajs-2137	40	49	of	of	ADP
iajs-2137	40	50	target	target	NOUN
iajs-2137	40	51	tissue	tissue	NOUN
iajs-2137	40	52	cell	cell	NOUN
iajs-2137	40	53	.	.	PUNCT
iajs-2137	41	1	which	which	PRON
iajs-2137	41	2	these	these	DET
iajs-2137	41	3	drugs	drug	NOUN
iajs-2137	41	4	were	be	AUX
iajs-2137	41	5	metabolized	metabolize	VERB
iajs-2137	41	6	via	via	ADP
iajs-2137	41	7	the	the	DET
iajs-2137	41	8	liver	liver	NOUN
iajs-2137	41	9	and	and	CCONJ
iajs-2137	41	10	excreted	excrete	VERB
iajs-2137	41	11	by	by	ADP
iajs-2137	41	12	liver	liver	NOUN
iajs-2137	41	13	or	or	CCONJ
iajs-2137	41	14	kidney	kidney	NOUN
iajs-2137	41	15	[	[	X
iajs-2137	41	16	18	18	NUM
iajs-2137	41	17	,	,	PUNCT
iajs-2137	41	18	19	19	NUM
iajs-2137	41	19	]	]	PUNCT
iajs-2137	41	20	.	.	PUNCT
iajs-2137	42	1	metformin	metformin	NOUN
iajs-2137	42	2	is	be	AUX
iajs-2137	42	3	another	another	DET
iajs-2137	42	4	drug	drug	NOUN
iajs-2137	42	5	which	which	PRON
iajs-2137	42	6	is	be	AUX
iajs-2137	42	7	used	use	VERB
iajs-2137	42	8	as	as	ADP
iajs-2137	42	9	hypoglycemic	hypoglycemic	ADJ
iajs-2137	42	10	agent	agent	NOUN
iajs-2137	42	11	from	from	ADP
iajs-2137	42	12	obese	obese	ADJ
iajs-2137	42	13	individuals	individual	NOUN
iajs-2137	42	14	,	,	PUNCT
iajs-2137	42	15	to	to	ADP
iajs-2137	42	16	prevention	prevention	NOUN
iajs-2137	42	17	of	of	ADP
iajs-2137	42	18	diabetes	diabetes	NOUN
iajs-2137	42	19	and	and	CCONJ
iajs-2137	42	20	widely	widely	ADV
iajs-2137	42	21	regarded	regard	VERB
iajs-2137	42	22	for	for	ADP
iajs-2137	42	23	the	the	DET
iajs-2137	42	24	treatment	treatment	NOUN
iajs-2137	42	25	of	of	ADP
iajs-2137	42	26	two	two	NUM
iajs-2137	42	27	type	type	NOUN
iajs-2137	42	28	diabetes	diabetes	NOUN
iajs-2137	42	29	[	[	X
iajs-2137	42	30	20	20	NUM
iajs-2137	42	31	,	,	PUNCT
iajs-2137	42	32	21	21	NUM
iajs-2137	42	33	]	]	PUNCT
iajs-2137	42	34	.	.	PUNCT
iajs-2137	43	1	by	by	ADP
iajs-2137	43	2	decreasing	decrease	VERB
iajs-2137	43	3	hepatic	hepatic	ADJ
iajs-2137	43	4	glucose	glucose	NOUN
iajs-2137	43	5	output	output	NOUN
iajs-2137	43	6	and	and	CCONJ
iajs-2137	43	7	inhibiting	inhibit	VERB
iajs-2137	43	8	gluconeogenesis	gluconeogenesis	NOUN
iajs-2137	43	9	.	.	PUNCT
iajs-2137	44	1	this	this	DET
iajs-2137	44	2	drug	drug	NOUN
iajs-2137	44	3	may	may	AUX
iajs-2137	44	4	be	be	AUX
iajs-2137	44	5	used	use	VERB
iajs-2137	44	6	alone	alone	ADJ
iajs-2137	44	7	or	or	CCONJ
iajs-2137	44	8	in	in	ADP
iajs-2137	44	9	combination	combination	NOUN
iajs-2137	44	10	with	with	ADP
iajs-2137	44	11	glimepiride	glimepiride	NOUN
iajs-2137	44	12	[	[	X
iajs-2137	44	13	18	18	NUM
iajs-2137	44	14	]	]	PUNCT
iajs-2137	44	15	.	.	PUNCT
iajs-2137	45	1	2	2	X
iajs-2137	45	2	.	.	X
iajs-2137	45	3	samples	sample	NOUN
iajs-2137	45	4	and	and	CCONJ
iajs-2137	45	5	methods	method	NOUN
iajs-2137	45	6	2.1	2.1	NUM
iajs-2137	45	7	.	.	PUNCT
iajs-2137	46	1	samples	sample	NOUN
iajs-2137	46	2	collection	collection	NOUN
iajs-2137	46	3	the	the	DET
iajs-2137	46	4	blood	blood	NOUN
iajs-2137	46	5	samples	sample	NOUN
iajs-2137	46	6	were	be	AUX
iajs-2137	46	7	taken	take	VERB
iajs-2137	46	8	from	from	ADP
iajs-2137	46	9	52	52	NUM
iajs-2137	46	10	diabetic	diabetic	ADJ
iajs-2137	46	11	male	male	ADJ
iajs-2137	46	12	patients	patient	NOUN
iajs-2137	46	13	with	with	ADP
iajs-2137	46	14	crf	crf	PROPN
iajs-2137	46	15	that	that	PRON
iajs-2137	46	16	are	be	AUX
iajs-2137	46	17	took	take	VERB
iajs-2137	46	18	anti	anti	ADJ
iajs-2137	46	19	diabetic	diabetic	ADJ
iajs-2137	46	20	drugs	drug	NOUN
iajs-2137	46	21	such	such	ADJ
iajs-2137	46	22	as	as	ADP
iajs-2137	46	23	glimepiride	glimepiride	NOUN
iajs-2137	46	24	and	and	CCONJ
iajs-2137	46	25	metformin	metformin	NOUN
iajs-2137	46	26	;	;	PUNCT
iajs-2137	46	27	their	their	PRON
iajs-2137	46	28	ages	age	NOUN
iajs-2137	46	29	ranged	range	VERB
iajs-2137	46	30	from	from	ADP
iajs-2137	46	31	(	(	PUNCT
iajs-2137	46	32	32	32	NUM
iajs-2137	46	33	-	-	SYM
iajs-2137	46	34	75	75	NUM
iajs-2137	46	35	)	)	PUNCT
iajs-2137	46	36	years	year	NOUN
iajs-2137	46	37	in	in	ADP
iajs-2137	46	38	al	al	PROPN
iajs-2137	46	39	-	-	PUNCT
iajs-2137	46	40	kindy	kindy	PROPN
iajs-2137	46	41	hospital/	hospital/	NUM
iajs-2137	46	42	baghdad	baghdad	PROPN
iajs-2137	46	43	-	-	PUNCT
iajs-2137	46	44	iraq	iraq	PROPN
iajs-2137	46	45	during	during	ADP
iajs-2137	46	46	the	the	DET
iajs-2137	46	47	period	period	NOUN
iajs-2137	46	48	from	from	ADP
iajs-2137	46	49	january	january	PROPN
iajs-2137	46	50	until	until	ADP
iajs-2137	46	51	the	the	DET
iajs-2137	46	52	end	end	NOUN
iajs-2137	46	53	of	of	ADP
iajs-2137	46	54	april	april	PROPN
iajs-2137	46	55	2018	2018	NUM
iajs-2137	46	56	and	and	CCONJ
iajs-2137	46	57	compared	compare	VERB
iajs-2137	46	58	them	they	PRON
iajs-2137	46	59	with	with	ADP
iajs-2137	46	60	25	25	NUM
iajs-2137	46	61	healthy	healthy	ADJ
iajs-2137	46	62	males	male	NOUN
iajs-2137	46	63	as	as	ADP
iajs-2137	46	64	control	control	NOUN
iajs-2137	46	65	group	group	NOUN
iajs-2137	46	66	;	;	PUNCT
iajs-2137	46	67	their	their	PRON
iajs-2137	46	68	ages	age	NOUN
iajs-2137	46	69	ranged	range	VERB
iajs-2137	46	70	from	from	ADP
iajs-2137	46	71	(	(	PUNCT
iajs-2137	46	72	20	20	NUM
iajs-2137	46	73	-	-	SYM
iajs-2137	46	74	64	64	NUM
iajs-2137	46	75	)	)	PUNCT
iajs-2137	46	76	years	year	NOUN
iajs-2137	46	77	.	.	PUNCT
iajs-2137	47	1	five	five	NUM
iajs-2137	47	2	milliliters	milliliter	NOUN
iajs-2137	47	3	of	of	ADP
iajs-2137	47	4	venous	venous	ADJ
iajs-2137	47	5	blood	blood	NOUN
iajs-2137	47	6	samples	sample	NOUN
iajs-2137	47	7	and	and	CCONJ
iajs-2137	47	8	allowed	allow	VERB
iajs-2137	47	9	to	to	PART
iajs-2137	47	10	clot	clot	VERB
iajs-2137	47	11	for	for	ADP
iajs-2137	47	12	20	20	NUM
iajs-2137	47	13	min	min	NOUN
iajs-2137	47	14	at	at	ADP
iajs-2137	47	15	room	room	NOUN
iajs-2137	47	16	temperature	temperature	NOUN
iajs-2137	47	17	,	,	PUNCT
iajs-2137	47	18	centrifuged	centrifuge	VERB
iajs-2137	47	19	at	at	ADP
iajs-2137	47	20	3000xgfor	3000xgfor	NUM
iajs-2137	47	21	4	4	NUM
iajs-2137	47	22	minutes	minute	NOUN
iajs-2137	47	23	,	,	PUNCT
iajs-2137	47	24	and	and	CCONJ
iajs-2137	47	25	then	then	ADV
iajs-2137	47	26	sera	sera	NOUN
iajs-2137	47	27	were	be	AUX
iajs-2137	47	28	collected	collect	VERB
iajs-2137	47	29	was	be	AUX
iajs-2137	47	30	stored	store	VERB
iajs-2137	47	31	at	at	ADP
iajs-2137	47	32	17c	17c	NUM
iajs-2137	47	33	◦	◦	NOUN
iajs-2137	47	34	until	until	ADP
iajs-2137	47	35	to	to	PART
iajs-2137	47	36	use	use	VERB
iajs-2137	47	37	.	.	PUNCT
iajs-2137	48	1	the	the	DET
iajs-2137	48	2	serum	serum	NOUN
iajs-2137	48	3	was	be	AUX
iajs-2137	48	4	utilized	utilize	VERB
iajs-2137	48	5	for	for	ADP
iajs-2137	48	6	the	the	DET
iajs-2137	48	7	estimations	estimation	NOUN
iajs-2137	48	8	of	of	ADP
iajs-2137	48	9	serum	serum	NOUN
iajs-2137	48	10	glucose	glucose	NOUN
iajs-2137	48	11	,	,	PUNCT
iajs-2137	48	12	total	total	ADJ
iajs-2137	48	13	protein	protein	NOUN
iajs-2137	48	14	,	,	PUNCT
iajs-2137	48	15	ca	can	AUX
iajs-2137	48	16	+2	+2	PROPN
iajs-2137	48	17	and	and	CCONJ
iajs-2137	48	18	k	k	PROPN
iajs-2137	49	1	+	+	NUM
iajs-2137	49	2	ions	ion	NOUN
iajs-2137	49	3	.	.	PUNCT
iajs-2137	50	1	2.2	2.2	NUM
iajs-2137	50	2	.	.	PUNCT
iajs-2137	50	3	determination	determination	NOUN
iajs-2137	50	4	of	of	ADP
iajs-2137	50	5	fasting	fast	VERB
iajs-2137	50	6	serum	serum	NOUN
iajs-2137	50	7	glucose	glucose	NOUN
iajs-2137	50	8	colorimetric	colorimetric	ADJ
iajs-2137	50	9	method	method	NOUN
iajs-2137	50	10	was	be	AUX
iajs-2137	50	11	used	use	VERB
iajs-2137	50	12	to	to	PART
iajs-2137	50	13	determine	determine	VERB
iajs-2137	50	14	of	of	ADP
iajs-2137	50	15	glucose	glucose	NOUN
iajs-2137	50	16	in	in	ADP
iajs-2137	50	17	the	the	DET
iajs-2137	50	18	sera	sera	NOUN
iajs-2137	50	19	was	be	AUX
iajs-2137	50	20	achieved	achieve	VERB
iajs-2137	50	21	by	by	ADP
iajs-2137	50	22	using	use	VERB
iajs-2137	50	23	linear	linear	PROPN
iajs-2137	50	24	kit	kit	PROPN
iajs-2137	50	25	.	.	PUNCT
iajs-2137	51	1	the	the	DET
iajs-2137	51	2	determination	determination	NOUN
iajs-2137	51	3	of	of	ADP
iajs-2137	51	4	glucose	glucose	NOUN
iajs-2137	51	5	level	level	NOUN
iajs-2137	51	6	done	do	VERB
iajs-2137	51	7	by	by	ADP
iajs-2137	51	8	enzymatic	enzymatic	ADJ
iajs-2137	51	9	oxidation	oxidation	NOUN
iajs-2137	51	10	of	of	ADP
iajs-2137	51	11	glucose	glucose	NOUN
iajs-2137	51	12	by	by	ADP
iajs-2137	51	13	glucose	glucose	NOUN
iajs-2137	51	14	oxidase	oxidase	NOUN
iajs-2137	51	15	to	to	PART
iajs-2137	51	16	produce	produce	VERB
iajs-2137	51	17	hydrogen	hydrogen	NOUN
iajs-2137	51	18	peroxide	peroxide	NOUN
iajs-2137	51	19	,	,	PUNCT
iajs-2137	51	20	and	and	CCONJ
iajs-2137	51	21	in	in	ADP
iajs-2137	51	22	the	the	DET
iajs-2137	51	23	presence	presence	NOUN
iajs-2137	51	24	of	of	ADP
iajs-2137	51	25	peroxidase	peroxidase	NOUN
iajs-2137	51	26	and	and	CCONJ
iajs-2137	51	27	4aminoantipyrine	4aminoantipyrine	NUM
iajs-2137	51	28	is	be	AUX
iajs-2137	51	29	oxidized	oxidize	VERB
iajs-2137	51	30	by	by	ADP
iajs-2137	51	31	hydrogen	hydrogen	NOUN
iajs-2137	51	32	peroxide	peroxide	NOUN
iajs-2137	51	33	then	then	ADV
iajs-2137	51	34	produce	produce	VERB
iajs-2137	51	35	quinoneimine	quinoneimine	NOUN
iajs-2137	51	36	as	as	SCONJ
iajs-2137	51	37	colored	colored	ADJ
iajs-2137	51	38	compound	compound	NOUN
iajs-2137	51	39	red	red	ADJ
iajs-2137	51	40	dye	dye	NOUN
iajs-2137	51	41	read	read	VERB
iajs-2137	51	42	at	at	ADP
iajs-2137	51	43	(	(	PUNCT
iajs-2137	51	44	500	500	NUM
iajs-2137	51	45	nm	nm	NOUN
iajs-2137	51	46	)	)	PUNCT
iajs-2137	51	47	,	,	PUNCT
iajs-2137	51	48	proportional	proportional	ADJ
iajs-2137	51	49	to	to	ADP
iajs-2137	51	50	the	the	DET
iajs-2137	51	51	concentration	concentration	NOUN
iajs-2137	51	52	of	of	ADP
iajs-2137	51	53	glucose	glucose	NOUN
iajs-2137	51	54	[	[	X
iajs-2137	51	55	22	22	NUM
iajs-2137	51	56	]	]	PUNCT
iajs-2137	51	57	.	.	PUNCT
iajs-2137	52	1	04	04	NUM
iajs-2137	53	1	ibn	ibn	PROPN
iajs-2137	53	2	al	al	PROPN
iajs-2137	53	3	-	-	PUNCT
iajs-2137	53	4	haitham	haitham	PROPN
iajs-2137	53	5	jour	jour	X
iajs-2137	53	6	.	.	PROPN
iajs-2137	53	7	for	for	ADP
iajs-2137	53	8	pure	pure	ADJ
iajs-2137	53	9	&	&	CCONJ
iajs-2137	53	10	appl	appl	PROPN
iajs-2137	53	11	.	.	PUNCT
iajs-2137	54	1	sci	sci	PROPN
iajs-2137	54	2	.	.	PROPN
iajs-2137	54	3	32	32	NUM
iajs-2137	54	4	(	(	PUNCT
iajs-2137	54	5	2	2	NUM
iajs-2137	54	6	)	)	PUNCT
iajs-2137	54	7	2019	2019	NUM
iajs-2137	54	8	2.3	2.3	NUM
iajs-2137	54	9	.	.	PUNCT
iajs-2137	55	1	determination	determination	NOUN
iajs-2137	55	2	of	of	ADP
iajs-2137	55	3	serum	serum	NOUN
iajs-2137	55	4	total	total	ADJ
iajs-2137	55	5	protein	protein	NOUN
iajs-2137	55	6	colorimetric	colorimetric	ADJ
iajs-2137	55	7	method	method	NOUN
iajs-2137	55	8	was	be	AUX
iajs-2137	55	9	used	use	VERB
iajs-2137	55	10	to	to	PART
iajs-2137	55	11	determine	determine	VERB
iajs-2137	55	12	of	of	ADP
iajs-2137	55	13	total	total	ADJ
iajs-2137	55	14	protein	protein	NOUN
iajs-2137	55	15	in	in	ADP
iajs-2137	55	16	the	the	DET
iajs-2137	55	17	sera	sera	NOUN
iajs-2137	55	18	of	of	ADP
iajs-2137	55	19	patient	patient	NOUN
iajs-2137	55	20	and	and	CCONJ
iajs-2137	55	21	control	control	NOUN
iajs-2137	55	22	groups	group	NOUN
iajs-2137	55	23	,	,	PUNCT
iajs-2137	55	24	by	by	ADP
iajs-2137	55	25	using	use	VERB
iajs-2137	55	26	linear	linear	PROPN
iajs-2137	55	27	kit	kit	PROPN
iajs-2137	55	28	.	.	PUNCT
iajs-2137	56	1	the	the	DET
iajs-2137	56	2	principle	principle	NOUN
iajs-2137	56	3	of	of	ADP
iajs-2137	56	4	this	this	DET
iajs-2137	56	5	method	method	NOUN
iajs-2137	56	6	is	be	AUX
iajs-2137	56	7	biuret	biuret	NOUN
iajs-2137	56	8	reaction	reaction	NOUN
iajs-2137	56	9	,	,	PUNCT
iajs-2137	56	10	when	when	SCONJ
iajs-2137	56	11	a	a	DET
iajs-2137	56	12	cleating	cleat	VERB
iajs-2137	56	13	compound	compound	NOUN
iajs-2137	56	14	formation	formation	NOUN
iajs-2137	56	15	between	between	ADP
iajs-2137	56	16	the	the	DET
iajs-2137	56	17	cu	cu	PROPN
iajs-2137	56	18	+2	+2	PROPN
iajs-2137	56	19	ion	ion	NOUN
iajs-2137	56	20	and	and	CCONJ
iajs-2137	56	21	the	the	DET
iajs-2137	56	22	peptide	peptide	NOUN
iajs-2137	56	23	bond	bond	NOUN
iajs-2137	56	24	in	in	ADP
iajs-2137	56	25	alkaline	alkaline	NOUN
iajs-2137	56	26	media	medium	NOUN
iajs-2137	56	27	to	to	PART
iajs-2137	56	28	give	give	VERB
iajs-2137	56	29	a	a	DET
iajs-2137	56	30	violet	violet	ADJ
iajs-2137	56	31	colored	colored	ADJ
iajs-2137	56	32	complex	complex	NOUN
iajs-2137	56	33	,	,	PUNCT
iajs-2137	56	34	and	and	CCONJ
iajs-2137	56	35	read	read	VERB
iajs-2137	56	36	at	at	ADP
iajs-2137	56	37	540	540	NUM
iajs-2137	56	38	nm	nm	NOUN
iajs-2137	56	39	.	.	PUNCT
iajs-2137	57	1	the	the	DET
iajs-2137	57	2	density	density	NOUN
iajs-2137	57	3	of	of	ADP
iajs-2137	57	4	color	color	NOUN
iajs-2137	57	5	is	be	AUX
iajs-2137	57	6	proportional	proportional	ADJ
iajs-2137	57	7	to	to	ADP
iajs-2137	57	8	the	the	DET
iajs-2137	57	9	concentration	concentration	NOUN
iajs-2137	57	10	of	of	ADP
iajs-2137	57	11	total	total	ADJ
iajs-2137	57	12	protein	protein	NOUN
iajs-2137	57	13	in	in	ADP
iajs-2137	57	14	the	the	DET
iajs-2137	57	15	serum	serum	NOUN
iajs-2137	57	16	[	[	X
iajs-2137	57	17	23	23	NUM
iajs-2137	57	18	]	]	PUNCT
iajs-2137	57	19	.	.	PUNCT
iajs-2137	58	1	2.4	2.4	NUM
iajs-2137	58	2	.	.	PUNCT
iajs-2137	59	1	determination	determination	NOUN
iajs-2137	59	2	of	of	ADP
iajs-2137	59	3	serum	serum	NOUN
iajs-2137	59	4	potassium	potassium	NOUN
iajs-2137	59	5	colorimetric	colorimetric	ADJ
iajs-2137	59	6	method	method	NOUN
iajs-2137	59	7	was	be	AUX
iajs-2137	59	8	used	use	VERB
iajs-2137	59	9	to	to	PART
iajs-2137	59	10	determine	determine	VERB
iajs-2137	59	11	of	of	ADP
iajs-2137	59	12	k	k	PROPN
iajs-2137	59	13	+	+	NOUN
iajs-2137	59	14	ion	ion	NOUN
iajs-2137	59	15	in	in	ADP
iajs-2137	59	16	the	the	DET
iajs-2137	59	17	sera	sera	NOUN
iajs-2137	59	18	of	of	ADP
iajs-2137	59	19	patient	patient	NOUN
iajs-2137	59	20	and	and	CCONJ
iajs-2137	59	21	control	control	NOUN
iajs-2137	59	22	,	,	PUNCT
iajs-2137	59	23	by	by	ADP
iajs-2137	59	24	using	use	VERB
iajs-2137	59	25	agape	agape	ADJ
iajs-2137	59	26	kit	kit	NOUN
iajs-2137	59	27	.	.	PUNCT
iajs-2137	60	1	the	the	DET
iajs-2137	60	2	principle	principle	NOUN
iajs-2137	60	3	of	of	ADP
iajs-2137	60	4	this	this	DET
iajs-2137	60	5	method	method	NOUN
iajs-2137	60	6	was	be	AUX
iajs-2137	60	7	depending	depend	VERB
iajs-2137	60	8	on	on	ADP
iajs-2137	60	9	reaction	reaction	NOUN
iajs-2137	60	10	between	between	ADP
iajs-2137	60	11	k	k	PROPN
iajs-2137	60	12	+	+	CCONJ
iajs-2137	60	13	that	that	DET
iajs-2137	60	14	presence	presence	NOUN
iajs-2137	60	15	in	in	ADP
iajs-2137	60	16	the	the	DET
iajs-2137	60	17	serum	serum	NOUN
iajs-2137	60	18	with	with	ADP
iajs-2137	60	19	sodium	sodium	NOUN
iajs-2137	60	20	tetraphenyl	tetraphenyl	NOUN
iajs-2137	60	21	borate	borate	NOUN
iajs-2137	60	22	,	,	PUNCT
iajs-2137	60	23	to	to	PART
iajs-2137	60	24	give	give	VERB
iajs-2137	60	25	k	k	NOUN
iajs-2137	60	26	+	+	CCONJ
iajs-2137	60	27	tetra	tetra	NOUN
iajs-2137	60	28	phenyl	phenyl	NOUN
iajs-2137	60	29	borate	borate	NOUN
iajs-2137	60	30	read	read	VERB
iajs-2137	60	31	at	at	ADP
iajs-2137	60	32	578	578	NUM
iajs-2137	60	33	nm	nm	NOUN
iajs-2137	60	34	[	[	X
iajs-2137	60	35	24	24	NUM
iajs-2137	60	36	]	]	PUNCT
iajs-2137	60	37	.	.	PUNCT
iajs-2137	61	1	this	this	DET
iajs-2137	61	2	procedure	procedure	NOUN
iajs-2137	61	3	was	be	AUX
iajs-2137	61	4	carried	carry	VERB
iajs-2137	61	5	out	out	ADP
iajs-2137	61	6	on	on	ADP
iajs-2137	61	7	the	the	DET
iajs-2137	61	8	patient	patient	NOUN
iajs-2137	61	9	and	and	CCONJ
iajs-2137	61	10	control	control	NOUN
iajs-2137	61	11	groups	group	NOUN
iajs-2137	61	12	.	.	PUNCT
iajs-2137	62	1	2.5	2.5	NUM
iajs-2137	62	2	.	.	PUNCT
iajs-2137	63	1	determination	determination	NOUN
iajs-2137	63	2	of	of	ADP
iajs-2137	63	3	serum	serum	NOUN
iajs-2137	63	4	calcium	calcium	NOUN
iajs-2137	63	5	colorimetric	colorimetric	ADJ
iajs-2137	63	6	method	method	NOUN
iajs-2137	63	7	was	be	AUX
iajs-2137	63	8	used	use	VERB
iajs-2137	63	9	to	to	PART
iajs-2137	63	10	determine	determine	VERB
iajs-2137	63	11	of	of	ADP
iajs-2137	63	12	total	total	NOUN
iajs-2137	63	13	ca	ca	NOUN
iajs-2137	63	14	+2	+2	PROPN
iajs-2137	63	15	in	in	ADP
iajs-2137	63	16	sera	sera	NOUN
iajs-2137	63	17	without	without	ADP
iajs-2137	63	18	deproteinization	deproteinization	NOUN
iajs-2137	63	19	was	be	AUX
iajs-2137	63	20	achieved	achieve	VERB
iajs-2137	63	21	by	by	ADP
iajs-2137	63	22	using	use	VERB
iajs-2137	63	23	human	human	ADJ
iajs-2137	63	24	kit	kit	PROPN
iajs-2137	63	25	.	.	PUNCT
iajs-2137	64	1	the	the	DET
iajs-2137	64	2	principle	principle	NOUN
iajs-2137	64	3	of	of	ADP
iajs-2137	64	4	this	this	DET
iajs-2137	64	5	method	method	NOUN
iajs-2137	64	6	depending	depend	VERB
iajs-2137	64	7	on	on	ADP
iajs-2137	64	8	ca	ca	NOUN
iajs-2137	64	9	+2	+2	PROPN
iajs-2137	64	10	ion	ion	NOUN
iajs-2137	64	11	reacts	react	VERB
iajs-2137	64	12	with	with	ADP
iajs-2137	64	13	the	the	DET
iajs-2137	64	14	8	8	NUM
iajs-2137	64	15	-	-	PUNCT
iajs-2137	64	16	hydroxy	hydroxy	NOUN
iajs-2137	64	17	quinoline	quinoline	NOUN
iajs-2137	64	18	in	in	ADP
iajs-2137	64	19	an	an	DET
iajs-2137	64	20	alkaline	alkaline	NOUN
iajs-2137	64	21	media	medium	NOUN
iajs-2137	64	22	.	.	PUNCT
iajs-2137	65	1	the	the	DET
iajs-2137	65	2	color	color	NOUN
iajs-2137	65	3	density	density	NOUN
iajs-2137	65	4	of	of	ADP
iajs-2137	65	5	the	the	DET
iajs-2137	65	6	ca-8	ca-8	NOUN
iajs-2137	65	7	-	-	PUNCT
iajs-2137	65	8	hq	hq	NOUN
iajs-2137	65	9	complex	complex	NOUN
iajs-2137	65	10	,	,	PUNCT
iajs-2137	65	11	read	read	VERB
iajs-2137	65	12	at	at	ADP
iajs-2137	65	13	wave	wave	NOUN
iajs-2137	65	14	length	length	NOUN
iajs-2137	65	15	(	(	PUNCT
iajs-2137	65	16	540	540	NUM
iajs-2137	65	17	nm	nm	NOUN
iajs-2137	65	18	)	)	PUNCT
iajs-2137	65	19	,	,	PUNCT
iajs-2137	65	20	is	be	AUX
iajs-2137	65	21	proportional	proportional	ADJ
iajs-2137	65	22	to	to	ADP
iajs-2137	65	23	the	the	DET
iajs-2137	65	24	quantity	quantity	NOUN
iajs-2137	65	25	of	of	ADP
iajs-2137	65	26	calcium	calcium	NOUN
iajs-2137	65	27	presence	presence	NOUN
iajs-2137	65	28	in	in	ADP
iajs-2137	65	29	the	the	DET
iajs-2137	65	30	sample	sample	NOUN
iajs-2137	65	31	.	.	PUNCT
iajs-2137	66	1	8	8	NUM
iajs-2137	66	2	-	-	PUNCT
iajs-2137	66	3	hydroxyquinoline	hydroxyquinoline	NOUN
iajs-2137	66	4	reacts	react	NOUN
iajs-2137	66	5	with	with	ADP
iajs-2137	66	6	calcium	calcium	NOUN
iajs-2137	66	7	to	to	PART
iajs-2137	66	8	formation	formation	VERB
iajs-2137	66	9	color	color	NOUN
iajs-2137	66	10	complex	complex	NOUN
iajs-2137	66	11	.	.	PUNCT
iajs-2137	67	1	and	and	CCONJ
iajs-2137	67	2	cresophthalein	cresophthalein	NOUN
iajs-2137	67	3	expunges	expunge	VERB
iajs-2137	67	4	interferences	interference	NOUN
iajs-2137	67	5	from	from	ADP
iajs-2137	67	6	proteins	protein	NOUN
iajs-2137	67	7	[	[	X
iajs-2137	67	8	25	25	NUM
iajs-2137	67	9	]	]	PUNCT
iajs-2137	67	10	.	.	PUNCT
iajs-2137	68	1	this	this	DET
iajs-2137	68	2	procedure	procedure	NOUN
iajs-2137	68	3	was	be	AUX
iajs-2137	68	4	carried	carry	VERB
iajs-2137	68	5	out	out	ADP
iajs-2137	68	6	on	on	ADP
iajs-2137	68	7	the	the	DET
iajs-2137	68	8	patient	patient	NOUN
iajs-2137	68	9	and	and	CCONJ
iajs-2137	68	10	control	control	NOUN
iajs-2137	68	11	groups	group	NOUN
iajs-2137	68	12	.	.	PUNCT
iajs-2137	69	1	3	3	X
iajs-2137	69	2	.	.	NOUN
iajs-2137	69	3	results	result	VERB
iajs-2137	69	4	biochemical	biochemical	ADJ
iajs-2137	69	5	parameters	parameter	NOUN
iajs-2137	69	6	in	in	ADP
iajs-2137	69	7	patients	patient	NOUN
iajs-2137	69	8	and	and	CCONJ
iajs-2137	69	9	controls	control	NOUN
iajs-2137	69	10	are	be	AUX
iajs-2137	69	11	listed	list	VERB
iajs-2137	69	12	in	in	ADP
iajs-2137	69	13	tables	table	NOUN
iajs-2137	69	14	.	.	PUNCT
iajs-2137	70	1	glucose	glucose	NOUN
iajs-2137	70	2	has	have	AUX
iajs-2137	70	3	been	be	AUX
iajs-2137	70	4	determined	determine	VERB
iajs-2137	70	5	.	.	PUNCT
iajs-2137	71	1	the	the	DET
iajs-2137	71	2	mean	mean	ADJ
iajs-2137	71	3	value	value	NOUN
iajs-2137	71	4	in	in	ADP
iajs-2137	71	5	table	table	NOUN
iajs-2137	71	6	1	1	NUM
iajs-2137	71	7	.	.	PUNCT
iajs-2137	71	8	showed	show	VERB
iajs-2137	71	9	hyperglycemia	hyperglycemia	NOUN
iajs-2137	71	10	.	.	PUNCT
iajs-2137	72	1	,	,	PUNCT
iajs-2137	72	2	increased	increase	VERB
iajs-2137	72	3	highly	highly	ADV
iajs-2137	72	4	significant	significant	ADJ
iajs-2137	72	5	(	(	PUNCT
iajs-2137	72	6	p	p	X
iajs-2137	72	7	=	=	NOUN
iajs-2137	72	8	0.004	0.004	NUM
iajs-2137	72	9	)	)	PUNCT
iajs-2137	72	10	of	of	ADP
iajs-2137	72	11	glucose	glucose	NOUN
iajs-2137	72	12	level	level	NOUN
iajs-2137	72	13	in	in	ADP
iajs-2137	72	14	the	the	DET
iajs-2137	72	15	sera	sera	NOUN
iajs-2137	72	16	of	of	ADP
iajs-2137	72	17	patients	patient	NOUN
iajs-2137	72	18	in	in	ADP
iajs-2137	72	19	comparision	comparision	NOUN
iajs-2137	72	20	with	with	ADP
iajs-2137	72	21	that	that	PRON
iajs-2137	72	22	of	of	ADP
iajs-2137	72	23	the	the	DET
iajs-2137	72	24	control	control	NOUN
iajs-2137	72	25	group	group	NOUN
iajs-2137	72	26	.	.	PUNCT
iajs-2137	73	1	table	table	NOUN
iajs-2137	73	2	1	1	NUM
iajs-2137	73	3	.	.	X
iajs-2137	73	4	glucose	glucose	NOUN
iajs-2137	73	5	mean	mean	NOUN
iajs-2137	73	6	level	level	NOUN
iajs-2137	73	7	in	in	ADP
iajs-2137	73	8	the	the	DET
iajs-2137	73	9	sera	sera	NOUN
iajs-2137	73	10	of	of	ADP
iajs-2137	73	11	control	control	NOUN
iajs-2137	73	12	and	and	CCONJ
iajs-2137	73	13	patients	patient	NOUN
iajs-2137	73	14	as	as	ADP
iajs-2137	73	15	test	test	NOUN
iajs-2137	73	16	group	group	NOUN
iajs-2137	73	17	with	with	ADP
iajs-2137	73	18	statistical	statistical	ADJ
iajs-2137	73	19	analysis	analysis	NOUN
iajs-2137	73	20	value	value	NOUN
iajs-2137	73	21	.	.	PUNCT
iajs-2137	74	1	total	total	ADJ
iajs-2137	74	2	protein	protein	NOUN
iajs-2137	74	3	has	have	AUX
iajs-2137	74	4	been	be	AUX
iajs-2137	74	5	determined	determine	VERB
iajs-2137	74	6	and	and	CCONJ
iajs-2137	74	7	mean	mean	ADJ
iajs-2137	74	8	value	value	NOUN
iajs-2137	74	9	showed	show	VERB
iajs-2137	74	10	in	in	ADP
iajs-2137	74	11	table	table	NOUN
iajs-2137	74	12	2	2	NUM
iajs-2137	74	13	.	.	PUNCT
iajs-2137	75	1	that	that	PRON
iajs-2137	75	2	demonstrated	demonstrated	AUX
iajs-2137	75	3	decreased	decrease	VERB
iajs-2137	75	4	highly	highly	ADV
iajs-2137	75	5	significant	significant	ADJ
iajs-2137	75	6	(	(	PUNCT
iajs-2137	75	7	p	p	X
iajs-2137	75	8	=	=	NOUN
iajs-2137	75	9	0.0002	0.0002	NUM
iajs-2137	75	10	)	)	PUNCT
iajs-2137	75	11	in	in	ADP
iajs-2137	75	12	total	total	ADJ
iajs-2137	75	13	protein	protein	NOUN
iajs-2137	75	14	level	level	NOUN
iajs-2137	75	15	in	in	ADP
iajs-2137	75	16	the	the	DET
iajs-2137	75	17	sera	sera	NOUN
iajs-2137	75	18	of	of	ADP
iajs-2137	75	19	patients	patient	NOUN
iajs-2137	75	20	in	in	ADP
iajs-2137	75	21	comparision	comparision	NOUN
iajs-2137	75	22	with	with	ADP
iajs-2137	75	23	that	that	PRON
iajs-2137	75	24	of	of	ADP
iajs-2137	75	25	the	the	DET
iajs-2137	75	26	control	control	NOUN
iajs-2137	75	27	group	group	NOUN
iajs-2137	75	28	.	.	PUNCT
iajs-2137	76	1	p	p	X
iajs-2137	76	2	-	-	PUNCT
iajs-2137	76	3	value	value	NOUN
iajs-2137	76	4	sd	sd	NOUN
iajs-2137	76	5	mean	mean	NOUN
iajs-2137	76	6	(	(	PUNCT
iajs-2137	76	7	mg	mg	PROPN
iajs-2137	76	8	/	/	SYM
iajs-2137	76	9	dl	dl	NOUN
iajs-2137	76	10	)	)	PUNCT
iajs-2137	76	11	age	age	NOUN
iajs-2137	76	12	/	/	SYM
iajs-2137	76	13	year	year	NOUN
iajs-2137	76	14	n	n	CCONJ
iajs-2137	76	15	(	(	PUNCT
iajs-2137	76	16	numbers	number	NOUN
iajs-2137	76	17	)	)	PUNCT
iajs-2137	76	18	groups	group	NOUN
iajs-2137	76	19	p=	p=	VERB
iajs-2137	76	20	0.004	0.004	NUM
iajs-2137	76	21	42.23	42.23	NUM
iajs-2137	76	22	189.2	189.2	NUM
iajs-2137	76	23	32	32	NUM
iajs-2137	76	24	-	-	SYM
iajs-2137	76	25	75	75	NUM
iajs-2137	76	26	25	25	NUM
iajs-2137	76	27	test	test	NOUN
iajs-2137	76	28	27.95	27.95	NUM
iajs-2137	76	29	110.5	110.5	NUM
iajs-2137	76	30	20	20	NUM
iajs-2137	76	31	-	-	SYM
iajs-2137	76	32	64	64	NUM
iajs-2137	76	33	25	25	NUM
iajs-2137	76	34	control	control	NOUN
iajs-2137	76	35	04	04	NUM
iajs-2137	77	1	ibn	ibn	PROPN
iajs-2137	77	2	al	al	PROPN
iajs-2137	77	3	-	-	PUNCT
iajs-2137	77	4	haitham	haitham	PROPN
iajs-2137	77	5	jour	jour	X
iajs-2137	77	6	.	.	PROPN
iajs-2137	77	7	for	for	ADP
iajs-2137	77	8	pure	pure	ADJ
iajs-2137	77	9	&	&	CCONJ
iajs-2137	77	10	appl	appl	PROPN
iajs-2137	77	11	.	.	PUNCT
iajs-2137	78	1	sci	sci	PROPN
iajs-2137	78	2	.	.	PROPN
iajs-2137	78	3	32	32	NUM
iajs-2137	78	4	(	(	PUNCT
iajs-2137	78	5	2	2	NUM
iajs-2137	78	6	)	)	SYM
iajs-2137	78	7	2019	2019	NUM
iajs-2137	78	8	table	table	NOUN
iajs-2137	78	9	2.total	2.total	NUM
iajs-2137	78	10	protein	protein	NOUN
iajs-2137	78	11	in	in	ADP
iajs-2137	78	12	the	the	DET
iajs-2137	78	13	sera	sera	NOUN
iajs-2137	78	14	of	of	ADP
iajs-2137	78	15	control	control	NOUN
iajs-2137	78	16	and	and	CCONJ
iajs-2137	78	17	patients	patient	NOUN
iajs-2137	78	18	as	as	ADP
iajs-2137	78	19	test	test	NOUN
iajs-2137	78	20	group	group	NOUN
iajs-2137	78	21	with	with	ADP
iajs-2137	78	22	statistical	statistical	ADJ
iajs-2137	78	23	analysis	analysis	NOUN
iajs-2137	78	24	value	value	NOUN
iajs-2137	78	25	.	.	PUNCT
iajs-2137	79	1	potassium	potassium	NOUN
iajs-2137	79	2	(	(	PUNCT
iajs-2137	79	3	k	k	NOUN
iajs-2137	79	4	+1	+1	PROPN
iajs-2137	79	5	)	)	PUNCT
iajs-2137	79	6	was	be	AUX
iajs-2137	79	7	measurment	measurment	NOUN
iajs-2137	79	8	have	have	AUX
iajs-2137	79	9	been	be	AUX
iajs-2137	79	10	a	a	DET
iajs-2137	79	11	results	result	NOUN
iajs-2137	79	12	that	that	PRON
iajs-2137	79	13	obtained	obtain	VERB
iajs-2137	79	14	from	from	ADP
iajs-2137	79	15	this	this	DET
iajs-2137	79	16	work	work	NOUN
iajs-2137	79	17	,	,	PUNCT
iajs-2137	79	18	and	and	CCONJ
iajs-2137	79	19	showed	show	VERB
iajs-2137	79	20	in	in	ADP
iajs-2137	79	21	the	the	DET
iajs-2137	79	22	table	table	NOUN
iajs-2137	79	23	3	3	X
iajs-2137	79	24	.	.	PUNCT
iajs-2137	80	1	the	the	DET
iajs-2137	80	2	mean	mean	ADJ
iajs-2137	80	3	value	value	NOUN
iajs-2137	80	4	manifested	manifest	VERB
iajs-2137	80	5	hyperkalaemia	hyperkalaemia	NOUN
iajs-2137	80	6	where	where	SCONJ
iajs-2137	80	7	potassium	potassium	NOUN
iajs-2137	80	8	level	level	NOUN
iajs-2137	80	9	in	in	ADP
iajs-2137	80	10	the	the	DET
iajs-2137	80	11	sera	sera	NOUN
iajs-2137	80	12	of	of	ADP
iajs-2137	80	13	patient	patient	ADJ
iajs-2137	80	14	group	group	NOUN
iajs-2137	80	15	increased	increase	VERB
iajs-2137	80	16	significantly	significantly	ADV
iajs-2137	80	17	with	with	ADP
iajs-2137	80	18	variations	variation	NOUN
iajs-2137	80	19	(	(	PUNCT
iajs-2137	80	20	p	p	X
iajs-2137	80	21	=	=	NOUN
iajs-2137	80	22	0.03	0.03	NUM
iajs-2137	80	23	)	)	PUNCT
iajs-2137	80	24	in	in	ADP
iajs-2137	80	25	comparision	comparision	NOUN
iajs-2137	80	26	with	with	ADP
iajs-2137	80	27	that	that	PRON
iajs-2137	80	28	of	of	ADP
iajs-2137	80	29	the	the	DET
iajs-2137	80	30	control	control	NOUN
iajs-2137	80	31	group	group	NOUN
iajs-2137	80	32	.	.	PUNCT
iajs-2137	81	1	table	table	NOUN
iajs-2137	81	2	3	3	NUM
iajs-2137	81	3	.	.	X
iajs-2137	81	4	potassium	potassium	NOUN
iajs-2137	81	5	mean	mean	NOUN
iajs-2137	81	6	level	level	NOUN
iajs-2137	81	7	in	in	ADP
iajs-2137	81	8	the	the	DET
iajs-2137	81	9	sera	sera	NOUN
iajs-2137	81	10	of	of	ADP
iajs-2137	81	11	control	control	NOUN
iajs-2137	81	12	and	and	CCONJ
iajs-2137	81	13	patients	patient	NOUN
iajs-2137	81	14	as	as	ADP
iajs-2137	81	15	test	test	NOUN
iajs-2137	81	16	group	group	NOUN
iajs-2137	81	17	with	with	ADP
iajs-2137	81	18	statistical	statistical	ADJ
iajs-2137	81	19	analysis	analysis	NOUN
iajs-2137	81	20	value	value	NOUN
iajs-2137	81	21	.	.	PUNCT
iajs-2137	82	1	calcium	calcium	NOUN
iajs-2137	82	2	measurement	measurement	NOUN
iajs-2137	82	3	results	result	NOUN
iajs-2137	82	4	demonstrated	demonstrate	VERB
iajs-2137	82	5	the	the	DET
iajs-2137	82	6	mean	mean	ADJ
iajs-2137	82	7	value	value	NOUN
iajs-2137	82	8	in	in	ADP
iajs-2137	82	9	table	table	NOUN
iajs-2137	82	10	4	4	NUM
iajs-2137	82	11	,	,	PUNCT
iajs-2137	82	12	showed	show	VERB
iajs-2137	82	13	non	non	ADJ
iajs-2137	82	14	significant	significant	ADJ
iajs-2137	82	15	variations	variation	NOUN
iajs-2137	82	16	(	(	PUNCT
iajs-2137	82	17	p>0.05	p>0.05	PROPN
iajs-2137	82	18	)	)	PUNCT
iajs-2137	82	19	in	in	ADP
iajs-2137	82	20	calcium	calcium	NOUN
iajs-2137	82	21	level	level	NOUN
iajs-2137	82	22	in	in	ADP
iajs-2137	82	23	the	the	DET
iajs-2137	82	24	sera	sera	NOUN
iajs-2137	82	25	of	of	ADP
iajs-2137	82	26	patients	patient	NOUN
iajs-2137	82	27	,	,	PUNCT
iajs-2137	82	28	in	in	ADP
iajs-2137	82	29	comparision	comparision	NOUN
iajs-2137	82	30	with	with	ADP
iajs-2137	82	31	control	control	NOUN
iajs-2137	82	32	group	group	NOUN
iajs-2137	82	33	.	.	PUNCT
iajs-2137	83	1	table	table	NOUN
iajs-2137	83	2	4	4	NUM
iajs-2137	83	3	.	.	PUNCT
iajs-2137	83	4	calcium	calcium	NOUN
iajs-2137	83	5	mean	mean	NOUN
iajs-2137	83	6	level	level	NOUN
iajs-2137	83	7	in	in	ADP
iajs-2137	83	8	the	the	DET
iajs-2137	83	9	sera	sera	NOUN
iajs-2137	83	10	of	of	ADP
iajs-2137	83	11	control	control	NOUN
iajs-2137	83	12	and	and	CCONJ
iajs-2137	83	13	patients	patient	NOUN
iajs-2137	83	14	as	as	ADP
iajs-2137	83	15	test	test	NOUN
iajs-2137	83	16	group	group	NOUN
iajs-2137	83	17	with	with	ADP
iajs-2137	83	18	statistical	statistical	ADJ
iajs-2137	83	19	analysis	analysis	NOUN
iajs-2137	83	20	value	value	NOUN
iajs-2137	83	21	.	.	PUNCT
iajs-2137	84	1	4	4	X
iajs-2137	84	2	.	.	X
iajs-2137	84	3	discussion	discussion	NOUN
iajs-2137	84	4	chronic	chronic	ADJ
iajs-2137	84	5	renal	renal	ADJ
iajs-2137	84	6	failure	failure	NOUN
iajs-2137	84	7	(	(	PUNCT
iajs-2137	84	8	crf	crf	NOUN
iajs-2137	84	9	)	)	PUNCT
iajs-2137	84	10	indicated	indicate	VERB
iajs-2137	84	11	to	to	ADP
iajs-2137	84	12	to	to	ADP
iajs-2137	84	13	an	an	DET
iajs-2137	84	14	irreversible	irreversible	ADJ
iajs-2137	84	15	deterioration	deterioration	NOUN
iajs-2137	84	16	in	in	ADP
iajs-2137	84	17	kidney	kidney	NOUN
iajs-2137	84	18	function	function	NOUN
iajs-2137	84	19	which	which	PRON
iajs-2137	84	20	developes	develop	VERB
iajs-2137	84	21	over	over	ADP
iajs-2137	84	22	of	of	ADP
iajs-2137	84	23	many	many	ADJ
iajs-2137	84	24	years	year	NOUN
iajs-2137	84	25	.	.	PUNCT
iajs-2137	84	26	,	,	PUNCT
iajs-2137	84	27	or	or	CCONJ
iajs-2137	84	28	function	function	NOUN
iajs-2137	84	29	and	and	CCONJ
iajs-2137	84	30	physiological	physiological	ADJ
iajs-2137	84	31	state	state	NOUN
iajs-2137	84	32	regarded	regard	VERB
iajs-2137	84	33	abnormal	abnormal	ADJ
iajs-2137	84	34	of	of	ADP
iajs-2137	84	35	kidney	kidney	NOUN
iajs-2137	84	36	that	that	PRON
iajs-2137	84	37	appear	appear	VERB
iajs-2137	84	38	for	for	ADP
iajs-2137	84	39	at	at	ADV
iajs-2137	84	40	least	least	ADV
iajs-2137	84	41	three	three	NUM
iajs-2137	84	42	months	month	NOUN
iajs-2137	84	43	or	or	CCONJ
iajs-2137	84	44	achronic	achronic	VERB
iajs-2137	84	45	significantly	significantly	ADV
iajs-2137	84	46	decreasing	decrease	VERB
iajs-2137	84	47	in	in	ADP
iajs-2137	84	48	kidney	kidney	NOUN
iajs-2137	84	49	function	function	NOUN
iajs-2137	84	50	[	[	X
iajs-2137	84	51	26	26	NUM
iajs-2137	84	52	]	]	PUNCT
iajs-2137	84	53	.	.	PUNCT
iajs-2137	85	1	total	total	ADJ
iajs-2137	85	2	protein	protein	NOUN
iajs-2137	85	3	measurement	measurement	NOUN
iajs-2137	85	4	was	be	AUX
iajs-2137	85	5	regarded	regard	VERB
iajs-2137	85	6	very	very	ADV
iajs-2137	85	7	important	important	ADJ
iajs-2137	85	8	in	in	ADP
iajs-2137	85	9	the	the	DET
iajs-2137	85	10	present	present	ADJ
iajs-2137	85	11	study	study	NOUN
iajs-2137	85	12	at	at	ADP
iajs-2137	85	13	end	end	NOUN
iajs-2137	85	14	stage	stage	NOUN
iajs-2137	85	15	of	of	ADP
iajs-2137	85	16	chronic	chronic	ADJ
iajs-2137	85	17	renal	renal	ADJ
iajs-2137	85	18	failure	failure	NOUN
iajs-2137	85	19	.	.	PUNCT
iajs-2137	86	1	there	there	PRON
iajs-2137	86	2	are	be	VERB
iajs-2137	86	3	many	many	ADJ
iajs-2137	86	4	physiological	physiological	ADJ
iajs-2137	86	5	and	and	CCONJ
iajs-2137	86	6	diseases	disease	NOUN
iajs-2137	86	7	were	be	AUX
iajs-2137	86	8	recorded	record	VERB
iajs-2137	86	9	lead	lead	NOUN
iajs-2137	86	10	to	to	ADP
iajs-2137	86	11	decreasing	decrease	VERB
iajs-2137	86	12	in	in	ADP
iajs-2137	86	13	sera	sera	NOUN
iajs-2137	86	14	of	of	ADP
iajs-2137	86	15	total	total	ADJ
iajs-2137	86	16	protein	protein	NOUN
iajs-2137	86	17	[	[	X
iajs-2137	86	18	27	27	NUM
iajs-2137	86	19	]	]	PUNCT
iajs-2137	86	20	.	.	PUNCT
iajs-2137	87	1	hypoproteinaemia	hypoproteinaemia	PROPN
iajs-2137	87	2	in	in	ADP
iajs-2137	87	3	diabetic	diabetic	ADJ
iajs-2137	87	4	patients	patient	NOUN
iajs-2137	87	5	as	as	SCONJ
iajs-2137	87	6	listed	list	VERB
iajs-2137	87	7	p	p	NOUN
iajs-2137	87	8	-	-	PUNCT
iajs-2137	87	9	value	value	NOUN
iajs-2137	87	10	sd	sd	NOUN
iajs-2137	87	11	mean	mean	NOUN
iajs-2137	87	12	(	(	PUNCT
iajs-2137	87	13	g	g	NOUN
iajs-2137	87	14	/	/	SYM
iajs-2137	87	15	dl	dl	NOUN
iajs-2137	87	16	)	)	PUNCT
iajs-2137	87	17	age	age	NOUN
iajs-2137	87	18	/	/	SYM
iajs-2137	87	19	year	year	NOUN
iajs-2137	87	20	n	n	CCONJ
iajs-2137	87	21	(	(	PUNCT
iajs-2137	87	22	numbers	number	NOUN
iajs-2137	87	23	)	)	PUNCT
iajs-2137	87	24	groups	group	NOUN
iajs-2137	87	25	p=	p=	VERB
iajs-2137	88	1	0.0002	0.0002	NUM
iajs-2137	88	2	0.91	0.91	NUM
iajs-2137	88	3	2.524	2.524	NUM
iajs-2137	88	4	32	32	NUM
iajs-2137	88	5	-	-	SYM
iajs-2137	88	6	75	75	NUM
iajs-2137	88	7	25	25	NUM
iajs-2137	88	8	test	test	NOUN
iajs-2137	88	9	0.46	0.46	NUM
iajs-2137	88	10	7.484	7.484	NUM
iajs-2137	88	11	20	20	NUM
iajs-2137	88	12	-	-	SYM
iajs-2137	88	13	64	64	NUM
iajs-2137	88	14	25	25	NUM
iajs-2137	88	15	control	control	NOUN
iajs-2137	88	16	p	p	NOUN
iajs-2137	88	17	-	-	PUNCT
iajs-2137	88	18	value	value	NOUN
iajs-2137	88	19	sd	sd	NOUN
iajs-2137	88	20	mean	mean	NOUN
iajs-2137	88	21	of	of	ADP
iajs-2137	88	22	(	(	PUNCT
iajs-2137	88	23	mmol	mmol	NOUN
iajs-2137	88	24	/	/	SYM
iajs-2137	88	25	l	l	NOUN
iajs-2137	88	26	)	)	PUNCT
iajs-2137	88	27	age	age	NOUN
iajs-2137	88	28	/	/	SYM
iajs-2137	88	29	year	year	NOUN
iajs-2137	88	30	n	n	CCONJ
iajs-2137	88	31	(	(	PUNCT
iajs-2137	88	32	numbers	number	NOUN
iajs-2137	88	33	)	)	PUNCT
iajs-2137	88	34	groups	group	NOUN
iajs-2137	88	35	p=	p=	VERB
iajs-2137	88	36	0.03	0.03	NUM
iajs-2137	88	37	0.94	0.94	NUM
iajs-2137	88	38	5.272	5.272	NUM
iajs-2137	88	39	32	32	NUM
iajs-2137	88	40	-	-	SYM
iajs-2137	88	41	75	75	NUM
iajs-2137	88	42	25	25	NUM
iajs-2137	88	43	test	test	NOUN
iajs-2137	88	44	0.44	0.44	NUM
iajs-2137	88	45	4.308	4.308	NUM
iajs-2137	88	46	20	20	NUM
iajs-2137	88	47	-	-	SYM
iajs-2137	88	48	64	64	NUM
iajs-2137	88	49	25	25	NUM
iajs-2137	88	50	control	control	NOUN
iajs-2137	88	51	p	p	NOUN
iajs-2137	88	52	-	-	PUNCT
iajs-2137	88	53	value	value	NOUN
iajs-2137	88	54	sd	sd	NOUN
iajs-2137	88	55	mean	mean	NOUN
iajs-2137	88	56	(	(	PUNCT
iajs-2137	88	57	mmol	mmol	NOUN
iajs-2137	88	58	/	/	SYM
iajs-2137	88	59	l	l	NOUN
iajs-2137	88	60	)	)	PUNCT
iajs-2137	88	61	age	age	NOUN
iajs-2137	88	62	/	/	SYM
iajs-2137	88	63	year	year	NOUN
iajs-2137	88	64	n	n	CCONJ
iajs-2137	88	65	(	(	PUNCT
iajs-2137	88	66	numbers	number	NOUN
iajs-2137	88	67	)	)	PUNCT
iajs-2137	88	68	groups	group	NOUN
iajs-2137	88	69	p	p	X
iajs-2137	88	70	>	>	X
iajs-2137	88	71	0.05	0.05	NUM
iajs-2137	88	72	1.36	1.36	NUM
iajs-2137	88	73	8.94	8.94	NUM
iajs-2137	88	74	32	32	NUM
iajs-2137	88	75	-	-	SYM
iajs-2137	88	76	75	75	NUM
iajs-2137	88	77	25	25	NUM
iajs-2137	88	78	test	test	NOUN
iajs-2137	88	79	0.62	0.62	NUM
iajs-2137	88	80	9.112	9.112	NUM
iajs-2137	88	81	20	20	NUM
iajs-2137	88	82	-	-	SYM
iajs-2137	88	83	64	64	NUM
iajs-2137	88	84	25	25	NUM
iajs-2137	88	85	control	control	NOUN
iajs-2137	88	86	04	04	NUM
iajs-2137	89	1	ibn	ibn	PROPN
iajs-2137	89	2	al	al	PROPN
iajs-2137	89	3	-	-	PUNCT
iajs-2137	89	4	haitham	haitham	PROPN
iajs-2137	89	5	jour	jour	X
iajs-2137	89	6	.	.	PROPN
iajs-2137	89	7	for	for	ADP
iajs-2137	89	8	pure	pure	ADJ
iajs-2137	89	9	&	&	CCONJ
iajs-2137	89	10	appl	appl	PROPN
iajs-2137	89	11	.	.	PUNCT
iajs-2137	90	1	sci	sci	PROPN
iajs-2137	90	2	.	.	PROPN
iajs-2137	90	3	32	32	NUM
iajs-2137	90	4	(	(	PUNCT
iajs-2137	90	5	2	2	NUM
iajs-2137	90	6	)	)	PUNCT
iajs-2137	90	7	2019	2019	NUM
iajs-2137	90	8	in	in	ADP
iajs-2137	90	9	table	table	NOUN
iajs-2137	90	10	2	2	NUM
iajs-2137	90	11	.	.	PUNCT
iajs-2137	90	12	attributed	attribute	VERB
iajs-2137	90	13	to	to	ADP
iajs-2137	90	14	increasing	increase	VERB
iajs-2137	90	15	of	of	ADP
iajs-2137	90	16	protein	protein	NOUN
iajs-2137	90	17	excretion	excretion	NOUN
iajs-2137	90	18	with	with	ADP
iajs-2137	90	19	urine	urine	NOUN
iajs-2137	90	20	as	as	ADV
iajs-2137	90	21	well	well	ADV
iajs-2137	90	22	as	as	ADP
iajs-2137	90	23	albumin	albumin	ADJ
iajs-2137	90	24	,	,	PUNCT
iajs-2137	90	25	in	in	ADP
iajs-2137	90	26	the	the	DET
iajs-2137	90	27	same	same	ADJ
iajs-2137	90	28	time	time	NOUN
iajs-2137	90	29	the	the	DET
iajs-2137	90	30	liver	liver	NOUN
iajs-2137	90	31	can	can	AUX
iajs-2137	90	32	not	not	PART
iajs-2137	90	33	be	be	AUX
iajs-2137	90	34	able	able	ADJ
iajs-2137	90	35	to	to	PART
iajs-2137	90	36	substitution	substitution	VERB
iajs-2137	90	37	this	this	DET
iajs-2137	90	38	protein	protein	NOUN
iajs-2137	90	39	loos	loo	VERB
iajs-2137	90	40	[	[	X
iajs-2137	90	41	28	28	NUM
iajs-2137	90	42	]	]	PUNCT
iajs-2137	90	43	.	.	PUNCT
iajs-2137	91	1	on	on	ADP
iajs-2137	91	2	the	the	DET
iajs-2137	91	3	other	other	ADJ
iajs-2137	91	4	hand	hand	NOUN
iajs-2137	91	5	,	,	PUNCT
iajs-2137	91	6	k	k	PROPN
iajs-2137	91	7	+	+	PROPN
iajs-2137	91	8	was	be	AUX
iajs-2137	91	9	regarded	regard	VERB
iajs-2137	91	10	a	a	DET
iajs-2137	91	11	major	major	ADJ
iajs-2137	91	12	important	important	ADJ
iajs-2137	91	13	cation	cation	NOUN
iajs-2137	91	14	in	in	ADP
iajs-2137	91	15	cells	cell	NOUN
iajs-2137	91	16	metabolism	metabolism	NOUN
iajs-2137	91	17	of	of	ADP
iajs-2137	91	18	nerve	nerve	NOUN
iajs-2137	91	19	and	and	CCONJ
iajs-2137	91	20	muscles	muscle	NOUN
iajs-2137	91	21	.	.	PUNCT
iajs-2137	92	1	it	it	PRON
iajs-2137	92	2	’s	’s	AUX
iajs-2137	92	3	mainly	mainly	ADV
iajs-2137	92	4	located	locate	VERB
iajs-2137	92	5	intracellular	intracellular	ADJ
iajs-2137	92	6	[	[	X
iajs-2137	92	7	29	29	NUM
iajs-2137	92	8	]	]	PUNCT
iajs-2137	92	9	.	.	PUNCT
iajs-2137	93	1	in	in	ADP
iajs-2137	93	2	the	the	DET
iajs-2137	93	3	present	present	ADJ
iajs-2137	93	4	study	study	NOUN
iajs-2137	93	5	hyperkalemia	hyperkalemia	NOUN
iajs-2137	93	6	is	be	AUX
iajs-2137	93	7	a	a	DET
iajs-2137	93	8	clear	clear	ADJ
iajs-2137	93	9	,	,	PUNCT
iajs-2137	93	10	was	be	AUX
iajs-2137	93	11	presented	present	VERB
iajs-2137	93	12	in	in	ADP
iajs-2137	93	13	table	table	NOUN
iajs-2137	93	14	3	3	NUM
iajs-2137	93	15	.	.	PUNCT
iajs-2137	94	1	and	and	CCONJ
iajs-2137	94	2	its	its	PRON
iajs-2137	94	3	metabolism	metabolism	NOUN
iajs-2137	94	4	related	relate	VERB
iajs-2137	94	5	with	with	ADP
iajs-2137	94	6	endocrine	endocrine	NOUN
iajs-2137	94	7	and	and	CCONJ
iajs-2137	94	8	some	some	DET
iajs-2137	94	9	other	other	ADJ
iajs-2137	94	10	drugs	drug	NOUN
iajs-2137	94	11	.	.	PUNCT
iajs-2137	94	12	,	,	PUNCT
iajs-2137	94	13	which	which	PRON
iajs-2137	94	14	was	be	AUX
iajs-2137	94	15	recorded	record	VERB
iajs-2137	94	16	and	and	CCONJ
iajs-2137	94	17	proved	prove	VERB
iajs-2137	94	18	in	in	ADP
iajs-2137	94	19	many	many	ADJ
iajs-2137	94	20	researches	research	NOUN
iajs-2137	94	21	.	.	PUNCT
iajs-2137	95	1	the	the	DET
iajs-2137	95	2	patient	patient	NOUN
iajs-2137	95	3	’s	’s	PART
iajs-2137	95	4	group	group	NOUN
iajs-2137	95	5	with	with	ADP
iajs-2137	95	6	crf	crf	PROPN
iajs-2137	95	7	in	in	ADP
iajs-2137	95	8	the	the	DET
iajs-2137	95	9	present	present	ADJ
iajs-2137	95	10	study	study	NOUN
iajs-2137	95	11	was	be	AUX
iajs-2137	95	12	administrated	administrate	VERB
iajs-2137	95	13	sulfonyl	sulfonyl	ADJ
iajs-2137	95	14	urea	urea	NOUN
iajs-2137	95	15	drug	drug	NOUN
iajs-2137	95	16	that	that	PRON
iajs-2137	95	17	affected	affect	VERB
iajs-2137	95	18	on	on	ADP
iajs-2137	95	19	the	the	DET
iajs-2137	95	20	endocrine	endocrine	NOUN
iajs-2137	95	21	system	system	NOUN
iajs-2137	95	22	and	and	CCONJ
iajs-2137	95	23	related	relate	VERB
iajs-2137	95	24	with	with	ADP
iajs-2137	95	25	k	k	PROPN
iajs-2137	96	1	+	+	PUNCT
iajs-2137	96	2	metabolism	metabolism	NOUN
iajs-2137	96	3	.	.	PUNCT
iajs-2137	97	1	hyperkalemia	hyperkalemia	NOUN
iajs-2137	97	2	that	that	PRON
iajs-2137	97	3	showed	show	VERB
iajs-2137	97	4	in	in	ADP
iajs-2137	97	5	our	our	PRON
iajs-2137	97	6	study	study	NOUN
iajs-2137	97	7	may	may	AUX
iajs-2137	97	8	be	be	AUX
iajs-2137	97	9	due	due	ADJ
iajs-2137	97	10	to	to	ADP
iajs-2137	97	11	inhibition	inhibition	NOUN
iajs-2137	97	12	of	of	ADP
iajs-2137	97	13	aldosterone	aldosterone	NOUN
iajs-2137	97	14	,	,	PUNCT
iajs-2137	97	15	which	which	PRON
iajs-2137	97	16	is	be	AUX
iajs-2137	97	17	found	find	VERB
iajs-2137	97	18	in	in	ADP
iajs-2137	97	19	other	other	ADJ
iajs-2137	97	20	metabolic	metabolic	NOUN
iajs-2137	97	21	pathways	pathway	NOUN
iajs-2137	97	22	,	,	PUNCT
iajs-2137	97	23	as	as	ADV
iajs-2137	97	24	well	well	ADV
iajs-2137	97	25	as	as	ADP
iajs-2137	97	26	metformin	metformin	NOUN
iajs-2137	97	27	inhibits	inhibit	VERB
iajs-2137	97	28	aldosteroneinduced	aldosteroneinduce	VERB
iajs-2137	97	29	cardio	cardio	NOUN
iajs-2137	97	30	fibroblast	fibroblast	ADJ
iajs-2137	97	31	activation	activation	NOUN
iajs-2137	97	32	[	[	X
iajs-2137	97	33	30	30	NUM
iajs-2137	97	34	]	]	PUNCT
iajs-2137	97	35	.	.	PUNCT
iajs-2137	98	1	aldosterone	aldosterone	NOUN
iajs-2137	98	2	induced	induce	VERB
iajs-2137	98	3	k	k	PROPN
iajs-2137	99	1	+	+	CCONJ
iajs-2137	99	2	potassium	potassium	NOUN
iajs-2137	99	3	excretion	excretion	NOUN
iajs-2137	99	4	in	in	ADP
iajs-2137	99	5	the	the	DET
iajs-2137	99	6	renal	renal	ADJ
iajs-2137	99	7	distal	distal	ADJ
iajs-2137	99	8	tubule	tubule	NOUN
iajs-2137	99	9	,	,	PUNCT
iajs-2137	99	10	and	and	CCONJ
iajs-2137	99	11	colonic	colonic	ADJ
iajs-2137	99	12	epithelium	epithelium	NOUN
iajs-2137	100	1	[	[	X
iajs-2137	100	2	31	31	NUM
iajs-2137	100	3	]	]	PUNCT
iajs-2137	100	4	.	.	PUNCT
iajs-2137	101	1	glimepiride	glimepiride	PROPN
iajs-2137	101	2	can	can	AUX
iajs-2137	101	3	effect	effect	VERB
iajs-2137	101	4	on	on	ADP
iajs-2137	101	5	the	the	DET
iajs-2137	101	6	surface	surface	NOUN
iajs-2137	101	7	of	of	ADP
iajs-2137	101	8	intracellular	intracellular	ADJ
iajs-2137	101	9	membrane	membrane	NOUN
iajs-2137	101	10	which	which	PRON
iajs-2137	101	11	caulked	caulk	VERB
iajs-2137	101	12	all	all	DET
iajs-2137	101	13	three	three	NUM
iajs-2137	101	14	types	type	NOUN
iajs-2137	101	15	of	of	ADP
iajs-2137	101	16	katp	katp	NOUN
iajs-2137	101	17	channel	channel	NOUN
iajs-2137	101	18	[	[	X
iajs-2137	101	19	32	32	NUM
iajs-2137	101	20	]	]	PUNCT
iajs-2137	101	21	.	.	PUNCT
iajs-2137	102	1	therefore	therefore	ADV
iajs-2137	102	2	,	,	PUNCT
iajs-2137	102	3	can	can	AUX
iajs-2137	102	4	patients	patient	NOUN
iajs-2137	102	5	with	with	ADP
iajs-2137	102	6	crf	crf	PROPN
iajs-2137	102	7	and	and	CCONJ
iajs-2137	102	8	diabetic	diabetic	ADJ
iajs-2137	102	9	patients	patient	NOUN
iajs-2137	102	10	who	who	PRON
iajs-2137	102	11	had	have	VERB
iajs-2137	102	12	low	low	ADJ
iajs-2137	102	13	insulin	insulin	NOUN
iajs-2137	102	14	levels	level	NOUN
iajs-2137	102	15	may	may	AUX
iajs-2137	102	16	be	be	AUX
iajs-2137	102	17	have	have	VERB
iajs-2137	102	18	hyperkalemia	hyperkalemia	NOUN
iajs-2137	102	19	.	.	PUNCT
iajs-2137	103	1	elevated	elevated	ADJ
iajs-2137	103	2	level	level	NOUN
iajs-2137	103	3	of	of	ADP
iajs-2137	103	4	the	the	DET
iajs-2137	103	5	ultimate	ultimate	ADJ
iajs-2137	103	6	hormone	hormone	NOUN
iajs-2137	103	7	is	be	AUX
iajs-2137	103	8	an	an	DET
iajs-2137	103	9	unnecessarily	unnecessarily	ADV
iajs-2137	103	10	by	by	ADP
iajs-2137	103	11	feedback	feedback	NOUN
iajs-2137	103	12	inhibition	inhibition	NOUN
iajs-2137	103	13	so	so	ADV
iajs-2137	103	14	many	many	ADJ
iajs-2137	103	15	of	of	ADP
iajs-2137	103	16	intermediate	intermediate	ADJ
iajs-2137	103	17	hormone	hormone	NOUN
iajs-2137	103	18	inhibits	inhibit	VERB
iajs-2137	103	19	the	the	DET
iajs-2137	103	20	release	release	NOUN
iajs-2137	103	21	of	of	ADP
iajs-2137	103	22	earlier	early	ADJ
iajs-2137	103	23	hormones	hormone	NOUN
iajs-2137	103	24	in	in	ADP
iajs-2137	103	25	the	the	DET
iajs-2137	103	26	cascade	cascade	NOUN
iajs-2137	103	27	,	,	PUNCT
iajs-2137	103	28	therefore	therefore	ADV
iajs-2137	103	29	cortisol	cortisol	NOUN
iajs-2137	103	30	signal	signal	VERB
iajs-2137	103	31	stress	stress	NOUN
iajs-2137	103	32	including	include	VERB
iajs-2137	103	33	,	,	PUNCT
iajs-2137	103	34	blood	blood	NOUN
iajs-2137	103	35	glucose	glucose	NOUN
iajs-2137	103	36	with	with	ADP
iajs-2137	103	37	diabetes	diabetes	NOUN
iajs-2137	103	38	mellitus	mellitus	NOUN
iajs-2137	103	39	by	by	ADP
iajs-2137	103	40	cortisol	cortisol	PROPN
iajs-2137	103	41	counter	counter	NOUN
iajs-2137	103	42	-	-	NOUN
iajs-2137	103	43	balances	balance	VERB
iajs-2137	103	44	those	those	PRON
iajs-2137	103	45	of	of	ADP
iajs-2137	103	46	insulin	insulin	NOUN
iajs-2137	103	47	[	[	X
iajs-2137	103	48	33	33	NUM
iajs-2137	103	49	]	]	PUNCT
iajs-2137	103	50	.	.	PUNCT
iajs-2137	104	1	5	5	X
iajs-2137	104	2	.	.	X
iajs-2137	104	3	conclusion	conclusion	NOUN
iajs-2137	104	4	we	we	PRON
iajs-2137	104	5	concluded	conclude	VERB
iajs-2137	104	6	any	any	DET
iajs-2137	104	7	patient	patient	NOUN
iajs-2137	104	8	that	that	SCONJ
iajs-2137	104	9	undergoing	undergo	VERB
iajs-2137	104	10	from	from	ADP
iajs-2137	104	11	chronic	chronic	ADJ
iajs-2137	104	12	renal	renal	ADJ
iajs-2137	104	13	failure	failure	NOUN
iajs-2137	104	14	and	and	CCONJ
iajs-2137	104	15	diabetes	diabetes	NOUN
iajs-2137	104	16	mellitus	mellitus	NOUN
iajs-2137	104	17	suffer	suffer	VERB
iajs-2137	104	18	from	from	ADP
iajs-2137	104	19	high	high	ADJ
iajs-2137	104	20	level	level	NOUN
iajs-2137	104	21	in	in	ADP
iajs-2137	104	22	sera	sera	NOUN
iajs-2137	104	23	potassium	potassium	NOUN
iajs-2137	104	24	when	when	SCONJ
iajs-2137	104	25	administration	administration	NOUN
iajs-2137	104	26	metformin	metformin	NOUN
iajs-2137	104	27	and	and	CCONJ
iajs-2137	104	28	glimepiride	glimepiride	NOUN
iajs-2137	104	29	.	.	PUNCT
iajs-2137	105	1	due	due	ADP
iajs-2137	105	2	to	to	ADP
iajs-2137	105	3	these	these	DET
iajs-2137	105	4	drugs	drug	NOUN
iajs-2137	105	5	affected	affect	VERB
iajs-2137	105	6	on	on	ADP
iajs-2137	105	7	the	the	DET
iajs-2137	105	8	potassium	potassium	NOUN
iajs-2137	105	9	metabolism	metabolism	NOUN
iajs-2137	105	10	.	.	PUNCT
iajs-2137	106	1	and	and	CCONJ
iajs-2137	106	2	do	do	AUX
iajs-2137	106	3	n’t	not	PART
iajs-2137	106	4	eating	eat	VERB
iajs-2137	106	5	any	any	DET
iajs-2137	106	6	dietary	dietary	NOUN
iajs-2137	106	7	which	which	PRON
iajs-2137	106	8	containing	contain	VERB
iajs-2137	106	9	on	on	ADP
iajs-2137	106	10	high	high	ADJ
iajs-2137	106	11	level	level	NOUN
iajs-2137	106	12	of	of	ADP
iajs-2137	106	13	potassium	potassium	NOUN
iajs-2137	106	14	or	or	CCONJ
iajs-2137	106	15	moderating	moderate	VERB
iajs-2137	106	16	the	the	DET
iajs-2137	106	17	dose	dose	NOUN
iajs-2137	106	18	of	of	ADP
iajs-2137	106	19	these	these	DET
iajs-2137	106	20	drugs	drug	NOUN
iajs-2137	106	21	to	to	ADP
iajs-2137	106	22	less	less	ADJ
iajs-2137	106	23	dose	dose	PROPN
iajs-2137	106	24	.	.	PROPN
iajs-2137	107	1	6	6	NUM
iajs-2137	107	2	.	.	X
iajs-2137	107	3	recommendation	recommendation	NOUN
iajs-2137	107	4	further	further	ADJ
iajs-2137	107	5	studies	study	NOUN
iajs-2137	107	6	were	be	AUX
iajs-2137	107	7	characterization	characterization	NOUN
iajs-2137	107	8	of	of	ADP
iajs-2137	107	9	these	these	DET
iajs-2137	107	10	drugs	drug	NOUN
iajs-2137	107	11	on	on	ADP
iajs-2137	107	12	other	other	ADJ
iajs-2137	107	13	metal	metal	NOUN
iajs-2137	107	14	ions	ion	NOUN
iajs-2137	107	15	metabolism	metabolism	NOUN
iajs-2137	107	16	.	.	PUNCT
iajs-2137	108	1	references	reference	NOUN
iajs-2137	108	2	1	1	NUM
iajs-2137	108	3	.	.	PUNCT
iajs-2137	108	4	aastha	aastha	PROPN
iajs-2137	108	5	,	,	PUNCT
iajs-2137	108	6	c.	c.	PROPN
iajs-2137	108	7	;	;	PUNCT
iajs-2137	108	8	rajeev	rajeev	PROPN
iajs-2137	108	9	,	,	PUNCT
iajs-2137	108	10	c	c	X
iajs-2137	108	11	;	;	PUNCT
iajs-2137	108	12	shalini	shalini	PROPN
iajs-2137	108	13	,	,	PUNCT
iajs-2137	108	14	j.	j.	PROPN
iajs-2137	108	15	microvascular	microvascular	PROPN
iajs-2137	108	16	and	and	CCONJ
iajs-2137	108	17	macrovascular	macrovascular	ADJ
iajs-2137	108	18	complications	complication	NOUN
iajs-2137	108	19	in	in	ADP
iajs-2137	108	20	diabetes	diabetes	NOUN
iajs-2137	108	21	mellitus	mellitus	PROPN
iajs-2137	108	22	distinctor	distinctor	PROPN
iajs-2137	108	23	continuum	continuum	PROPN
iajs-2137	108	24	.	.	PUNCT
iajs-2137	109	1	indian	indian	PROPN
iajs-2137	109	2	journal	journal	PROPN
iajs-2137	109	3	of	of	ADP
iajs-2137	109	4	endocrinology	endocrinology	NOUN
iajs-2137	109	5	and	and	CCONJ
iajs-2137	109	6	metabolism.2016	metabolism.2016	PROPN
iajs-2137	109	7	,	,	PUNCT
iajs-2137	109	8	20	20	NUM
iajs-2137	109	9	,	,	PUNCT
iajs-2137	109	10	546	546	NUM
iajs-2137	109	11	-	-	SYM
iajs-2137	109	12	551	551	NUM
iajs-2137	109	13	.	.	NOUN
iajs-2137	110	1	2	2	X
iajs-2137	110	2	.	.	X
iajs-2137	110	3	go	go	VERB
iajs-2137	110	4	,	,	PUNCT
iajs-2137	110	5	a.s	a.s	PROPN
iajs-2137	110	6	.	.	PROPN
iajs-2137	110	7	;	;	PUNCT
iajs-2137	110	8	yang	yang	PROPN
iajs-2137	110	9	,	,	PUNCT
iajs-2137	110	10	j.	j.	PROPN
iajs-2137	110	11	;	;	PUNCT
iajs-2137	110	12	tan	tan	PROPN
iajs-2137	110	13	,	,	PUNCT
iajs-2137	110	14	t.c	t.c	PROPN
iajs-2137	110	15	.	.	PROPN
iajs-2137	110	16	;	;	PUNCT
iajs-2137	111	1	cabrera	cabrera	PROPN
iajs-2137	111	2	,	,	PUNCT
iajs-2137	111	3	c.s	c.s	PROPN
iajs-2137	111	4	.	.	PROPN
iajs-2137	111	5	;	;	PUNCT
iajs-2137	111	6	stefansson	stefansson	PROPN
iajs-2137	111	7	,	,	PUNCT
iajs-2137	111	8	b.v	b.v	PROPN
iajs-2137	111	9	.	.	PROPN
iajs-2137	111	10	;	;	PUNCT
iajs-2137	111	11	greasley	greasley	PROPN
iajs-2137	111	12	,	,	PUNCT
iajs-2137	111	13	p.j	p.j	PROPN
iajs-2137	111	14	.	.	PROPN
iajs-2137	111	15	;	;	PUNCT
iajs-2137	111	16	ordonez	ordonez	PROPN
iajs-2137	111	17	,	,	PUNCT
iajs-2137	111	18	j.d	j.d	PROPN
iajs-2137	111	19	.	.	PROPN
iajs-2137	111	20	contemporary	contemporary	ADJ
iajs-2137	111	21	rates	rate	NOUN
iajs-2137	111	22	and	and	CCONJ
iajs-2137	111	23	predictors	predictor	NOUN
iajs-2137	111	24	of	of	ADP
iajs-2137	111	25	fast	fast	ADJ
iajs-2137	111	26	progression	progression	NOUN
iajs-2137	111	27	of	of	ADP
iajs-2137	111	28	chronic	chronic	ADJ
iajs-2137	111	29	kidney	kidney	NOUN
iajs-2137	111	30	disease	disease	NOUN
iajs-2137	111	31	in	in	ADP
iajs-2137	111	32	adults	adult	NOUN
iajs-2137	111	33	with	with	ADP
iajs-2137	111	34	and	and	CCONJ
iajs-2137	111	35	without	without	ADP
iajs-2137	111	36	diabetes	diabetes	NOUN
iajs-2137	111	37	mellitus	mellitus	NOUN
iajs-2137	111	38	.	.	PUNCT
iajs-2137	112	1	bmc	bmc	PROPN
iajs-2137	112	2	nephrology.2018	nephrology.2018	PROPN
iajs-2137	112	3	,	,	PUNCT
iajs-2137	112	4	19	19	NUM
iajs-2137	112	5	,	,	PUNCT
iajs-2137	112	6	1	1	NUM
iajs-2137	112	7	-	-	SYM
iajs-2137	112	8	13	13	NUM
iajs-2137	112	9	.	.	PUNCT
iajs-2137	113	1	3	3	X
iajs-2137	113	2	.	.	X
iajs-2137	113	3	reznik	reznik	X
iajs-2137	113	4	,	,	PUNCT
iajs-2137	113	5	y.	y.	NOUN
iajs-2137	113	6	;	;	PUNCT
iajs-2137	113	7	habteab	habteab	NOUN
iajs-2137	113	8	,	,	PUNCT
iajs-2137	113	9	a.	a.	NOUN
iajs-2137	113	10	;	;	PUNCT
iajs-2137	113	11	castaneda	castaneda	PROPN
iajs-2137	113	12	,	,	PUNCT
iajs-2137	113	13	j.	j.	PROPN
iajs-2137	113	14	;	;	PUNCT
iajs-2137	113	15	shin	shin	PROPN
iajs-2137	113	16	,	,	PUNCT
iajs-2137	113	17	j.	j.	PROPN
iajs-2137	113	18	;	;	PUNCT
iajs-2137	113	19	joubert	joubert	PROPN
iajs-2137	113	20	,	,	PUNCT
iajs-2137	113	21	m.	m.	NOUN
iajs-2137	113	22	contribution	contribution	NOUN
iajs-2137	113	23	of	of	ADP
iajs-2137	113	24	basal	basal	NOUN
iajs-2137	113	25	and	and	CCONJ
iajs-2137	113	26	postprandial	postprandial	ADJ
iajs-2137	113	27	hyperglycaemia	hyperglycaemia	NOUN
iajs-2137	113	28	in	in	ADP
iajs-2137	113	29	type	type	NOUN
iajs-2137	113	30	2	2	NUM
iajs-2137	113	31	diabetes	diabetes	NOUN
iajs-2137	113	32	patients	patient	NOUN
iajs-2137	113	33	treated	treat	VERB
iajs-2137	113	34	by	by	ADP
iajs-2137	113	35	an	an	DET
iajs-2137	113	36	intensified	intensify	VERB
iajs-2137	113	37	insulin	insulin	NOUN
iajs-2137	113	38	regimen	regiman	NOUN
iajs-2137	113	39	:	:	PUNCT
iajs-2137	113	40	impact	impact	NOUN
iajs-2137	113	41	of	of	ADP
iajs-2137	113	42	pump	pump	NOUN
iajs-2137	113	43	therapy	therapy	NOUN
iajs-2137	113	44	in	in	ADP
iajs-2137	113	45	the	the	DET
iajs-2137	113	46	opt2mise	opt2mise	PROPN
iajs-2137	113	47	trial	trial	NOUN
iajs-2137	113	48	.	.	PUNCT
iajs-2137	114	1	diabetes	diabetes	NOUN
iajs-2137	114	2	,	,	PUNCT
iajs-2137	114	3	obesity	obesity	NOUN
iajs-2137	114	4	and	and	CCONJ
iajs-2137	114	5	metabolism.2018	metabolism.2018	NOUN
iajs-2137	114	6	,	,	PUNCT
iajs-2137	114	7	20	20	NUM
iajs-2137	114	8	,	,	PUNCT
iajs-2137	114	9	2435	2435	NUM
iajs-2137	114	10	-	-	SYM
iajs-2137	114	11	2441	2441	NUM
iajs-2137	114	12	.	.	PUNCT
iajs-2137	115	1	4	4	X
iajs-2137	115	2	.	.	X
iajs-2137	115	3	kaplan	kaplan	PROPN
iajs-2137	115	4	,	,	PUNCT
iajs-2137	115	5	l.a	l.a	PROPN
iajs-2137	115	6	.	.	PROPN
iajs-2137	115	7	;	;	PUNCT
iajs-2137	115	8	kazmierczak	kazmierczak	PROPN
iajs-2137	115	9	,	,	PUNCT
iajs-2137	115	10	s.c	s.c	PROPN
iajs-2137	115	11	.	.	PROPN
iajs-2137	115	12	;	;	PUNCT
iajs-2137	115	13	pesce	pesce	PROPN
iajs-2137	115	14	,	,	PUNCT
iajs-2137	115	15	a.j	a.j	PROPN
iajs-2137	115	16	.	.	PROPN
iajs-2137	115	17	clinical	clinical	ADJ
iajs-2137	115	18	chemistry	chemistry	NOUN
iajs-2137	115	19	:	:	PUNCT
iajs-2137	115	20	theory	theory	NOUN
iajs-2137	115	21	,	,	PUNCT
iajs-2137	115	22	analysis	analysis	NOUN
iajs-2137	115	23	,	,	PUNCT
iajs-2137	115	24	correlation	correlation	NOUN
iajs-2137	115	25	.	.	PUNCT
iajs-2137	115	26	4	4	NUM
iajs-2137	115	27	th	th	NUM
iajs-2137	115	28	edition	edition	NOUN
iajs-2137	115	29	.	.	PUNCT
iajs-2137	116	1	mosby	mosby	PROPN
iajs-2137	116	2	inc	inc	PROPN
iajs-2137	116	3	.	.	PROPN
iajs-2137	116	4	,	,	PUNCT
iajs-2137	116	5	library	library	NOUN
iajs-2137	116	6	of	of	ADP
iajs-2137	116	7	congress	congress	PROPN
iajs-2137	116	8	,	,	PUNCT
iajs-2137	116	9	2003	2003	NUM
iajs-2137	116	10	.	.	PUNCT
iajs-2137	117	1	5	5	X
iajs-2137	117	2	.	.	X
iajs-2137	117	3	sarnak	sarnak	PROPN
iajs-2137	117	4	,	,	PUNCT
iajs-2137	117	5	m.j	m.j	PROPN
iajs-2137	117	6	.	.	PROPN
iajs-2137	117	7	;	;	PUNCT
iajs-2137	117	8	greene	greene	PROPN
iajs-2137	117	9	,	,	PUNCT
iajs-2137	117	10	t.	t.	PROPN
iajs-2137	117	11	;	;	PUNCT
iajs-2137	117	12	wang	wang	PROPN
iajs-2137	117	13	,	,	PUNCT
iajs-2137	117	14	x.	x.	PROPN
iajs-2137	117	15	;	;	PUNCT
iajs-2137	117	16	beck	beck	PROPN
iajs-2137	117	17	,	,	PUNCT
iajs-2137	117	18	g.	g.	PROPN
iajs-2137	117	19	;	;	PUNCT
iajs-2137	117	20	kusek	kusek	PROPN
iajs-2137	117	21	,	,	PUNCT
iajs-2137	117	22	j.w	j.w	PROPN
iajs-2137	117	23	.	.	PROPN
iajs-2137	117	24	;	;	PUNCT
iajs-2137	117	25	collins	collins	PROPN
iajs-2137	117	26	,	,	PUNCT
iajs-2137	117	27	a.j	a.j	PROPN
iajs-2137	117	28	.	.	PROPN
iajs-2137	117	29	;	;	PUNCT
iajs-2137	117	30	levey	levey	PROPN
iajs-2137	117	31	,	,	PUNCT
iajs-2137	117	32	a.s	a.s	PROPN
iajs-2137	117	33	.	.	PUNCT
iajs-2137	118	1	the	the	DET
iajs-2137	118	2	effect	effect	NOUN
iajs-2137	118	3	of	of	ADP
iajs-2137	118	4	a	a	DET
iajs-2137	118	5	lower	low	ADJ
iajs-2137	118	6	target	target	NOUN
iajs-2137	118	7	blood	blood	NOUN
iajs-2137	118	8	pressure	pressure	NOUN
iajs-2137	118	9	on	on	ADP
iajs-2137	118	10	the	the	DET
iajs-2137	118	11	progression	progression	NOUN
iajs-2137	118	12	of	of	ADP
iajs-2137	118	13	kidney	kidney	NOUN
iajs-2137	118	14	disease	disease	NOUN
iajs-2137	118	15	:	:	PUNCT
iajs-2137	118	16	long	long	ADJ
iajs-2137	118	17	08	08	NUM
iajs-2137	118	18	ibn	ibn	PROPN
iajs-2137	118	19	al	al	PROPN
iajs-2137	118	20	-	-	PUNCT
iajs-2137	118	21	haitham	haitham	PROPN
iajs-2137	118	22	jour	jour	X
iajs-2137	118	23	.	.	PROPN
iajs-2137	119	1	for	for	ADP
iajs-2137	119	2	pure	pure	ADJ
iajs-2137	119	3	&	&	CCONJ
iajs-2137	119	4	appl	appl	PROPN
iajs-2137	119	5	.	.	PUNCT
iajs-2137	120	1	sci	sci	PROPN
iajs-2137	120	2	.	.	PROPN
iajs-2137	120	3	32	32	NUM
iajs-2137	120	4	(	(	PUNCT
iajs-2137	120	5	2	2	NUM
iajs-2137	120	6	)	)	SYM
iajs-2137	120	7	2019	2019	NUM
iajs-2137	120	8	term	term	NOUN
iajs-2137	120	9	follow	follow	NOUN
iajs-2137	120	10	-	-	PUNCT
iajs-2137	120	11	up	up	NOUN
iajs-2137	120	12	of	of	ADP
iajs-2137	120	13	the	the	DET
iajs-2137	120	14	modification	modification	NOUN
iajs-2137	120	15	of	of	ADP
iajs-2137	120	16	diet	diet	NOUN
iajs-2137	120	17	in	in	ADP
iajs-2137	120	18	renal	renal	ADJ
iajs-2137	120	19	disease	disease	NOUN
iajs-2137	120	20	study	study	NOUN
iajs-2137	120	21	.	.	PUNCT
iajs-2137	121	1	annals	annal	NOUN
iajs-2137	121	2	of	of	ADP
iajs-2137	121	3	internal	internal	ADJ
iajs-2137	121	4	medicine	medicine	NOUN
iajs-2137	121	5	.	.	PUNCT
iajs-2137	122	1	2005	2005	NUM
iajs-2137	122	2	,	,	PUNCT
iajs-2137	122	3	142	142	NUM
iajs-2137	122	4	,	,	PUNCT
iajs-2137	122	5	342	342	NUM
iajs-2137	122	6	-	-	SYM
iajs-2137	122	7	351	351	NUM
iajs-2137	122	8	.	.	NOUN
iajs-2137	123	1	6	6	NUM
iajs-2137	123	2	.	.	X
iajs-2137	123	3	eriksen	eriksen	PROPN
iajs-2137	123	4	,	,	PUNCT
iajs-2137	123	5	b.o	b.o	PROPN
iajs-2137	123	6	.	.	PROPN
iajs-2137	123	7	;	;	PUNCT
iajs-2137	123	8	ingebretsen	ingebretsen	PROPN
iajs-2137	123	9	,	,	PUNCT
iajs-2137	123	10	o.c	o.c	PROPN
iajs-2137	123	11	.	.	PROPN
iajs-2137	124	1	the	the	DET
iajs-2137	124	2	progression	progression	NOUN
iajs-2137	124	3	of	of	ADP
iajs-2137	124	4	chronic	chronic	ADJ
iajs-2137	124	5	kidney	kidney	NOUN
iajs-2137	124	6	disease	disease	NOUN
iajs-2137	124	7	:	:	PUNCT
iajs-2137	124	8	a	a	DET
iajs-2137	124	9	10	10	NUM
iajs-2137	124	10	-	-	PUNCT
iajs-2137	124	11	year	year	NOUN
iajs-2137	124	12	population	population	NOUN
iajs-2137	124	13	-	-	PUNCT
iajs-2137	124	14	based	base	VERB
iajs-2137	124	15	study	study	NOUN
iajs-2137	124	16	of	of	ADP
iajs-2137	124	17	the	the	DET
iajs-2137	124	18	effects	effect	NOUN
iajs-2137	124	19	of	of	ADP
iajs-2137	124	20	gender	gender	NOUN
iajs-2137	124	21	and	and	CCONJ
iajs-2137	124	22	age	age	NOUN
iajs-2137	124	23	.	.	PUNCT
iajs-2137	125	1	kidney	kidney	PROPN
iajs-2137	125	2	international	international	PROPN
iajs-2137	125	3	.	.	PUNCT
iajs-2137	126	1	2006	2006	NUM
iajs-2137	126	2	,	,	PUNCT
iajs-2137	126	3	69	69	NUM
iajs-2137	126	4	,	,	PUNCT
iajs-2137	126	5	375	375	NUM
iajs-2137	126	6	-	-	SYM
iajs-2137	126	7	382	382	NUM
iajs-2137	126	8	.	.	PUNCT
iajs-2137	127	1	7	7	X
iajs-2137	127	2	.	.	X
iajs-2137	127	3	beckett	beckett	PROPN
iajs-2137	127	4	,	,	PUNCT
iajs-2137	127	5	g.	g.	PROPN
iajs-2137	127	6	;	;	PUNCT
iajs-2137	127	7	walker	walker	PROPN
iajs-2137	127	8	,	,	PUNCT
iajs-2137	127	9	s.	s.	PROPN
iajs-2137	127	10	;	;	PUNCT
iajs-2137	127	11	rae	rae	PROPN
iajs-2137	127	12	,	,	PUNCT
iajs-2137	127	13	p.	p.	PROPN
iajs-2137	127	14	;	;	PUNCT
iajs-2137	127	15	ashby	ashby	PROPN
iajs-2137	127	16	,	,	PUNCT
iajs-2137	127	17	p.	p.	NOUN
iajs-2137	127	18	lecture	lecture	NOUN
iajs-2137	127	19	notes	note	VERB
iajs-2137	127	20	clinical	clinical	ADJ
iajs-2137	127	21	biochemistry	biochemistry	NOUN
iajs-2137	127	22	.	.	PUNCT
iajs-2137	128	1	4	4	NUM
iajs-2137	128	2	th	th	NUM
iajs-2137	128	3	edition	edition	NOUN
iajs-2137	128	4	.	.	PUNCT
iajs-2137	129	1	blackwell	blackwell	PROPN
iajs-2137	129	2	publishing	publishing	NOUN
iajs-2137	129	3	,	,	PUNCT
iajs-2137	129	4	2005	2005	NUM
iajs-2137	129	5	.	.	PUNCT
iajs-2137	130	1	8	8	NUM
iajs-2137	130	2	.	.	NUM
iajs-2137	130	3	shils	shil	NOUN
iajs-2137	130	4	,	,	PUNCT
iajs-2137	130	5	m.e	m.e	PROPN
iajs-2137	130	6	.	.	PROPN
iajs-2137	130	7	;	;	PUNCT
iajs-2137	130	8	oslen	oslen	VERB
iajs-2137	130	9	,	,	PUNCT
iajs-2137	130	10	j.a	j.a	PROPN
iajs-2137	130	11	.	.	PROPN
iajs-2137	130	12	;	;	PUNCT
iajs-2137	130	13	shike	shike	PROPN
iajs-2137	130	14	,	,	PUNCT
iajs-2137	130	15	m.	m.	NOUN
iajs-2137	130	16	;	;	PUNCT
iajs-2137	130	17	ross	ross	PROPN
iajs-2137	130	18	,	,	PUNCT
iajs-2137	130	19	a.c	a.c	PROPN
iajs-2137	130	20	.	.	PROPN
iajs-2137	130	21	modern	modern	ADJ
iajs-2137	130	22	nutrition	nutrition	NOUN
iajs-2137	130	23	in	in	ADP
iajs-2137	130	24	health	health	NOUN
iajs-2137	130	25	and	and	CCONJ
iajs-2137	130	26	disease	disease	NOUN
iajs-2137	130	27	.	.	PUNCT
iajs-2137	131	1	9	9	NUM
iajs-2137	131	2	th	th	NUM
iajs-2137	131	3	ed	ed	NOUN
iajs-2137	131	4	.	.	PUNCT
iajs-2137	132	1	baltimore	baltimore	PROPN
iajs-2137	132	2	:	:	PUNCT
iajs-2137	132	3	williams	williams	PROPN
iajs-2137	132	4	&	&	CCONJ
iajs-2137	132	5	wilkins	wilkins	PROPN
iajs-2137	132	6	,	,	PUNCT
iajs-2137	132	7	1999	1999	NUM
iajs-2137	132	8	.	.	PUNCT
iajs-2137	133	1	9	9	X
iajs-2137	133	2	.	.	X
iajs-2137	133	3	tai	tai	PROPN
iajs-2137	133	4	,	,	PUNCT
iajs-2137	133	5	v.	v.	PROPN
iajs-2137	133	6	;	;	PUNCT
iajs-2137	133	7	leung	leung	PROPN
iajs-2137	133	8	,	,	PUNCT
iajs-2137	133	9	w.	w.	PROPN
iajs-2137	133	10	;	;	PUNCT
iajs-2137	133	11	grey	grey	PROPN
iajs-2137	133	12	,	,	PUNCT
iajs-2137	133	13	a.	a.	NOUN
iajs-2137	133	14	;	;	PUNCT
iajs-2137	133	15	reid	reid	PROPN
iajs-2137	133	16	,	,	PUNCT
iajs-2137	133	17	i.r	i.r	PROPN
iajs-2137	133	18	.	.	PROPN
iajs-2137	133	19	;	;	PUNCT
iajs-2137	133	20	bolland	bolland	PROPN
iajs-2137	133	21	,	,	PUNCT
iajs-2137	133	22	m.j	m.j	PROPN
iajs-2137	133	23	.	.	PROPN
iajs-2137	133	24	calcium	calcium	NOUN
iajs-2137	133	25	intake	intake	NOUN
iajs-2137	133	26	and	and	CCONJ
iajs-2137	133	27	bone	bone	NOUN
iajs-2137	133	28	mineral	mineral	NOUN
iajs-2137	133	29	density	density	NOUN
iajs-2137	133	30	:	:	PUNCT
iajs-2137	133	31	systematic	systematic	ADJ
iajs-2137	133	32	review	review	NOUN
iajs-2137	133	33	and	and	CCONJ
iajs-2137	133	34	meta	meta	ADJ
iajs-2137	133	35	-	-	PUNCT
iajs-2137	133	36	analysis	analysis	NOUN
iajs-2137	133	37	.	.	PUNCT
iajs-2137	134	1	bmj	bmj	PROPN
iajs-2137	134	2	.	.	PROPN
iajs-2137	134	3	2015	2015	NUM
iajs-2137	134	4	,	,	PUNCT
iajs-2137	134	5	351	351	NUM
iajs-2137	134	6	,	,	PUNCT
iajs-2137	134	7	1	1	NUM
iajs-2137	134	8	-	-	SYM
iajs-2137	134	9	14	14	NUM
iajs-2137	134	10	.	.	PUNCT
iajs-2137	135	1	10	10	NUM
iajs-2137	135	2	.	.	X
iajs-2137	136	1	yang	yang	PROPN
iajs-2137	136	2	,	,	PUNCT
iajs-2137	136	3	c.y	c.y	PROPN
iajs-2137	136	4	.	.	PROPN
iajs-2137	136	5	;	;	PUNCT
iajs-2137	137	1	chen	chen	PROPN
iajs-2137	137	2	,	,	PUNCT
iajs-2137	137	3	f.a	f.a	PROPN
iajs-2137	137	4	.	.	PROPN
iajs-2137	137	5	;	;	PUNCT
iajs-2137	137	6	chen	chen	PROPN
iajs-2137	137	7	,	,	PUNCT
iajs-2137	137	8	c.f	c.f	PROPN
iajs-2137	137	9	.	.	PROPN
iajs-2137	137	10	;	;	PUNCT
iajs-2137	137	11	liu	liu	PROPN
iajs-2137	137	12	,	,	PUNCT
iajs-2137	137	13	w.s	w.s	PROPN
iajs-2137	137	14	.	.	PROPN
iajs-2137	137	15	;	;	PUNCT
iajs-2137	137	16	shih	shih	PROPN
iajs-2137	137	17	,	,	PUNCT
iajs-2137	137	18	c.j	c.j	PROPN
iajs-2137	137	19	.	.	PROPN
iajs-2137	137	20	;	;	PUNCT
iajs-2137	137	21	ou	ou	PROPN
iajs-2137	137	22	,	,	PUNCT
iajs-2137	137	23	s.m	s.m	PROPN
iajs-2137	137	24	.	.	PROPN
iajs-2137	137	25	;	;	PUNCT
iajs-2137	137	26	yang	yang	PROPN
iajs-2137	137	27	,	,	PUNCT
iajs-2137	137	28	w.c	w.c	PROPN
iajs-2137	137	29	.	.	PROPN
iajs-2137	137	30	;	;	PUNCT
iajs-2137	138	1	lin	lin	PROPN
iajs-2137	138	2	,	,	PUNCT
iajs-2137	138	3	c.c	c.c	PROPN
iajs-2137	138	4	.	.	PROPN
iajs-2137	138	5	;	;	PUNCT
iajs-2137	138	6	yang	yang	PROPN
iajs-2137	138	7	,	,	PUNCT
iajs-2137	138	8	a.h	a.h	PROPN
iajs-2137	138	9	.	.	PROPN
iajs-2137	138	10	diagnostic	diagnostic	ADJ
iajs-2137	138	11	accuracy	accuracy	NOUN
iajs-2137	138	12	of	of	ADP
iajs-2137	138	13	urine	urine	NOUN
iajs-2137	138	14	protein	protein	NOUN
iajs-2137	138	15	/	/	SYM
iajs-2137	138	16	creatinine	creatinine	NOUN
iajs-2137	138	17	ratio	ratio	NOUN
iajs-2137	138	18	is	be	AUX
iajs-2137	138	19	influenced	influence	VERB
iajs-2137	138	20	by	by	ADP
iajs-2137	138	21	urine	urine	NOUN
iajs-2137	138	22	concentration	concentration	NOUN
iajs-2137	138	23	.	.	PUNCT
iajs-2137	139	1	plos	plos	PROPN
iajs-2137	139	2	one	one	NUM
iajs-2137	139	3	.	.	PUNCT
iajs-2137	139	4	2015	2015	NUM
iajs-2137	139	5	,	,	PUNCT
iajs-2137	139	6	10	10	NUM
iajs-2137	139	7	,	,	PUNCT
iajs-2137	139	8	1	1	NUM
iajs-2137	139	9	-	-	SYM
iajs-2137	139	10	13	13	NUM
iajs-2137	139	11	.	.	PUNCT
iajs-2137	139	12	11	11	NUM
iajs-2137	139	13	.	.	PUNCT
iajs-2137	140	1	anderson	anderson	PROPN
iajs-2137	140	2	,	,	PUNCT
iajs-2137	140	3	j.j	j.j	PROPN
iajs-2137	140	4	.	.	PROPN
iajs-2137	140	5	;	;	PUNCT
iajs-2137	140	6	garner	garner	PROPN
iajs-2137	140	7	,	,	PUNCT
iajs-2137	140	8	s.c	s.c	PROPN
iajs-2137	140	9	.	.	PROPN
iajs-2137	140	10	calcium	calcium	NOUN
iajs-2137	140	11	and	and	CCONJ
iajs-2137	140	12	phosphorus	phosphorus	NOUN
iajs-2137	140	13	in	in	ADP
iajs-2137	140	14	health	health	NOUN
iajs-2137	140	15	and	and	CCONJ
iajs-2137	140	16	disease	disease	NOUN
iajs-2137	140	17	.	.	PUNCT
iajs-2137	141	1	crc	crc	PROPN
iajs-2137	141	2	press.1995	press.1995	PROPN
iajs-2137	141	3	.	.	PROPN
iajs-2137	142	1	12	12	NUM
iajs-2137	142	2	.	.	PUNCT
iajs-2137	143	1	robert	robert	PROPN
iajs-2137	143	2	,	,	PUNCT
iajs-2137	143	3	k.	k.	PROPN
iajs-2137	143	4	;	;	PUNCT
iajs-2137	143	5	murray	murray	PROPN
iajs-2137	143	6	,	,	PUNCT
iajs-2137	143	7	r.k	r.k	PROPN
iajs-2137	143	8	.	.	PROPN
iajs-2137	143	9	;	;	PUNCT
iajs-2137	143	10	daryl	daryl	PROPN
iajs-2137	143	11	,	,	PUNCT
iajs-2137	143	12	k.	k.	PROPN
iajs-2137	143	13	;	;	PUNCT
iajs-2137	143	14	granner	granner	ADJ
iajs-2137	143	15	,	,	PUNCT
iajs-2137	143	16	d.k	d.k	PROPN
iajs-2137	143	17	.	.	PROPN
iajs-2137	143	18	;	;	PUNCT
iajs-2137	143	19	rodwell	rodwell	PROPN
iajs-2137	143	20	,	,	PUNCT
iajs-2137	143	21	v.w	v.w	PROPN
iajs-2137	143	22	.	.	PROPN
iajs-2137	143	23	chapter	chapter	NOUN
iajs-2137	143	24	41	41	NUM
iajs-2137	143	25	.	.	PUNCT
iajs-2137	144	1	harper	harper	NOUN
iajs-2137	144	2	’s	’s	PART
iajs-2137	144	3	illustrated	illustrate	VERB
iajs-2137	144	4	biochemistry	biochemistry	NOUN
iajs-2137	144	5	.	.	PUNCT
iajs-2137	145	1	27	27	NUM
iajs-2137	145	2	th	th	NUM
iajs-2137	145	3	edition	edition	NOUN
iajs-2137	145	4	.	.	PUNCT
iajs-2137	145	5	mcgraw	mcgraw	PROPN
iajs-2137	145	6	-	-	PUNCT
iajs-2137	145	7	hill	hill	NOUN
iajs-2137	145	8	companies	company	NOUN
iajs-2137	145	9	,	,	PUNCT
iajs-2137	145	10	2006	2006	NUM
iajs-2137	145	11	.	.	PUNCT
iajs-2137	146	1	13	13	NUM
iajs-2137	146	2	.	.	PUNCT
iajs-2137	146	3	shcriff	shcriff	PROPN
iajs-2137	146	4	,	,	PUNCT
iajs-2137	146	5	d.s	d.s	PROPN
iajs-2137	146	6	.	.	PROPN
iajs-2137	146	7	medical	medical	PROPN
iajs-2137	146	8	biochemistry	biochemistry	PROPN
iajs-2137	146	9	.	.	PUNCT
iajs-2137	147	1	jaypee	jaypee	PROPN
iajs-2137	147	2	brather	brather	PROPN
iajs-2137	147	3	medical	medical	ADJ
iajs-2137	147	4	publishers	publisher	NOUN
iajs-2137	147	5	(	(	PUNCT
iajs-2137	147	6	p	p	X
iajs-2137	147	7	)	)	PUNCT
iajs-2137	147	8	limited	limited	ADJ
iajs-2137	147	9	.	.	PUNCT
iajs-2137	148	1	1	1	NUM
iajs-2137	148	2	th	th	NUM
iajs-2137	148	3	edition	edition	NOUN
iajs-2137	148	4	.	.	PUNCT
iajs-2137	149	1	emca	emca	PROPN
iajs-2137	149	2	house	house	PROPN
iajs-2137	149	3	,	,	PUNCT
iajs-2137	149	4	india	india	PROPN
iajs-2137	149	5	,	,	PUNCT
iajs-2137	149	6	2004	2004	NUM
iajs-2137	149	7	.	.	PUNCT
iajs-2137	150	1	14	14	NUM
iajs-2137	150	2	.	.	X
iajs-2137	151	1	palmer	palmer	PROPN
iajs-2137	151	2	,	,	PUNCT
iajs-2137	151	3	b.f	b.f	PROPN
iajs-2137	151	4	.	.	PROPN
iajs-2137	151	5	regulation	regulation	NOUN
iajs-2137	151	6	of	of	ADP
iajs-2137	151	7	potassium	potassium	NOUN
iajs-2137	151	8	homeostasis	homeostasis	NOUN
iajs-2137	151	9	.	.	PUNCT
iajs-2137	152	1	clinical	clinical	ADJ
iajs-2137	152	2	journal	journal	NOUN
iajs-2137	152	3	of	of	ADP
iajs-2137	152	4	the	the	DET
iajs-2137	152	5	american	american	ADJ
iajs-2137	152	6	society	society	NOUN
iajs-2137	152	7	of	of	ADP
iajs-2137	152	8	nephrology	nephrology	NOUN
iajs-2137	152	9	.	.	PUNCT
iajs-2137	153	1	2015	2015	NUM
iajs-2137	153	2	,	,	PUNCT
iajs-2137	153	3	10	10	NUM
iajs-2137	153	4	,	,	PUNCT
iajs-2137	153	5	1050	1050	NUM
iajs-2137	153	6	-	-	SYM
iajs-2137	153	7	1060	1060	NUM
iajs-2137	153	8	.	.	PUNCT
iajs-2137	154	1	15	15	NUM
iajs-2137	154	2	.	.	X
iajs-2137	154	3	hall	hall	PROPN
iajs-2137	154	4	,	,	PUNCT
iajs-2137	154	5	j.a	j.a	PROPN
iajs-2137	154	6	.	.	PROPN
iajs-2137	154	7	;	;	PUNCT
iajs-2137	154	8	yerramilli	yerramilli	NOUN
iajs-2137	154	9	,	,	PUNCT
iajs-2137	154	10	m.	m.	NOUN
iajs-2137	154	11	;	;	PUNCT
iajs-2137	154	12	obare	obare	PROPN
iajs-2137	154	13	,	,	PUNCT
iajs-2137	154	14	e.	e.	PROPN
iajs-2137	154	15	;	;	PUNCT
iajs-2137	154	16	yu	yu	PROPN
iajs-2137	154	17	,	,	PUNCT
iajs-2137	154	18	s.	s.	PROPN
iajs-2137	154	19	;	;	PUNCT
iajs-2137	154	20	jewell	jewell	PROPN
iajs-2137	154	21	,	,	PUNCT
iajs-2137	154	22	d.e	d.e	PROPN
iajs-2137	154	23	.	.	PROPN
iajs-2137	154	24	comparison	comparison	NOUN
iajs-2137	154	25	of	of	ADP
iajs-2137	154	26	serum	serum	NOUN
iajs-2137	154	27	concentrations	concentration	NOUN
iajs-2137	154	28	of	of	ADP
iajs-2137	154	29	symmetric	symmetric	ADJ
iajs-2137	154	30	dimethylarginine	dimethylarginine	NOUN
iajs-2137	154	31	and	and	CCONJ
iajs-2137	154	32	creatinine	creatinine	NOUN
iajs-2137	154	33	as	as	ADP
iajs-2137	154	34	kidney	kidney	NOUN
iajs-2137	154	35	function	function	NOUN
iajs-2137	154	36	biomarkers	biomarker	NOUN
iajs-2137	154	37	in	in	ADP
iajs-2137	154	38	healthy	healthy	ADJ
iajs-2137	154	39	geriatric	geriatric	ADJ
iajs-2137	154	40	cats	cat	NOUN
iajs-2137	154	41	fed	feed	VERB
iajs-2137	154	42	reduced	reduce	VERB
iajs-2137	154	43	protein	protein	NOUN
iajs-2137	154	44	foods	food	NOUN
iajs-2137	154	45	enriched	enrich	VERB
iajs-2137	154	46	with	with	ADP
iajs-2137	154	47	fish	fish	NOUN
iajs-2137	154	48	oil	oil	NOUN
iajs-2137	154	49	,	,	PUNCT
iajs-2137	154	50	lcarnitine	lcarnitine	NOUN
iajs-2137	154	51	,	,	PUNCT
iajs-2137	154	52	and	and	CCONJ
iajs-2137	154	53	medium	medium	ADJ
iajs-2137	154	54	-	-	PUNCT
iajs-2137	154	55	chain	chain	NOUN
iajs-2137	154	56	triglycerides	triglyceride	NOUN
iajs-2137	154	57	.	.	PUNCT
iajs-2137	155	1	the	the	DET
iajs-2137	155	2	veterinary	veterinary	ADJ
iajs-2137	155	3	journal	journal	NOUN
iajs-2137	155	4	.	.	PUNCT
iajs-2137	156	1	2014	2014	NUM
iajs-2137	156	2	,	,	PUNCT
iajs-2137	156	3	202	202	NUM
iajs-2137	156	4	,	,	PUNCT
iajs-2137	156	5	588	588	NUM
iajs-2137	156	6	-	-	SYM
iajs-2137	156	7	596	596	NUM
iajs-2137	156	8	.	.	PUNCT
iajs-2137	157	1	16	16	NUM
iajs-2137	157	2	.	.	PUNCT
iajs-2137	158	1	hamaguchi	hamaguchi	PROPN
iajs-2137	158	2	,	,	PUNCT
iajs-2137	158	3	t.	t.	PROPN
iajs-2137	158	4	;	;	PUNCT
iajs-2137	158	5	hirose	hirose	PROPN
iajs-2137	158	6	,	,	PUNCT
iajs-2137	158	7	t.	t.	PROPN
iajs-2137	158	8	;	;	PUNCT
iajs-2137	158	9	asakawa	asakawa	PROPN
iajs-2137	158	10	,	,	PUNCT
iajs-2137	158	11	h.	h.	PROPN
iajs-2137	158	12	;	;	PUNCT
iajs-2137	158	13	itoh	itoh	ADJ
iajs-2137	158	14	,	,	PUNCT
iajs-2137	158	15	y.	y.	PROPN
iajs-2137	158	16	;	;	PUNCT
iajs-2137	158	17	kamado	kamado	PROPN
iajs-2137	158	18	,	,	PUNCT
iajs-2137	158	19	k.	k.	PROPN
iajs-2137	158	20	;	;	PUNCT
iajs-2137	158	21	tokunaga	tokunaga	NOUN
iajs-2137	158	22	,	,	PUNCT
iajs-2137	158	23	k.	k.	PROPN
iajs-2137	158	24	;	;	PUNCT
iajs-2137	158	25	tomita	tomita	PROPN
iajs-2137	158	26	,	,	PUNCT
iajs-2137	158	27	k.	k.	PROPN
iajs-2137	158	28	;	;	PUNCT
iajs-2137	158	29	masuda	masuda	PROPN
iajs-2137	158	30	,	,	PUNCT
iajs-2137	158	31	h.	h.	PROPN
iajs-2137	158	32	;	;	PUNCT
iajs-2137	158	33	watanabe	watanabe	PROPN
iajs-2137	158	34	,	,	PUNCT
iajs-2137	158	35	n.	n.	PROPN
iajs-2137	158	36	;	;	PUNCT
iajs-2137	158	37	namba	namba	PROPN
iajs-2137	158	38	,	,	PUNCT
iajs-2137	158	39	m.	m.	NOUN
iajs-2137	158	40	efficacy	efficacy	NOUN
iajs-2137	158	41	of	of	ADP
iajs-2137	158	42	glimepiride	glimepiride	NOUN
iajs-2137	158	43	in	in	ADP
iajs-2137	158	44	type	type	NOUN
iajs-2137	158	45	2	2	NUM
iajs-2137	158	46	diabetic	diabetic	ADJ
iajs-2137	158	47	patients	patient	NOUN
iajs-2137	158	48	treated	treat	VERB
iajs-2137	158	49	with	with	ADP
iajs-2137	158	50	glibenclamide	glibenclamide	NOUN
iajs-2137	158	51	.	.	PUNCT
iajs-2137	159	1	diabetes	diabetes	NOUN
iajs-2137	159	2	research	research	NOUN
iajs-2137	159	3	and	and	CCONJ
iajs-2137	159	4	clinical	clinical	ADJ
iajs-2137	159	5	practice	practice	NOUN
iajs-2137	159	6	.	.	PUNCT
iajs-2137	160	1	2004,66	2004,66	NUM
iajs-2137	160	2	,	,	PUNCT
iajs-2137	160	3	s129	s129	PROPN
iajs-2137	160	4	-	-	PUNCT
iajs-2137	160	5	s132	s132	PROPN
iajs-2137	160	6	.	.	PROPN
iajs-2137	161	1	17	17	NUM
iajs-2137	161	2	.	.	PUNCT
iajs-2137	162	1	al	al	PROPN
iajs-2137	162	2	-	-	PUNCT
iajs-2137	162	3	madhagi	madhagi	PROPN
iajs-2137	162	4	,	,	PUNCT
iajs-2137	162	5	w.	w.	PROPN
iajs-2137	162	6	;	;	PUNCT
iajs-2137	162	7	abdulbari	abdulbari	PROPN
iajs-2137	162	8	,	,	PUNCT
iajs-2137	162	9	a.a	a.a	PROPN
iajs-2137	162	10	.	.	PROPN
iajs-2137	162	11	;	;	PUNCT
iajs-2137	162	12	khaled	khaled	PROPN
iajs-2137	162	13	,	,	PUNCT
iajs-2137	162	14	a.a	a.a	PROPN
iajs-2137	162	15	.	.	PROPN
iajs-2137	162	16	;	;	PUNCT
iajs-2137	162	17	ahmed	ahmed	PROPN
iajs-2137	162	18	,	,	PUNCT
iajs-2137	162	19	s.z	s.z	PROPN
iajs-2137	162	20	.	.	PROPN
iajs-2137	162	21	;	;	PUNCT
iajs-2137	162	22	mansour	mansour	PROPN
iajs-2137	162	23	,	,	PUNCT
iajs-2137	162	24	n.n	n.n	PROPN
iajs-2137	162	25	.	.	PROPN
iajs-2137	162	26	;	;	PUNCT
iajs-2137	162	27	mohamed	mohamed	PROPN
iajs-2137	162	28	,	,	PUNCT
iajs-2137	162	29	k.	k.	PROPN
iajs-2137	162	30	formulation	formulation	NOUN
iajs-2137	162	31	and	and	CCONJ
iajs-2137	162	32	evaluation	evaluation	NOUN
iajs-2137	162	33	of	of	ADP
iajs-2137	162	34	new	new	ADJ
iajs-2137	162	35	glimepiride	glimepiride	NOUN
iajs-2137	162	36	sublingual	sublingual	ADJ
iajs-2137	162	37	tablets	tablet	NOUN
iajs-2137	162	38	.	.	PUNCT
iajs-2137	163	1	journal	journal	PROPN
iajs-2137	163	2	of	of	ADP
iajs-2137	163	3	pharmaceutics	pharmaceutic	NOUN
iajs-2137	163	4	.	.	PUNCT
iajs-2137	164	1	2017	2017	NUM
iajs-2137	164	2	,	,	PUNCT
iajs-2137	164	3	2017	2017	NUM
iajs-2137	164	4	,	,	PUNCT
iajs-2137	164	5	1	1	NUM
iajs-2137	164	6	-	-	SYM
iajs-2137	164	7	5	5	NUM
iajs-2137	164	8	.	.	NUM
iajs-2137	164	9	18	18	NUM
iajs-2137	164	10	.	.	PUNCT
iajs-2137	165	1	mary	mary	PROPN
iajs-2137	165	2	,	,	PUNCT
iajs-2137	165	3	j.	j.	PROPN
iajs-2137	165	4	;	;	PUNCT
iajs-2137	165	5	richard	richard	PROPN
iajs-2137	165	6	,	,	PUNCT
iajs-2137	165	7	a.	a.	PROPN
iajs-2137	165	8	;	;	PUNCT
iajs-2137	165	9	pamela	pamela	PROPN
iajs-2137	165	10	,	,	PUNCT
iajs-2137	165	11	c.	c.	PROPN
iajs-2137	165	12	lippincotts	lippincotts	PROPN
iajs-2137	165	13	illustrated	illustrate	VERB
iajs-2137	165	14	reviews	review	NOUN
iajs-2137	165	15	pharmacology	pharmacology	NOUN
iajs-2137	165	16	.	.	PUNCT
iajs-2137	166	1	2	2	NUM
iajs-2137	166	2	nd	nd	NUM
iajs-2137	166	3	edition	edition	NOUN
iajs-2137	166	4	.	.	PUNCT
iajs-2137	167	1	1997	1997	NUM
iajs-2137	167	2	.	.	PUNCT
iajs-2137	168	1	19	19	NUM
iajs-2137	168	2	.	.	X
iajs-2137	168	3	nissen	nissen	PROPN
iajs-2137	168	4	,	,	PUNCT
iajs-2137	168	5	s.e	s.e	PROPN
iajs-2137	168	6	.	.	PROPN
iajs-2137	168	7	;	;	PUNCT
iajs-2137	168	8	nicholls	nicholls	PROPN
iajs-2137	168	9	,	,	PUNCT
iajs-2137	168	10	s.j	s.j	PROPN
iajs-2137	168	11	.	.	PROPN
iajs-2137	168	12	;	;	PUNCT
iajs-2137	168	13	wolski	wolski	PROPN
iajs-2137	168	14	,	,	PUNCT
iajs-2137	168	15	k.	k.	PROPN
iajs-2137	168	16	;	;	PUNCT
iajs-2137	168	17	nesto	nesto	PROPN
iajs-2137	168	18	,	,	PUNCT
iajs-2137	168	19	r.	r.	PROPN
iajs-2137	168	20	;	;	PUNCT
iajs-2137	168	21	kupfer	kupfer	PROPN
iajs-2137	168	22	,	,	PUNCT
iajs-2137	168	23	s.	s.	PROPN
iajs-2137	168	24	;	;	PUNCT
iajs-2137	168	25	perez	perez	PROPN
iajs-2137	168	26	,	,	PUNCT
iajs-2137	168	27	a.	a.	NOUN
iajs-2137	168	28	;	;	PUNCT
iajs-2137	168	29	jure	jure	PROPN
iajs-2137	168	30	,	,	PUNCT
iajs-2137	168	31	h.	h.	PROPN
iajs-2137	168	32	;	;	PUNCT
iajs-2137	168	33	de	de	X
iajs-2137	168	34	larochellière	larochellière	NOUN
iajs-2137	168	35	,	,	PUNCT
iajs-2137	168	36	r.	r.	PROPN
iajs-2137	168	37	;	;	PUNCT
iajs-2137	168	38	staniloae	staniloae	PROPN
iajs-2137	168	39	,	,	PUNCT
iajs-2137	168	40	c.s	c.s	PROPN
iajs-2137	168	41	.	.	PROPN
iajs-2137	168	42	;	;	PUNCT
iajs-2137	168	43	mavromatis	mavromatis	PROPN
iajs-2137	168	44	,	,	PUNCT
iajs-2137	168	45	k.	k.	PROPN
iajs-2137	168	46	;	;	PUNCT
iajs-2137	168	47	saw	see	VERB
iajs-2137	168	48	,	,	PUNCT
iajs-2137	168	49	j.	j.	PROPN
iajs-2137	168	50	comparison	comparison	NOUN
iajs-2137	168	51	of	of	ADP
iajs-2137	168	52	pioglitazone	pioglitazone	NOUN
iajs-2137	168	53	vs	vs	ADP
iajs-2137	168	54	glimepiride	glimepiride	NOUN
iajs-2137	168	55	on	on	ADP
iajs-2137	168	56	progression	progression	NOUN
iajs-2137	168	57	of	of	ADP
iajs-2137	168	58	coronary	coronary	ADJ
iajs-2137	168	59	atherosclerosis	atherosclerosis	NOUN
iajs-2137	168	60	in	in	ADP
iajs-2137	168	61	patients	patient	NOUN
iajs-2137	168	62	with	with	ADP
iajs-2137	168	63	type	type	NOUN
iajs-2137	168	64	2	2	NUM
iajs-2137	168	65	diabetes	diabete	NOUN
iajs-2137	168	66	:	:	PUNCT
iajs-2137	168	67	the	the	DET
iajs-2137	168	68	periscope	periscope	NOUN
iajs-2137	168	69	randomized	randomize	VERB
iajs-2137	168	70	controlled	control	VERB
iajs-2137	168	71	trial	trial	NOUN
iajs-2137	168	72	.	.	PUNCT
iajs-2137	169	1	jama	jama	PROPN
iajs-2137	169	2	.	.	PUNCT
iajs-2137	170	1	2008	2008	NUM
iajs-2137	170	2	,	,	PUNCT
iajs-2137	170	3	299	299	NUM
iajs-2137	170	4	,	,	PUNCT
iajs-2137	170	5	1561	1561	NUM
iajs-2137	170	6	-	-	SYM
iajs-2137	170	7	1573	1573	NUM
iajs-2137	170	8	.	.	PUNCT
iajs-2137	171	1	20	20	NUM
iajs-2137	171	2	.	.	PUNCT
iajs-2137	172	1	nathan	nathan	PROPN
iajs-2137	172	2	,	,	PUNCT
iajs-2137	172	3	d.m	d.m	PROPN
iajs-2137	172	4	.	.	PUNCT
iajs-2137	172	5	;	;	PUNCT
iajs-2137	172	6	buse	buse	NOUN
iajs-2137	172	7	,	,	PUNCT
iajs-2137	172	8	j.b	j.b	PROPN
iajs-2137	172	9	.	.	PUNCT
iajs-2137	172	10	;	;	PUNCT
iajs-2137	172	11	davidson	davidson	PROPN
iajs-2137	172	12	,	,	PUNCT
iajs-2137	172	13	m.b	m.b	PROPN
iajs-2137	172	14	.	.	PROPN
iajs-2137	172	15	;	;	PUNCT
iajs-2137	172	16	ferrannini	ferrannini	PROPN
iajs-2137	172	17	,	,	PUNCT
iajs-2137	172	18	e.	e.	PROPN
iajs-2137	172	19	;	;	PUNCT
iajs-2137	172	20	holman	holman	PROPN
iajs-2137	172	21	,	,	PUNCT
iajs-2137	172	22	r.r	r.r	PROPN
iajs-2137	172	23	.	.	PROPN
iajs-2137	172	24	;	;	PUNCT
iajs-2137	172	25	sherwin	sherwin	PROPN
iajs-2137	172	26	,	,	PUNCT
iajs-2137	172	27	r.	r.	PROPN
iajs-2137	172	28	;	;	PUNCT
iajs-2137	172	29	zinman	zinman	PROPN
iajs-2137	172	30	,	,	PUNCT
iajs-2137	172	31	b.	b.	PROPN
iajs-2137	172	32	american	american	PROPN
iajs-2137	172	33	diabetes	diabetes	PROPN
iajs-2137	172	34	association	association	PROPN
iajs-2137	172	35	;	;	PUNCT
iajs-2137	172	36	european	european	PROPN
iajs-2137	172	37	association	association	PROPN
iajs-2137	172	38	for	for	ADP
iajs-2137	172	39	study	study	NOUN
iajs-2137	172	40	of	of	ADP
iajs-2137	172	41	diabetes	diabetes	NOUN
iajs-2137	172	42	.	.	PUNCT
iajs-2137	173	1	medical	medical	ADJ
iajs-2137	173	2	management	management	NOUN
iajs-2137	173	3	of	of	ADP
iajs-2137	173	4	hyperglycemia	hyperglycemia	NOUN
iajs-2137	173	5	in	in	ADP
iajs-2137	173	6	type	type	NOUN
iajs-2137	173	7	2	2	NUM
iajs-2137	173	8	diabetes	diabetes	NOUN
iajs-2137	173	9	:	:	PUNCT
iajs-2137	173	10	a	a	DET
iajs-2137	173	11	consensus	consensus	NOUN
iajs-2137	173	12	algorithm	algorithm	NOUN
iajs-2137	173	13	for	for	ADP
iajs-2137	173	14	the	the	DET
iajs-2137	173	15	initiation	initiation	NOUN
iajs-2137	173	16	and	and	CCONJ
iajs-2137	173	17	adjustment	adjustment	NOUN
iajs-2137	173	18	of	of	ADP
iajs-2137	173	19	therapy	therapy	NOUN
iajs-2137	173	20	:	:	PUNCT
iajs-2137	173	21	a	a	DET
iajs-2137	173	22	consensus	consensus	NOUN
iajs-2137	173	23	statement	statement	NOUN
iajs-2137	173	24	of	of	ADP
iajs-2137	173	25	the	the	DET
iajs-2137	173	26	american	american	ADJ
iajs-2137	173	27	diabetes	diabetes	PROPN
iajs-2137	173	28	association	association	PROPN
iajs-2137	173	29	and	and	CCONJ
iajs-2137	173	30	the	the	DET
iajs-2137	173	31	european	european	PROPN
iajs-2137	173	32	association	association	PROPN
iajs-2137	173	33	for	for	ADP
iajs-2137	173	34	the	the	DET
iajs-2137	173	35	study	study	NOUN
iajs-2137	173	36	of	of	ADP
iajs-2137	173	37	diabetes	diabetes	NOUN
iajs-2137	173	38	.	.	PUNCT
iajs-2137	174	1	diabetes	diabetes	NOUN
iajs-2137	174	2	care	care	NOUN
iajs-2137	174	3	.	.	PUNCT
iajs-2137	175	1	2009	2009	NUM
iajs-2137	175	2	,	,	PUNCT
iajs-2137	175	3	32,193–203	32,193–203	NUM
iajs-2137	175	4	.	.	PUNCT
iajs-2137	175	5	00	00	PUNCT
iajs-2137	176	1	ibn	ibn	PROPN
iajs-2137	176	2	al	al	PROPN
iajs-2137	176	3	-	-	PUNCT
iajs-2137	176	4	haitham	haitham	PROPN
iajs-2137	176	5	jour	jour	X
iajs-2137	176	6	.	.	PROPN
iajs-2137	176	7	for	for	ADP
iajs-2137	176	8	pure	pure	ADJ
iajs-2137	176	9	&	&	CCONJ
iajs-2137	176	10	appl	appl	PROPN
iajs-2137	176	11	.	.	PUNCT
iajs-2137	177	1	sci	sci	PROPN
iajs-2137	177	2	.	.	PROPN
iajs-2137	177	3	32	32	NUM
iajs-2137	177	4	(	(	PUNCT
iajs-2137	177	5	2	2	NUM
iajs-2137	177	6	)	)	PUNCT
iajs-2137	177	7	2019	2019	NUM
iajs-2137	177	8	21	21	NUM
iajs-2137	177	9	.	.	PUNCT
iajs-2137	178	1	rodbard	rodbard	NOUN
iajs-2137	178	2	,	,	PUNCT
iajs-2137	178	3	h.	h.	PROPN
iajs-2137	178	4	;	;	PUNCT
iajs-2137	178	5	jellinger	jellinger	PROPN
iajs-2137	178	6	,	,	PUNCT
iajs-2137	178	7	p.	p.	PROPN
iajs-2137	178	8	;	;	PUNCT
iajs-2137	178	9	davidson	davidson	PROPN
iajs-2137	178	10	,	,	PUNCT
iajs-2137	178	11	j.	j.	PROPN
iajs-2137	178	12	;	;	PUNCT
iajs-2137	178	13	einhorn	einhorn	PROPN
iajs-2137	178	14	,	,	PUNCT
iajs-2137	178	15	d.	d.	PROPN
iajs-2137	178	16	;	;	PUNCT
iajs-2137	178	17	garber	garber	PROPN
iajs-2137	178	18	,	,	PUNCT
iajs-2137	178	19	a.	a.	NOUN
iajs-2137	178	20	;	;	PUNCT
iajs-2137	178	21	grunberger	grunberger	NOUN
iajs-2137	178	22	,	,	PUNCT
iajs-2137	178	23	g.	g.	PROPN
iajs-2137	178	24	;	;	PUNCT
iajs-2137	178	25	handelsman	handelsman	PROPN
iajs-2137	178	26	,	,	PUNCT
iajs-2137	178	27	y.	y.	PROPN
iajs-2137	178	28	;	;	PUNCT
iajs-2137	178	29	horton	horton	PROPN
iajs-2137	178	30	,	,	PUNCT
iajs-2137	178	31	e.	e.	PROPN
iajs-2137	178	32	;	;	PUNCT
iajs-2137	178	33	lebovitz	lebovitz	PROPN
iajs-2137	178	34	,	,	PUNCT
iajs-2137	178	35	h.	h.	PROPN
iajs-2137	178	36	;	;	PUNCT
iajs-2137	178	37	levy	levy	NOUN
iajs-2137	178	38	,	,	PUNCT
iajs-2137	178	39	p.	p.	NOUN
iajs-2137	178	40	;	;	PUNCT
iajs-2137	178	41	moghissi	moghissi	ADJ
iajs-2137	178	42	,	,	PUNCT
iajs-2137	178	43	e.	e.	PROPN
iajs-2137	178	44	statement	statement	PROPN
iajs-2137	178	45	by	by	ADP
iajs-2137	178	46	an	an	DET
iajs-2137	178	47	american	american	PROPN
iajs-2137	178	48	association	association	NOUN
iajs-2137	178	49	of	of	ADP
iajs-2137	178	50	clinical	clinical	ADJ
iajs-2137	178	51	endocrinologists	endocrinologist	NOUN
iajs-2137	178	52	/	/	SYM
iajs-2137	178	53	american	american	PROPN
iajs-2137	178	54	college	college	PROPN
iajs-2137	178	55	of	of	ADP
iajs-2137	178	56	endocrinology	endocrinology	NOUN
iajs-2137	178	57	consensus	consensus	NOUN
iajs-2137	178	58	panel	panel	NOUN
iajs-2137	178	59	on	on	ADP
iajs-2137	178	60	type	type	NOUN
iajs-2137	178	61	2	2	NUM
iajs-2137	178	62	diabetes	diabetes	NOUN
iajs-2137	178	63	mellitus	mellitus	NOUN
iajs-2137	178	64	:	:	PUNCT
iajs-2137	178	65	an	an	DET
iajs-2137	178	66	algorithm	algorithm	NOUN
iajs-2137	178	67	for	for	ADP
iajs-2137	178	68	glycemic	glycemic	ADJ
iajs-2137	178	69	control	control	NOUN
iajs-2137	178	70	.	.	PUNCT
iajs-2137	179	1	endocrine	endocrine	ADJ
iajs-2137	179	2	practice	practice	NOUN
iajs-2137	179	3	.	.	PUNCT
iajs-2137	180	1	2009	2009	NUM
iajs-2137	180	2	,	,	PUNCT
iajs-2137	180	3	15	15	NUM
iajs-2137	180	4	,	,	PUNCT
iajs-2137	180	5	540	540	NUM
iajs-2137	180	6	-	-	SYM
iajs-2137	180	7	559	559	NUM
iajs-2137	180	8	.	.	PUNCT
iajs-2137	181	1	22	22	NUM
iajs-2137	181	2	.	.	PUNCT
iajs-2137	182	1	young	young	ADJ
iajs-2137	182	2	,	,	PUNCT
iajs-2137	182	3	d.s	d.s	PROPN
iajs-2137	182	4	.	.	PROPN
iajs-2137	182	5	effect	effect	NOUN
iajs-2137	182	6	of	of	ADP
iajs-2137	182	7	drugs	drug	NOUN
iajs-2137	182	8	on	on	ADP
iajs-2137	182	9	clinical	clinical	ADJ
iajs-2137	182	10	laboratory	laboratory	NOUN
iajs-2137	182	11	tests	test	NOUN
iajs-2137	182	12	.	.	PUNCT
iajs-2137	183	1	5	5	NUM
iajs-2137	183	2	th	th	NUM
iajs-2137	183	3	edition	edition	NOUN
iajs-2137	183	4	.	.	PUNCT
iajs-2137	184	1	aacc	aacc	PROPN
iajs-2137	184	2	press	press	PROPN
iajs-2137	184	3	.	.	PUNCT
iajs-2137	185	1	2000	2000	NUM
iajs-2137	185	2	.	.	PUNCT
iajs-2137	186	1	23	23	NUM
iajs-2137	186	2	.	.	PUNCT
iajs-2137	187	1	michael	michael	PROPN
iajs-2137	187	2	,	,	PUNCT
iajs-2137	187	3	b.	b.	PROPN
iajs-2137	187	4	;	;	PUNCT
iajs-2137	187	5	edward	edward	PROPN
iajs-2137	187	6	,	,	PUNCT
iajs-2137	187	7	p.	p.	PROPN
iajs-2137	187	8	;	;	PUNCT
iajs-2137	187	9	larry	larry	PROPN
iajs-2137	187	10	,	,	PUNCT
iajs-2137	187	11	e.	e.	PROPN
iajs-2137	187	12	clinical	clinical	ADJ
iajs-2137	187	13	chemiustry	chemiustry	NOUN
iajs-2137	187	14	-	-	PUNCT
iajs-2137	187	15	principle	principle	NOUN
iajs-2137	187	16	,	,	PUNCT
iajs-2137	187	17	techniques	technique	NOUN
iajs-2137	187	18	,	,	PUNCT
iajs-2137	187	19	correlations	correlation	NOUN
iajs-2137	187	20	.	.	PUNCT
iajs-2137	187	21	7	7	NUM
iajs-2137	187	22	th	th	NUM
iajs-2137	187	23	edition	edition	NOUN
iajs-2137	187	24	.	.	PUNCT
iajs-2137	188	1	c576	c576	PROPN
iajs-2137	188	2	.	.	PUNCT
iajs-2137	189	1	new	new	ADJ
iajs-2137	189	2	yourk	yourk	PROPN
iajs-2137	189	3	.	.	PUNCT
iajs-2137	190	1	2013	2013	NUM
iajs-2137	190	2	.	.	PUNCT
iajs-2137	191	1	24	24	NUM
iajs-2137	191	2	.	.	PUNCT
iajs-2137	192	1	henry	henry	PROPN
iajs-2137	192	2	,	,	PUNCT
iajs-2137	192	3	r.	r.	PROPN
iajs-2137	192	4	f.	f.	PROPN
iajs-2137	193	1	clinical	clinical	ADJ
iajs-2137	193	2	chemistry	chemistry	NOUN
iajs-2137	193	3	principle	principle	NOUN
iajs-2137	193	4	and	and	CCONJ
iajs-2137	193	5	technique	technique	NOUN
iajs-2137	193	6	.	.	PUNCT
iajs-2137	194	1	2	2	NUM
iajs-2137	194	2	nd	nd	NUM
iajs-2137	194	3	edition	edition	NOUN
iajs-2137	194	4	.	.	PUNCT
iajs-2137	195	1	1974	1974	NUM
iajs-2137	195	2	.	.	PUNCT
iajs-2137	196	1	25	25	NUM
iajs-2137	196	2	.	.	PUNCT
iajs-2137	197	1	lópez	lópez	NOUN
iajs-2137	197	2	-	-	PUNCT
iajs-2137	197	3	herce	herce	PROPN
iajs-2137	197	4	,	,	PUNCT
iajs-2137	197	5	j.	j.	PROPN
iajs-2137	197	6	;	;	PUNCT
iajs-2137	197	7	borrego	borrego	PROPN
iajs-2137	197	8	,	,	PUNCT
iajs-2137	197	9	r.	r.	PROPN
iajs-2137	197	10	;	;	PUNCT
iajs-2137	197	11	bustinza	bustinza	NUM
iajs-2137	197	12	,	,	PUNCT
iajs-2137	197	13	a.	a.	NOUN
iajs-2137	197	14	;	;	PUNCT
iajs-2137	197	15	carrillo	carrillo	PROPN
iajs-2137	197	16	,	,	PUNCT
iajs-2137	197	17	a.	a.	PROPN
iajs-2137	197	18	elevated	elevated	PROPN
iajs-2137	197	19	carboxyhemoglobin	carboxyhemoglobin	PROPN
iajs-2137	197	20	associated	associate	VERB
iajs-2137	197	21	with	with	ADP
iajs-2137	197	22	sodium	sodium	NOUN
iajs-2137	197	23	nitroprusside	nitroprusside	ADJ
iajs-2137	197	24	treatment	treatment	NOUN
iajs-2137	197	25	.	.	PUNCT
iajs-2137	198	1	intensive	intensive	ADJ
iajs-2137	198	2	care	care	NOUN
iajs-2137	198	3	medicine.2005	medicine.2005	PROPN
iajs-2137	198	4	,	,	PUNCT
iajs-2137	198	5	31	31	NUM
iajs-2137	198	6	,	,	PUNCT
iajs-2137	198	7	12351238	12351238	NUM
iajs-2137	198	8	.	.	PUNCT
iajs-2137	199	1	26	26	NUM
iajs-2137	199	2	.	.	X
iajs-2137	200	1	wen	wen	PROPN
iajs-2137	200	2	,	,	PUNCT
iajs-2137	200	3	c.p	c.p	PROPN
iajs-2137	200	4	.	.	PROPN
iajs-2137	200	5	;	;	PUNCT
iajs-2137	200	6	matsushita	matsushita	PROPN
iajs-2137	200	7	,	,	PUNCT
iajs-2137	200	8	k.	k.	PROPN
iajs-2137	200	9	;	;	PUNCT
iajs-2137	200	10	coresh	coresh	PROPN
iajs-2137	200	11	,	,	PUNCT
iajs-2137	200	12	j.	j.	PROPN
iajs-2137	200	13	;	;	PUNCT
iajs-2137	200	14	iseki	iseki	PROPN
iajs-2137	200	15	,	,	PUNCT
iajs-2137	200	16	k.	k.	PROPN
iajs-2137	200	17	;	;	PUNCT
iajs-2137	200	18	islam	islam	PROPN
iajs-2137	200	19	,	,	PUNCT
iajs-2137	200	20	m.	m.	NOUN
iajs-2137	200	21	;	;	PUNCT
iajs-2137	200	22	katz	katz	PROPN
iajs-2137	200	23	,	,	PUNCT
iajs-2137	200	24	r.	r.	PROPN
iajs-2137	200	25	;	;	PUNCT
iajs-2137	200	26	mcclellan	mcclellan	PROPN
iajs-2137	200	27	,	,	PUNCT
iajs-2137	200	28	w.	w.	PROPN
iajs-2137	200	29	;	;	PUNCT
iajs-2137	200	30	peralta	peralta	PROPN
iajs-2137	200	31	,	,	PUNCT
iajs-2137	200	32	c.a	c.a	PROPN
iajs-2137	200	33	.	.	PROPN
iajs-2137	200	34	;	;	PUNCT
iajs-2137	200	35	wang	wang	PROPN
iajs-2137	200	36	,	,	PUNCT
iajs-2137	200	37	h.	h.	PROPN
iajs-2137	200	38	;	;	PUNCT
iajs-2137	200	39	de	de	PROPN
iajs-2137	200	40	zeeuw	zeeuw	PROPN
iajs-2137	200	41	,	,	PUNCT
iajs-2137	200	42	d.	d.	PROPN
iajs-2137	200	43	;	;	PUNCT
iajs-2137	200	44	astor	astor	PROPN
iajs-2137	200	45	,	,	PUNCT
iajs-2137	200	46	b.c	b.c	PROPN
iajs-2137	200	47	.	.	PROPN
iajs-2137	200	48	relative	relative	ADJ
iajs-2137	200	49	risks	risk	NOUN
iajs-2137	200	50	of	of	ADP
iajs-2137	200	51	chronic	chronic	ADJ
iajs-2137	200	52	kidney	kidney	NOUN
iajs-2137	200	53	disease	disease	NOUN
iajs-2137	200	54	for	for	ADP
iajs-2137	200	55	mortality	mortality	NOUN
iajs-2137	200	56	and	and	CCONJ
iajs-2137	200	57	end	end	NOUN
iajs-2137	200	58	-	-	PUNCT
iajs-2137	200	59	stage	stage	NOUN
iajs-2137	200	60	renal	renal	ADJ
iajs-2137	200	61	disease	disease	NOUN
iajs-2137	200	62	across	across	ADP
iajs-2137	200	63	races	race	NOUN
iajs-2137	200	64	are	be	AUX
iajs-2137	200	65	similar	similar	ADJ
iajs-2137	200	66	.	.	PUNCT
iajs-2137	201	1	kidney	kidney	PROPN
iajs-2137	201	2	international	international	PROPN
iajs-2137	201	3	.	.	PUNCT
iajs-2137	202	1	2014	2014	NUM
iajs-2137	202	2	,	,	PUNCT
iajs-2137	202	3	86	86	NUM
iajs-2137	202	4	,	,	PUNCT
iajs-2137	202	5	819	819	NUM
iajs-2137	202	6	-	-	SYM
iajs-2137	202	7	827	827	NUM
iajs-2137	202	8	.	.	PUNCT
iajs-2137	203	1	27	27	NUM
iajs-2137	203	2	.	.	PUNCT
iajs-2137	204	1	frances	frances	PROPN
iajs-2137	204	2	,	,	PUNCT
iajs-2137	204	3	t.f	t.f	PROPN
iajs-2137	204	4	.	.	PROPN
iajs-2137	204	5	;	;	PUNCT
iajs-2137	204	6	marshall	marshall	PROPN
iajs-2137	204	7	,	,	PUNCT
iajs-2137	204	8	b.a	b.a	PROPN
iajs-2137	204	9	.	.	PROPN
iajs-2137	204	10	manual	manual	NOUN
iajs-2137	204	11	of	of	ADP
iajs-2137	204	12	laboratory	laboratory	NOUN
iajs-2137	204	13	diagnostic	diagnostic	ADJ
iajs-2137	204	14	tests	test	NOUN
iajs-2137	204	15	.	.	PUNCT
iajs-2137	205	1	7	7	NUM
iajs-2137	205	2	th	th	NUM
iajs-2137	205	3	ed	ed	NOUN
iajs-2137	205	4	.	.	PUNCT
iajs-2137	206	1	lippincott	lippincott	PROPN
iajs-2137	206	2	williams	williams	PROPN
iajs-2137	206	3	&	&	CCONJ
iajs-2137	206	4	wilkins	wilkins	PROPN
iajs-2137	206	5	.	.	PUNCT
iajs-2137	206	6	philadelphia	philadelphia	PROPN
iajs-2137	206	7	,	,	PUNCT
iajs-2137	206	8	2004	2004	NUM
iajs-2137	206	9	.	.	PUNCT
iajs-2137	207	1	28	28	NUM
iajs-2137	207	2	.	.	X
iajs-2137	208	1	fujigaki	fujigaki	PROPN
iajs-2137	208	2	,	,	PUNCT
iajs-2137	208	3	y.	y.	PROPN
iajs-2137	208	4	;	;	PUNCT
iajs-2137	208	5	nagase	nagase	PROPN
iajs-2137	208	6	,	,	PUNCT
iajs-2137	208	7	m.	m.	NOUN
iajs-2137	208	8	;	;	PUNCT
iajs-2137	208	9	kobayasi	kobayasi	PROPN
iajs-2137	208	10	,	,	PUNCT
iajs-2137	208	11	s.	s.	PROPN
iajs-2137	208	12	;	;	PUNCT
iajs-2137	208	13	hidaka	hidaka	PROPN
iajs-2137	208	14	,	,	PUNCT
iajs-2137	208	15	s.	s.	PROPN
iajs-2137	208	16	;	;	PUNCT
iajs-2137	208	17	shimomura	shimomura	NOUN
iajs-2137	208	18	,	,	PUNCT
iajs-2137	208	19	m.	m.	NOUN
iajs-2137	208	20	;	;	PUNCT
iajs-2137	208	21	hishida	hishida	PROPN
iajs-2137	208	22	,	,	PUNCT
iajs-2137	208	23	a.	a.	PROPN
iajs-2137	208	24	intragbm	intragbm	PROPN
iajs-2137	208	25	site	site	NOUN
iajs-2137	208	26	of	of	ADP
iajs-2137	208	27	the	the	DET
iajs-2137	208	28	functional	functional	ADJ
iajs-2137	208	29	filtration	filtration	NOUN
iajs-2137	208	30	barrier	barrier	NOUN
iajs-2137	208	31	for	for	ADP
iajs-2137	208	32	endogenous	endogenous	ADJ
iajs-2137	208	33	proteins	protein	NOUN
iajs-2137	208	34	in	in	ADP
iajs-2137	208	35	rats	rat	NOUN
iajs-2137	208	36	.	.	PUNCT
iajs-2137	209	1	kidney	kidney	PROPN
iajs-2137	209	2	international	international	PROPN
iajs-2137	209	3	.	.	PUNCT
iajs-2137	210	1	1993	1993	NUM
iajs-2137	210	2	,	,	PUNCT
iajs-2137	210	3	43	43	NUM
iajs-2137	210	4	,	,	PUNCT
iajs-2137	210	5	567	567	NUM
iajs-2137	210	6	-	-	SYM
iajs-2137	210	7	574	574	NUM
iajs-2137	210	8	.	.	PUNCT
iajs-2137	211	1	29	29	NUM
iajs-2137	211	2	.	.	PUNCT
iajs-2137	212	1	waller	waller	PROPN
iajs-2137	212	2	,	,	PUNCT
iajs-2137	212	3	a.p	a.p	PROPN
iajs-2137	212	4	.	.	PROPN
iajs-2137	212	5	;	;	PUNCT
iajs-2137	212	6	heigenhauser	heigenhauser	PROPN
iajs-2137	212	7	,	,	PUNCT
iajs-2137	212	8	g.j	g.j	PROPN
iajs-2137	212	9	.	.	PROPN
iajs-2137	212	10	;	;	PUNCT
iajs-2137	212	11	geor	geor	PROPN
iajs-2137	212	12	,	,	PUNCT
iajs-2137	212	13	r.j	r.j	PROPN
iajs-2137	212	14	.	.	PROPN
iajs-2137	212	15	;	;	PUNCT
iajs-2137	212	16	spriet	spriet	PROPN
iajs-2137	212	17	,	,	PUNCT
iajs-2137	212	18	l.l	l.l	PROPN
iajs-2137	212	19	.	.	PROPN
iajs-2137	212	20	;	;	PUNCT
iajs-2137	212	21	lindinger	lindinger	PROPN
iajs-2137	212	22	,	,	PUNCT
iajs-2137	212	23	m.i	m.i	PROPN
iajs-2137	212	24	.	.	PROPN
iajs-2137	212	25	fluid	fluid	ADJ
iajs-2137	212	26	and	and	CCONJ
iajs-2137	212	27	electrolyte	electrolyte	ADJ
iajs-2137	212	28	supplementation	supplementation	NOUN
iajs-2137	212	29	after	after	ADP
iajs-2137	212	30	prolonged	prolong	VERB
iajs-2137	212	31	moderate	moderate	ADJ
iajs-2137	212	32	-	-	PUNCT
iajs-2137	212	33	intensity	intensity	NOUN
iajs-2137	212	34	exercise	exercise	NOUN
iajs-2137	212	35	enhances	enhance	VERB
iajs-2137	212	36	muscle	muscle	NOUN
iajs-2137	212	37	glycogen	glycogen	NOUN
iajs-2137	212	38	resynthesis	resynthesis	NOUN
iajs-2137	212	39	in	in	ADP
iajs-2137	212	40	standardbred	standardbred	ADJ
iajs-2137	212	41	horses	horse	NOUN
iajs-2137	212	42	.	.	PUNCT
iajs-2137	213	1	journal	journal	PROPN
iajs-2137	213	2	of	of	ADP
iajs-2137	213	3	applied	apply	VERB
iajs-2137	213	4	physiology	physiology	NOUN
iajs-2137	213	5	.	.	PUNCT
iajs-2137	214	1	2009	2009	NUM
iajs-2137	214	2	,	,	PUNCT
iajs-2137	214	3	106	106	NUM
iajs-2137	214	4	,	,	PUNCT
iajs-2137	214	5	91	91	NUM
iajs-2137	214	6	-	-	SYM
iajs-2137	214	7	100	100	NUM
iajs-2137	214	8	.	.	PUNCT
iajs-2137	215	1	30	30	NUM
iajs-2137	215	2	.	.	PUNCT
iajs-2137	216	1	mummidi	mummidi	PROPN
iajs-2137	216	2	,	,	PUNCT
iajs-2137	216	3	s.	s.	PROPN
iajs-2137	216	4	;	;	PUNCT
iajs-2137	216	5	das	das	PROPN
iajs-2137	216	6	,	,	PUNCT
iajs-2137	216	7	n.a	n.a	PROPN
iajs-2137	216	8	.	.	PROPN
iajs-2137	216	9	;	;	PUNCT
iajs-2137	216	10	carpenter	carpenter	PROPN
iajs-2137	216	11	,	,	PUNCT
iajs-2137	216	12	a.j	a.j	PROPN
iajs-2137	216	13	.	.	PROPN
iajs-2137	216	14	;	;	PUNCT
iajs-2137	216	15	kandikattu	kandikattu	PROPN
iajs-2137	216	16	,	,	PUNCT
iajs-2137	216	17	h.	h.	PROPN
iajs-2137	216	18	;	;	PUNCT
iajs-2137	216	19	krenz	krenz	PROPN
iajs-2137	216	20	,	,	PUNCT
iajs-2137	216	21	m.	m.	NOUN
iajs-2137	216	22	;	;	PUNCT
iajs-2137	216	23	siebenlist	siebenlist	NOUN
iajs-2137	216	24	,	,	PUNCT
iajs-2137	216	25	u.	u.	PROPN
iajs-2137	216	26	;	;	PUNCT
iajs-2137	216	27	valente	valente	PROPN
iajs-2137	216	28	,	,	PUNCT
iajs-2137	216	29	a.j	a.j	PROPN
iajs-2137	216	30	.	.	PROPN
iajs-2137	216	31	;	;	PUNCT
iajs-2137	216	32	chandrasekar	chandrasekar	PROPN
iajs-2137	216	33	,	,	PUNCT
iajs-2137	216	34	b.	b.	PROPN
iajs-2137	216	35	metformin	metformin	PROPN
iajs-2137	216	36	inhibits	inhibit	VERB
iajs-2137	216	37	aldosterone	aldosterone	NOUN
iajs-2137	216	38	-	-	PUNCT
iajs-2137	216	39	induced	induce	VERB
iajs-2137	216	40	cardiac	cardiac	ADJ
iajs-2137	216	41	fibroblast	fibroblast	ADJ
iajs-2137	216	42	activation	activation	NOUN
iajs-2137	216	43	,	,	PUNCT
iajs-2137	216	44	migration	migration	NOUN
iajs-2137	216	45	and	and	CCONJ
iajs-2137	216	46	proliferation	proliferation	NOUN
iajs-2137	216	47	in	in	ADP
iajs-2137	216	48	vitro	vitro	NOUN
iajs-2137	216	49	,	,	PUNCT
iajs-2137	216	50	and	and	CCONJ
iajs-2137	216	51	reverses	reverse	VERB
iajs-2137	216	52	aldosterone+	aldosterone+	PRON
iajs-2137	216	53	salt	salt	NOUN
iajs-2137	216	54	-	-	PUNCT
iajs-2137	216	55	induced	induce	VERB
iajs-2137	216	56	cardiac	cardiac	ADJ
iajs-2137	216	57	fibrosis	fibrosis	NOUN
iajs-2137	216	58	in	in	ADP
iajs-2137	216	59	vivo	vivo	NOUN
iajs-2137	216	60	.	.	PUNCT
iajs-2137	217	1	journal	journal	NOUN
iajs-2137	217	2	of	of	ADP
iajs-2137	217	3	molecular	molecular	ADJ
iajs-2137	217	4	and	and	CCONJ
iajs-2137	217	5	cellular	cellular	ADJ
iajs-2137	217	6	cardiology	cardiology	NOUN
iajs-2137	217	7	.	.	PUNCT
iajs-2137	218	1	2016	2016	NUM
iajs-2137	218	2	,	,	PUNCT
iajs-2137	218	3	98	98	NUM
iajs-2137	218	4	,	,	PUNCT
iajs-2137	218	5	95	95	NUM
iajs-2137	218	6	-	-	SYM
iajs-2137	218	7	102	102	NUM
iajs-2137	218	8	.	.	PUNCT
iajs-2137	219	1	31	31	NUM
iajs-2137	219	2	.	.	PUNCT
iajs-2137	219	3	musso	musso	PROPN
iajs-2137	219	4	,	,	PUNCT
iajs-2137	219	5	c.g	c.g	PROPN
iajs-2137	219	6	.	.	PROPN
iajs-2137	219	7	potassium	potassium	NOUN
iajs-2137	219	8	metabolism	metabolism	NOUN
iajs-2137	219	9	in	in	ADP
iajs-2137	219	10	patients	patient	NOUN
iajs-2137	219	11	with	with	ADP
iajs-2137	219	12	chronic	chronic	ADJ
iajs-2137	219	13	kidney	kidney	NOUN
iajs-2137	219	14	disease	disease	NOUN
iajs-2137	219	15	(	(	PUNCT
iajs-2137	219	16	ckd	ckd	PROPN
iajs-2137	219	17	)	)	PUNCT
iajs-2137	219	18	,	,	PUNCT
iajs-2137	219	19	part	part	NOUN
iajs-2137	220	1	i	i	PRON
iajs-2137	220	2	:	:	PUNCT
iajs-2137	220	3	patients	patient	NOUN
iajs-2137	220	4	not	not	PART
iajs-2137	220	5	on	on	ADP
iajs-2137	220	6	dialysis	dialysis	NOUN
iajs-2137	220	7	(	(	PUNCT
iajs-2137	220	8	stages	stage	NOUN
iajs-2137	220	9	3	3	NUM
iajs-2137	220	10	-	-	SYM
iajs-2137	220	11	4	4	NUM
iajs-2137	220	12	)	)	PUNCT
iajs-2137	220	13	.	.	PUNCT
iajs-2137	221	1	international	international	ADJ
iajs-2137	221	2	urology	urology	NOUN
iajs-2137	221	3	and	and	CCONJ
iajs-2137	221	4	nephrology	nephrology	NOUN
iajs-2137	221	5	.	.	PUNCT
iajs-2137	222	1	2004	2004	NUM
iajs-2137	222	2	,	,	PUNCT
iajs-2137	222	3	36	36	NUM
iajs-2137	222	4	,	,	PUNCT
iajs-2137	222	5	465	465	NUM
iajs-2137	222	6	-468	-468	PROPN
iajs-2137	222	7	.	.	PUNCT
iajs-2137	223	1	32	32	NUM
iajs-2137	223	2	.	.	PUNCT
iajs-2137	224	1	song	song	PROPN
iajs-2137	224	2	,	,	PUNCT
iajs-2137	224	3	d.k	d.k	PROPN
iajs-2137	224	4	.	.	PROPN
iajs-2137	224	5	;	;	PUNCT
iajs-2137	224	6	ashcroft	ashcroft	PROPN
iajs-2137	224	7	,	,	PUNCT
iajs-2137	224	8	f.m	f.m	PROPN
iajs-2137	224	9	.	.	PROPN
iajs-2137	224	10	glimepiride	glimepiride	NOUN
iajs-2137	224	11	block	block	NOUN
iajs-2137	224	12	of	of	ADP
iajs-2137	224	13	cloned	cloned	ADJ
iajs-2137	224	14	β	β	NOUN
iajs-2137	224	15	-	-	NOUN
iajs-2137	224	16	cell	cell	NOUN
iajs-2137	224	17	,	,	PUNCT
iajs-2137	224	18	cardiac	cardiac	ADJ
iajs-2137	224	19	and	and	CCONJ
iajs-2137	224	20	smooth	smooth	ADJ
iajs-2137	224	21	muscle	muscle	NOUN
iajs-2137	224	22	k	k	PROPN
iajs-2137	224	23	atp	atp	PROPN
iajs-2137	224	24	channels	channel	NOUN
iajs-2137	224	25	.	.	PUNCT
iajs-2137	225	1	british	british	ADJ
iajs-2137	225	2	journal	journal	PROPN
iajs-2137	225	3	of	of	ADP
iajs-2137	225	4	pharmacology	pharmacology	NOUN
iajs-2137	225	5	.	.	PUNCT
iajs-2137	226	1	2001	2001	NUM
iajs-2137	226	2	,	,	PUNCT
iajs-2137	226	3	133	133	NUM
iajs-2137	226	4	,	,	PUNCT
iajs-2137	226	5	193	193	NUM
iajs-2137	226	6	-	-	SYM
iajs-2137	226	7	199	199	NUM
iajs-2137	226	8	.	.	PUNCT
iajs-2137	227	1	33	33	NUM
iajs-2137	227	2	.	.	PUNCT
iajs-2137	228	1	david	david	PROPN
iajs-2137	228	2	,	,	PUNCT
iajs-2137	228	3	l.	l.	PROPN
iajs-2137	228	4	n.	n.	PROPN
iajs-2137	228	5	;	;	PUNCT
iajs-2137	228	6	michael	michael	PROPN
iajs-2137	228	7	,	,	PUNCT
iajs-2137	228	8	m.	m.	NOUN
iajs-2137	228	9	c.	c.	PROPN
iajs-2137	228	10	lehninger	lehninger	PROPN
iajs-2137	228	11	.	.	PUNCT
iajs-2137	229	1	principles	principle	NOUN
iajs-2137	229	2	of	of	ADP
iajs-2137	229	3	biochemistry	biochemistry	NOUN
iajs-2137	229	4	.	.	PUNCT
iajs-2137	230	1	4	4	NUM
iajs-2137	230	2	th	th	NUM
iajs-2137	230	3	edition	edition	NOUN
iajs-2137	230	4	,	,	PUNCT
iajs-2137	230	5	2004	2004	NUM
iajs-2137	230	6	.	.	PUNCT
iajs-2137	230	7	https://www.uptodate.com/contents/definition-and-staging-of-chronic-kidney-disease-in-adults/abstract/39	https://www.uptodate.com/contents/definition-and-staging-of-chronic-kidney-disease-in-adults/abstract/39	PROPN
iajs-2137	230	8	https://www.uptodate.com/contents/definition-and-staging-of-chronic-kidney-disease-in-adults/abstract/39	https://www.uptodate.com/contents/definition-and-staging-of-chronic-kidney-disease-in-adults/abstract/39	PROPN
iajs-2137	230	9	https://www.uptodate.com/contents/definition-and-staging-of-chronic-kidney-disease-in-adults/abstract/39	https://www.uptodate.com/contents/definition-and-staging-of-chronic-kidney-disease-in-adults/abstract/39	NOUN
iajs-2137	230	10	https://www.uptodate.com/contents/definition-and-staging-of-chronic-kidney-disease-in-adults/abstract/39	https://www.uptodate.com/contents/definition-and-staging-of-chronic-kidney-disease-in-adults/abstract/39	NOUN